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Abstract
In mitosis, ‘surveillance control mechanisms’ regulate transitions across
the several stages of cell division. The so called ‘Mitotic-Spindle-
Assembly-Checkpoint (MSAC)’ and ‘Exit-From-Mitosis (EFM)’ are
examples of such mechanisms. MSAC ensures the correct segregation
of chromosomes by preventing cell-cycle progression until all chromo-
somes have made proper bipolar attachments to the mitotic spindle
through their kinetochores. EFM ensures that each of the two daughter
nuclei receives one copy of each chromosome. Both mechanisms are
seemingly regulated by the so called ‘Anaphase-Promoting-Complex
(APC)’, bound, in turn, to either ‘Cdc20’ or ‘Cdh1’, which are asso-
ciated regulatory proteins. APC remains inactive during metaphase.
In the transition from metaphase to anaphase, and only after all
chromosomes are attached, a newly formed ‘APC:Cdc20’ complex
mediates the ubiquitination and degradation of the protein ‘Securin’;
this leads, in turn, to the activation of the protein ‘Separase’, the
dissolution of the so called ‘Cohesin Complex’, and, eventually, to
chromatid separation. ‘APC:Cdc20’ also mediates the initial phase of
‘Cyclin B’ proteolysis. In the transition from anaphase to telophase,
APC:Cdh1 completely ubiquitinates ‘Cyclin B’, thus inactivating a pro-
tein called ‘CyclinB:Cdk1-Mitotic-Kinase’ and triggering the exit from
mitosis. Both MSAC and EFM prevent chromosome miss-segregation
and aneuploidy, and their failure eventually leads to cell death; both
mechanisms have been implicated in cancer. Our understanding of
mitotic regulatory mechanisms has significantly improved in recent
years. Yet, MSAC and EFM remain poorly understood. Hence, we
benefited from in-silico modeling and simulation approaches embed-
ded in a cross-disciplinary framework, typically referred to as Systems
Biology, in order to contribute to a deeper understanding of these
mitotic regulatory mechanisms. We first focused on the question how
‘Cdc20’ availability is controlled prior to the attachments of all chro-
mosomes; or, in other words, how ‘APC:Cdc20’ formation is eventually
prevented. It had been proposed that Cdc20 remains fully sequestered
until the last chromosome is attached. By using a Systems Biology
approach to this question, we built-up and tested predictions from
a series of dynamic models fed with empirical data (Ibrahim et al.,
2008b,c). According to our results, cells are unable to completely
sequester Cdc20 until the last chromosome is attached. Next, we
asked whether a complex called ‘MCC’ might be able to fully prevent
‘APC:Cdc20’ formation by binding APC, thereby sequestering it fully,
prior to the attachment of all chromosomes. To tackle this question,
we built-up a combined in-silico model fed with empirical data on
APC levels prior to chromosome attachment (Ibrahim et al., 2008a).
Our results then showed that MCC can fully sequester APC prior to
chromosome attachment. This would eventually prevent ‘APC:Cdc20’
activity. From the later results, one still needs to ask how a complex
like ‘MCC:APC’ would fall apart after chromosome attachment. In
order to address this question, we constructed two equally suitable
model variants, called the “Dissociation” and “Convey” models, and
validated them by means of mutation experiments (Ibrahim et al.,
2008a). Moreover, we also developed and tested the robustness of a
qualitative model of MSAC (Ibrahim et al., 2007). Finally, we incorpo-
rated an adapted ‘EFM-model’ involving ‘APC:Cdh1’ activity into an
integrative model involving APC:Ccd20 activity, thereby addressing
simultaneously the functioning of both transition control mechanisms,
MSAC and EFM.
Deutsche Zusammenfassung
Die U¨berga¨nge zwischen den einzelnen Phasen der Mitose werden
durch ‘surveillance control mechanisms’ reguliert. Zwei Beispiele hi-
erfu¨r sind der ‘Mitotic-Spindle-Assembly-Checkpoint (MSAC)’ und
der ‘Exit-From-Mitosis (EFM)’. MSAC sichert die korrekte Teilung
der Chromosomen, indem der Fortschritt des Zellzyklus angehalten
wird, bis alle Chromosomen durch ihre Kinetochore fest mit dem mito-
tischen Spindelapparat verbunden sind. EFM stellt sicher, dass jeder
der beiden Zellkerne nach der Teilung u¨ber genau eine Kopie eines
jeden Chromosomes verfu¨gt.
Beide Mechanismen werden anscheinend durch den ‘Anaphase-
Promoting-Complex (APC)’ reguliert, welcher wiederum an die
regulativen Proteine ‘Cdc20’ und ‘Cdh1’ gebunden ist. APC bleibt
inaktiv wa¨hrend der Metaphase. Beim U¨bergang von der Metaphase
zur Anaphase, nachdem alle Chromosomen an den Spindelapparat
gekoppelt sind, katalysiert der neu geformte ‘APC:Cdc20’ Komplex
die Ubiquitination und Degradierung des Proteins ‘Securin’; dies
wiederum fu¨hrt zur Aktivierung des Proteins ‘Separase’, zur Auflo¨sung
des ‘Cohesin Komplexes’ und zur Trennung der Chromatide.
‘APC:Cdc20’ katalysiert auch die Fru¨hphase der Proteolyse des ‘Cy-
clin B’. Beim U¨bergang von Anaphase zu Telophase wird ‘Cyclin B’
komplett durch APC:Cdh1 ubiquitiniert, was zur Inaktivierung des Pro-
teins ‘CyclinB:Cdk1-Mitotic-Kinase’ und schließlich zum Austritt aus
der Mitose fu¨hrt. Sowohl MSAC als auch EFM verhindern fehlerhafte
Chromosomenteilung und Aneuploidie, ihr Versagen fu¨hrt zum Zelltod.
Beide Mechanismen sind mit der Entstehung von Krebserkrankungen
in Verbindung gebracht worden.
In den letzten Jahren hat sich unser Versta¨ndnis der regulativen Mech-
anismen in der Mitose drastisch verbessert, aber MSAC und EFM sind
weiterhin schlecht verstanden. In silico Modellierungs- und Simulation-
sansa¨tze - eingebettet in die interdisziplina¨re Systembiologie - ko¨nnen
uns helfen, ein tieferes Versta¨ndnis dieser regulativen Mechanismen zu
erreichen.
Wir haben uns zuerst auf die Frage konzentriert, wie die Verfu¨gbarkeit
von ‘Cdc20’ vor dem Andocken der Chromosomen kontrolliert wird,
oder in anderen Worten, wie die Bildung von ‘APC:Cdc20’ verhin-
dert wird. Ein bestehender Vorschlag besagt, dass Cdc20 vollsta¨ndig
festgehalten wird bis das letzte Chromosom angedockt ist. In einem
systembiologischen Zugang zu dieser Fragestellung haben wir eine
Reihe von dynamischen Modellen erstellt, basierend auf empirischen
Daten (Ibrahim et al., 2008b,c), um Vorhersagen zu erstellen und zu
testen. Unsere Ergebnisse implizieren, dass Zellen Cdc20 nicht kom-
plett bis zum Andocken des letzten Chromosomes festhalten ko¨nnen.
Als na¨chstes fragten wir, ob der sogenannte ‘MCC’ Komplex in der
Lage sein ko¨nnte, die Bildung von ‘APC:Cdc20’ vor dem Andocken
aller Chromosome vollsta¨ndig zu verhindern, indem er APC bindet und
festha¨lt. Um diese Frage zu attackieren, haben wir ein kombiniertes
in silico Model erstellt und mit empirischen Daten u¨ber APC Levels
vor dem Andocken der Chromosomen gefu¨ttert (Ibrahim et al., 2008a).
Unsere Ergebnisse zeigen, dass MCC APC vollsta¨nding festhalten
kann, was die Aktivita¨t von ‘APC:Cdc20’ verhindern wu¨rde.
Aufbauend auf diesem Resultat stellt sich nun die Frage, wie der
‘MCC:APC’ Komplex nach dem Andocken der Chromosome auseinan-
derfa¨llt. Um diese Frage zu addressieren, haben wir zwei Modellvari-
anten erstellt - die sogenannten “Dissociation” und “Convey” Modelle
- und diese mit Hilfe von Mutationsexperimenten validiert (Ibrahim
et al., 2008a). Daru¨ber hinaus haben wir ein qualitatives Modell von
MSAC erstellt und dessen Robustheit untersucht (Ibrahim et al., 2007).
Zum Abschluss haben wir ein ‘EFM’ Modell, welches ‘APC:Cdh1’
Aktivita¨t mitbeachtet, in ein integratives Modell inklusive APC:Cdc20
eingefu¨gt. Das entstandene Modell entha¨lt nun gleichzeitig die Funk-
tion von MSAC und EFM, der beiden Mechanismen der Transition-
skontrolle.
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Chapter 1
Orientation, Motivation and Aim of
the study
“Mathematics, rightly viewed, possesses not only truth, but
supreme beauty - a beauty cold and austere, like that of
sculpture”. Bertrand Russell (1872 - 1970)
“Biologists must constantly keep in mind that what they see
was not designed, but rather evolved”.
Francis Crick, What Mad Pursuit, 1990, p.138.
Contents
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1
1. ORIENTATION, MOTIVATION AND AIM OF THE STUDY
1.1 Why to use a Systems Biology Approach to Mi-
tosis Transition Controls?
The renowned theoretical and applied mathematician Norbert Wiener stated
that living organisms can be thought of as systems governed by feedback and
regulatory mechanisms, which are, in turn, plausible of being understood (Wiener,
1948). The study of both complexity (Holland, 1995) and control theory (von
Bertalanffy, 1968) now receives increasing attention by scientists following the so
called “Systems Biology” approach to research. Some refer to Systems Biology
as an emergent field that “studies cells as spatiotemporal networks of interacting
molecules using an integrative approach of theory (mathematics, physics, en-
gineering), experimental biology (genetics, molecular biology, physiology), and
quantitative network-wide analytical measurement (analytical biochemistry, imag-
ing) (Bruggeman, 2007).” Systems Biology therefore deals with modeling and
simulation, and involves concepts from mathematics, computer science, physics,
biochemistry, and engineering.
Living systems are undoubtedly complex. They exhibit organizational principles,
chemical uniqueness, variability, genetic programs, and historical nature, properties
embedded in the concepts of pleiotropy and polygeny (Mayr, 1982). It follows
that only systems, or subsystems, that show their own dynamics, but not their
isolated, constitutive elements, can be thought of as the subject matter of functional
biology (Nu´nˇez and Marco, 2007). We need to examine the structure and dynamics
of biological functions, rather than the characteristics of the isolated parts of a cell
or organism. In the context of cell biology, this may have a major impact on the
future of biological and medical research (Kitano, 2002b,a). There is a need which
drives Systems Biology. It relies on an increasing knowledge on a cell’s constitutive
elements, accompanied by a simultaneous lack of comparable knowledge on the
ensuing interactions and organizing principles that govern them. Computer science
already proved fruitful in biology, and it now appears as increasingly difficult to
study complex cellular functions without the help of computational, modeling
approaches.
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Controls?
Mitosis can be thought of as a finely regulated and exceedingly complex process.
During the process of cell division, a cell’s chromosomes are eventually distributed
between two daughter nuclei. Molecular biologists typically characterize the
activity, aggregation and interactions of tens of cellular elements involved in mitosis,
although the relation between such interacting elements and their respective
environment remains still elusive. Predictions, therefore, are not straightforward.
There is a need for a system-level understating of the regulatory mechanisms
involved in mitosis. This might be of major relevance for medical research, as
well as for a better understating of other cellular processes. We shall refer to our
work as to “Systems Biology of Mitosis”. Our focus is on human cells, and we
benefit from modeling and simulation approaches embedded in a cross-disciplinary
framework, in order to contribute to a deeper understanding of mitotic regulatory
mechanisms. Below there is a list of items that may help in illustrating what we
can gain from a Systems Biology approach to mitosis.
Identifying a System’s Structure: Understanding the functioning of a bio-
chemical network demands identifying its underlying pathways. One can
obtain knowledge about the several elements involved in the mechanisms
controlling mitosis, as well as information on their -isolated- interactions. Yet,
one also needs to ask whether and how these elements and interactions are
topologically organized. This would eventually allow understanding a system’s
functional structure by means of accessible network models. Analyzing these
networks would lead, in turn, to the development of new, testable hypotheses.
(e.g., Appendix A, Section A.2)
Capturing a System’s Behavior: Modeling and simulation approaches allow
qualitative as well as quantitative analyzes of a system’s behaviour. They
permit to capture not only the dynamics of an evolving system, but also its
specific state at any given time on the basis of kinetic data. To this end, one
uses deterministic (ODEs), stochastic (particle simulation), or even mixed
(SDEs) modeling approaches. (See Chapters 3-7)
Evaluating a System’s Intrinsic Properties: A Systems Biology approach
to mitosis allows predictions based on stability and sensitivity analyzes. It
also allows capturing the effects of noise, bifurcations, and chaotic attractors.
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Chapter 6 helps in illustrating the relevance of these intrinsic properties in
the context of a qualitative model of anaphase initiation.
Capturing a System’s Signalling Pathways: The functioning of the transition
control mechanisms depends upon regulating signals; a Systems Biology
account of such signals would eventually lead to a deeper understanding of
the entire process of mitosis. (e.g., Chapter 5).
3D-Modeling: A Systems Biology approach to mitosis allows evaluating spe-
cific effects of a three-dimensional ‘environment’ on those interactions occurring
among the several elements of a network. The term ‘environment’ here refers
to variations arising from diffusion effects, the movements of microtubules,
changes in the cell volume, localization and binding specificities, etc. This is
important because the functioning of the several networks controlling mitosis
influences the cellular space, and vice versa; there is a cross-talk between a
given environment and the functional processes embedded in it (Figure 1.1).
To tackle the effects of such a phenomenon, one benefits from partial differ-
ential equations (PDEs), cellular automate, or even mixed approaches like
stochastic partial differential equations (SPDEs). By means of such tools, rich
dynamics and powerful predictions are within reach.
Mutual Benefits Across Disciplines: Systems Biology demands a fusion of
concepts from several disciplines, thereby integrating different computational
instruments into a general computational infrastructure. In the present context,
new concepts arise from well-established and tested results from mathematics,
computer science, molecular biology, and biochemistry. It is sometimes difficult
to handle data arising from such an inter-disciplinary approach. As a by-
product of the present work, a software tool, called “Mitosis Arena”, is being
developed to help in visualizing and interpreting the flood of data related
to mitosis transitions control mechanisms (Figure 1.1). Such a tool would
eventually be integrated and communicated via SBML (Systems Biology
Markup Language).
A cross-talk between theoretical and empirical accounts of mitosis: Bi-
ological research can sometimes be the subject of ontological reductionism;
4
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Systems Biology aims to counterbalance such a tendency. We suggest that a
Systems Biology approach to mitosis would prove fruitful in proposing testable
hypotheses, simply because it gives off useful predictions based on the count-
less interactions among the various cellular elements whose behaviors cannot
simultaneously be addressed in the laboratory. (See, for example, Chapter 5)
Mitosis Arena
Simulation of a three−dimensional
chromosome movement.
cellular space including
Mitosis Network Models
Simulation of network dynamics
Deterministic (ODEs), 
Stochastic (SDEs), or
Petri Net
Figure 1.1: Schematic diagram of the simulation environment. The new tool called
Mitosis Arena will allow to load a network model (SBML) describing the bio-
chemical reaction mechanism. The simulation includes the three-dimensional move-
ment of the chromosomes, which influences the bio-chemical dynamics through a
changing topology and which in turn is influenced by the state of the bio-chemical
network species. This tool is necessary, because understanding the network control-
ling mitosis requires also to consider a changing cellular space whose topological
change is influenced by the biochemical network, and vice versa where the spatial
structure influences the dynamics of the biochemical system.
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1.2 Background, Specific Problems, and Results
In the present context, our emphasize is on two different, still connected mi-
tosis transition control mechanisms, namely, the Mitotic Spindle Assembly
Checkpoint (MSAC) and Exit From Mitosis (EFM). MSAC ensures the correct
segregation of chromosomes by restraining cell-cycle progression from entering
anaphase until all chromosomes have made proper bipolar attachments to the
mitotic spindle. MSAC thus ensures the fidelity of chromosome segregation; its
failure leads to aneuploidy (Kim and Kao, 2005; Steuerwald, 2005), for example,
and might contribute to cancer (Compton, 2006; Gupta et al., 2003). In principle,
MSAC controls the activity of a complex of proteins called “Anaphase Promoting
Complex”, or APC, during the transition from metaphase to anaphase, when
chromosomes are not yet attached. MSAC becomes inactive once all chromosomes
are attached. At this time, APC interacts with its co-activator, a protein called
“Cell Division Cycle”, or Cdc20. The active, ensuing complex “APC:Cdc20” has
two functions. First, it activates a protein called “Separase”, involved in breaking-
up the so called “Cohesion ring”, which eventually leads to the separation of the
sister chromatids. Second, APC:Cdc20 is involved in the partial degradation of
“Cyclin B”, the mitotic cyclin. Mitosis then progresses, and becomes the subject
of the second transition control mechanism, the Exit From Mitosis mechanism.
Generally speaking, EFM ensures that each of the two daughter nuclei receives
one copy of each chromosome. Its main role is to guarantee a full degradation of
Cyclin B via the activity of the complex “APC:Cdh1”, formed by APC and its
second co-activator, a protein called Cdh1. After the full degradation of Cyclin B,
the process of cell division progresses into cytokinesis.
Both MSAC and EFM are complex mechanisms involving numerous interacting
elements. They are the subject of complex dynamics, in addition. Therefore
their functional and topological structures remain still poorly understood. At
present, no model provides a satisfactory account of how MSAC actually works.
In contrast, there are several models describing how EFM works, all them based
on data from yeast. These two mechanisms have not yet been integrated into a
6
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single model. Here we aim to contribute towards an integrative model explaining
both MSAC and EFM in human cells.
We first focused on the question how the availability of Cdc20 is controlled prior to
the attachments of all chromosomes. In other words, how APC:Cdc20 formation is
eventually prevented. It has been proposed that Cdc20 remains fully sequestered
until the last chromosome is attached. The first candidate thought to fully
sequester Cdc20 appeared to be a MSAC -protein called “Mad2”(e.g., Luo et al.,
2002; Sironi et al., 2001a). Two basic models, called “Exchange” (Luo et al., 2004)
and “Template” (DeAntoni et al., 2005a), have been developed on the basis of such
hypothesis. By using a Systems Biology approach to this question, we built-up a
series of dynamic models, fed them with empirical data, and tested predictions
from both the Template and the Exchange models. Our results indicate that
Mad2 is not sufficient to fully sequester Cdc20, and that only the Template model
appears to be partially consistent with our simulations (See Chapter 3). It has also
been proposed that a second protein, called “BubR1”, can sequester Cdc20 prior
to the attachment of all chromosomes (e.g., Bolanos-Garcia et al., 2005; Davenport
et al., 2006). BubR1 binds Cdc20 within two seemingly different contexts. In
the first context, it forms an isolated complex with Cdc20, whereas in the second
it is part of a larger complex of proteins (BubR1, Cdc20, Mad2, Bub3) called
“Mitotic Checkpoint Complex”, or MCC. We incorporated both contexts in two
different models, and found that Cdc20 can be fully sequestered by BubR1 neither
in the first nor in the second context. Moreover, it has been postulated that MCC
formation can be either Kinetochore-independent (KIM) or Kinetochore-dependent
(KDM) ( Musacchio and Salmon, 2007; for details, see Chapter 4). We found that
only the Kinetochore-dependent model can -partially- account for the availability
of Cdc20 both before and after the attachment of all chromosomes. Next, we asked
whether MCC might be able to fully prevent APC:Cdc20 formation by binding
APC, thereby sequestering it fully, prior to the attachment of all chromosomes. To
tackle this question, we built-up an in-silico model that combines the Template
model, the MCC-Kinetochore-dependent formation model, and empirical data
on APC levels prior to chromosome attachment. Our results show that MCC
can fully sequester APC prior to chromosome attachment, thereby preventing
7
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APC:Cdc20 activity. If this was the case in nature, one would also need to ask
how such a complex as the MCC:APC complex would fall apart after chromosome
attachment. Hence, we built-up two equally suitable model variants addressing
this issue, called “Dissociation” and the “Convey” models, and validated them by
means of mutation experiments (see Chapter 5). Moreover, we also developed a
qualitative model of MSAC , and tested its robustness (see Chapter 6). Finally,
we incorporated an adapted EFM model that involves the activity of APC:Cdh1
into an integrative model that also involves the activity of APC:Ccd20. Hence, we
addressed simultaneously the functioning of both transition control mechanisms,
MSAC and EFM. This integrative model is presented in Chapter 7.
Important questions still remain open. For example, how the checkpoint remains
active until all kinetochores are attached? Answering this kind of questions,
however, demands understanding how the mitosis transition control mechanisms
work in three dimensions. For such an understanding to be achieved, new tools
are needed. Therefore, we are currently developing a software tool called “Mitosis
Arena”, in order to test network models of mitosis within a 3-D framework.
“Mitosis Arena” will be available to the scientific community, so that alternative
models could easily be studied within a dynamical 3-D environment (Figure 1.1).
It has been designed in accordance with standard languages (i.e., SBML), and
would eventually be combined with other Systems Biology software tools.
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Chapter 2
Mitosis Transition Controls
“It is the weight, not numbers of experiments that is
to be regarded”. Isaac Newton (1642-1727)
“Biology will tell you a lot of things, but there are
many that it can not explain and you need to look at
physics instead”. Walter Gilbert(1932-)
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2.1 Cell Division
Cell1 division is accomplished by means of two different processes in eukaryotes:
mitosis2 and meiosis3. During mitosis, a somatic cell (and also eukaryotic unicel-
lular organisms) divides to produce two genetically identical cells. In contrast,
during meiosis, a sex cell undergoes two stages of cell division resulting in four
haploid cells (gametes) each of which has only a single complement of chromosomes.
In this thesis we will focus on transition control mechanisms of mitosis.
In an elaborate series of events known as “cell cycle”, chromosomes4,5 are replicated
and then, together with other components, distributed into the two daughter cells.
The cell cycle is composed of five distinct phases: G1 (Gap 1), S (Synthesis)-phase,
G2 (Gap 2) (which are collectively called interphase), Mitosis and Cytokinesis
(which are collectively called M-phase) (see Figure 2.1). During interphase, the
rate of biosynthetic activity is high. During G1 various proteins are synthesised
that are required in S-phase, for example those needed for DNA replication. G1’s
duration is highly variable; in humans it can take between 6-12 h. Most cells in
G1 become committed to either continued division or exit from the cell cycle. A
cell may pause for an extended period in G1 or may even enter in a non-dividing
state called G0. In S-phase the DNA is replicated so that at the end of this
phase the genome is duplicated from 2n to 4n. In human’s cells, the S-phase lasts
6-8 h. The cell then enters into G2. Now proteins are synthesised which are for
example involved in the production of microtubules required during mitosis. In
humans G2 lasts 3-4h. Finally, after G2, the cell enters into M-phase, during
which chromosomes are segregated into the two daughter cells. This process last
1Robert Hooke (1635 1703), an English polymath, was the first person to coined the
term “cell” to describe the basic unit of life, after viewing slices of cork through a microscope in
about 1663.
2Mitosis has been first identified by the anatomist Walther Flemming (1882).
3Meiosis has been first identified by the German embryologist Oscar Hertwig (1875).
4Chromosomes are organized structures of DNA and proteins. A chromosome contains
a single continuous piece of DNA, which contains many genes, regulatory elements and other
nucleotide sequences. Chromosomes also contain DNA-bound proteins, which serve to package
the DNA and control its functions.
5Karl Wilhelm von Ngeli (1817 1891), a Swiss botanist, he discovered what would later
become known as chromosomes.
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Figure 2.1: Cell cycle phases in eukaryotic cells. Interphase consisting of G1, S,
and G2 -phases, is followed by M-phase, consists of mitosis (or could be meiosis)
and cytokinesis. G0 refers to a pause period or an extended periods in G1 or
even inter nondividing state. The time course is an example for the human cell
cycle. G1, occurs before S-phase, whereas G2 occurs before M-phase. The DNA
is 2n in both G0 and G1, and 4n in both G2 and M -phases. n is the number of
DNA strands The figure also depict cell cycle checkpoints. In interphase, G1/S
is the first checkpoint, followed by G2/M. In M-phase, the mitosis checkpoint “
metaphase-to-anaphase transition checkpoint”.
approximately 1 h in human cells. Chromosome segregation of newly replicated
sister chromatids1 into daughter cells is a critical and central event. It ensures
that both of the newly divided cells receive a full complement of chromosomes. If
this event is not properly completed, the newly divided cells will probably lack
essential genes resulting in cellular malfunction.
From a technical point of view, cells behave like an oscillator. In mitosis, two new
daughter cells are created from the mother cell. In G1, these daughter cells grow
until they reach a mass which allows them to enter a new round of duplication.
This new round begins with entry into the S-phase. Once genome duplication is
1Sister chromatids are identical copies of a chromosome. In other words, sister chromatids
contain the same genes
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completed, the cell prepares for division in G2. In mitosis, when a checkpoint has
checked the correct state of the cell, the cell finally dives and creates new daughter
cells. During this oscillation, the cell runs through kinetically very different states:
static or semi-static, dynamic, intermediate and steady-states. When modeling
the mitotic transition control, all input and output signals across these cell cycle
phases must be incorporated as precisely as possible (see Appendix A). In doing
this, the work can benefit from a deterministic and stochastic modeling base for
biochemical reaction networks.
This work focuses on the mechanisms controlling human mitosis. The goal is to
understand how chromosomes segregation is controlled by the mitotic checkpoint.
Since the proteins carrying out these mechanisms were already identified in
experimental laboratories, this work intends to tackle how these proteins interact
with each other and which are the rules for their combined function. Ultimately,
we intend to simulate empirical knowledge and formulate straight forward, useful
predictions to be experimentally tested in the future. The goal is to determine
the essential features of mitotic control of the meta- to anaphase transition.
2.2 Mitosis
The German anatomist Walther Flemming1(1882), a pioneer of mitosis research,
was one of the first scientists to give a detailed description of the numerous events
during cell division in animals and named the division of somatic cells “mitosis”.
He originally minted the term “mitosis” from the Greek word for thread, reflecting
the shape of mitotic chromosomes. Mitosis is the most dramatic period of the cell
cycle, involving a major reorganization of virtually all cell components. Although
many of the details of mitosis vary among different organisms, the fundamental
processes that ensure the faithful segregation of sister chromatids are conserved
in all eukaryotes. These basic events of mitosis include chromosome condensation,
1Walther Flemming: (1843-1905) a founder of the science of cytogenetics (the study of
the cell’s hereditary material, the chromosomes). He was the first to observe and describe
systematically the behaviour of chromosomes in the cell nucleus during normal cell division
(mitosis).
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formation of the mitotic spindle, and attachment of chromosomes to the spindle
microtubules1. Sister chromatids then separate from each other and move to
opposite poles of the spindle, followed by the formation of daughter nuclei (see
Figure 2.3).
Mitosis is simply described as having four stages: prophase, metaphase, anaphase,2
and telophase3; these stages follow one to another as a continuous process without
interruption. The entire four-stage division process in human cells lasts about one
hour in average.
Prophase During prophase the chromosomes become condensed and key proteins
bind the kinetochores4 preparing for spindle5 attachment. Centrioles6 begin
moving to opposite ends of the cell and fibers extend from the centrosomes. The
nuclear membrane dissolves. Proteins link the multi-protein kinetochore complex
at the centromeres with the microtubules and the chromosomes move to the
equatorial plate. Sometimes, this stage is classified in two sub-stages, Prophase
and late Prophase or Prometaphase (see Figure 2.3).
1Microtubule: Eukaryotic cells rely on self assembling array of microtubules (MTs) known
as the spindle to effect chromosome segregation. MTs emanate from microtubule organizing
centers (MTOCs) and form attachments with the cell cortex and with anti-parallel MTs from
the opposite pole. Moreover, MTs attach to the chromosomes by binding to the kinetochore. A
microtubule is a polymer of globular tubulin subunits, which are arranged in a cylindrical tube
measuring about 25 nm in diameter (see Figure 2.2)
2Prophase, metaphase and anaphase were first coined by Eduard Strasburger in 1884.
3Telophase was first introduced by Martin Heidenhain in 1894
4The kinetochore is a large A multiprotein structure, positioned at the central constriction
of each chromosome, contains two regions: an inner kinetochore, which is tightly associated
with the centromere DNA; and an outer kinetochore, which interacts with microtubules (see
Figures 2.2 and 2.8). Kinetochores consist of more than 45 different proteins. Many of these
proteins are conserved throughout eukaryote species (see Figure 2.8).
The centromere is a single site on the chromosome that is responsible for assembling the kineto-
chore, which mediates chromosome attachment to the microtubule spindle and all chromosome
movements.
5Spindle is a network of protein fibers that forms in the cytoplasm of a cell during cell
division. The spindle grows forth from the centrosomes and attaches to the chromosomes after
the latter have been replicated, and the nuclear membrane dissolves. Once attached, the spindle
fibers contract, pulling the replicate chromosomes apart to opposite poles of the dividing cell. It
often referred to as the mitotic spindle during mitosis and the meiotic spindle during meiosis.
6Centrioles are cylindrical structures, found in eukaryotic, that are composed of groupings
of microtubules arranged in pattern. They help to organize the assembly of microtubules during
cell division.
15
2. MITOSIS TRANSITION CONTROLS
Figure 2.2: Organization of the kinetochore. A complex structure that specifies
the attachments between the chromosomes and microtubules of the spindle and
is thus essential for accurate chromosome segregation. The left hand side refers
to the sister chromatids. The right hand side refers to the kinetochore structure.
The eukaryotic kinetochore consists of an inner, gap, and outer regions. The blue
stained material are the microtubules that form the mitotic spindle. The Navajo
White color refers to the centromere
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Figure 2.3: Depiction of the distinct stages of mitosis. Interphase is divided
into G1-, S- and G2-phase, followed by M-phase, which is divided into mitosis
and cytokinesis. Mitosis is simply described as having four stages: prophase,
metaphase, anaphase, and telophase; the stages follow one another as a continuous
process without interruption or pause.
Metaphase In this stage, chromosomes are attached to microtubule spindles via
their kinetochores followed by alignment on the metaphase plate half way between
the two spindle poles. This state is controlled by the mitotic checkpoint. Once all
the chromosomes are aligned, mitosis can progress into the next stage.
Anaphase The paired chromosomes separate at the kinetochores and move to
opposite sides of the cell. Motion results from a combination of kinetochore
movement along the spindle microtubules and through the physical interaction of
polar microtubules.
Telophase After successful segregation of the chromosomes, chromatids arrive
at opposite poles of the cell and new membranes are formed around the daughter
nuclei. The chromosomes disperse and are no longer visible under the light
microscope. The spindle fibers disperse and partitioning of the cell begins.
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Cytokinesis It is the final phase, the cell cytoplasm of the mother cell is physically
divided in two daughter cells. Cytokinesis was one of the first cell cycle events
observed by cell biological techniques (see Figure 2.3).
Two essential transition control mechanisms, namely, ‘initiation of anaphase” and
“exit from mitosis”, govern mitosis. In the following sections, these mechanisms
are described.
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2.3 Checkpoints in Cell Cycle Regulation
Checkpoints are surveillance control mechanisms that monitor the progression of
the cell cycle, so that in the case of malfunction the cell cycle can be arrested
at a given stage by specific signals. The central components of the cell cycle
control system are a family of enzymes called cyclin-dependent kinases (Cdks).
Like others protein kinases, Cdks catalyze the covalent attachment of phosphate
groups derived from ATP to protein substrates. This phosphorylation results
in changes in the substrate’s enzymatic activity or its interaction with other
element species. A cyclin-dependent kinase is activated by association with a
cyclin forming a cyclin-dependent kinase complex. Different types of cyclins are
produced at different cell cycle phases. Cyclins and CDKs determine a cell’s
progress through the cell cycle (see Table 2.1). Malfunctions of any control during
cell division might lead to serous diseases (see section 2.4.2). In order to avoid
any failure, the cell verifies that proper conditions are satisfied at crucial steps in
the division process. In general, cell cycle progression is governed by three major
checkpoints (Figure 2.1).
 The first checkpoint control occurs in G1-phase, and is called the G1/S
checkpoint. It checks the cell size, nutritional, status DNA/cellular damage
mating status and growth factor availability. In case of damage during G1, it
will delay the onset of S-phase and DNA replication.
 The second checkpoint control occurs in G2-phase, and is called the G2/M
checkpoint. It monitors the completion of DNA replication and assures
accurate transmission of genetic material and the completion of mitosis.
 The third checkpoint is the metaphase-to-anaphase transition control (mitotic,
or chromosome segregation, or division control) named the Mitotic Spindle
Assembly Checkpoint (MSAC)(in order to differentiate it from the Meiosis
checkpoint). The MSAC functions to ensure faithful chromosome segregation
by delaying cell division until all chromosomes are correctly oriented on the
mitotic spindle. It is an important element of mitosis transition control and
thus, is a main focus of this thesis.
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The Major Cyclins and Cdks
Homo sapiens Saccharomyces cerevisiae
Cyclin:Cdk Cyclin Cdk partner Cyclin Cdk partner
complex
G1-Cdk Cyclin D∗ Cdk4, Cdk6 Cln3 Cdk1∗∗
G1/S-Cdk Cyclin E Cdk2 Cln1, 2 Cdk1
S-Cdk Cyclin A Cdk2 Clb5, 6 Cdk1
M-Cdk Cyclin B Cdk1∗∗ Clb1, 2, 3,4 Cdk1
Table 2.1: The major cyclins and Cdks for progression through the cell cycle in
Homo sapiens and Budding Yeast. ∗There are three D cyclins in mammals (cyclins
D1, D2, and D3), ∗∗The original name of Cdk1 was Cdc2 in both Homo sapiens
and fission yeast, and Cdc28 in budding yeast. For S. pombe, the major cyclins
are; Puc1, Cig2, Cdc13, and Puc1 for G1/S, S, M, and G1 -phases respectively.
This table has been taken and modified from (Alberts et al., 2002). The bold line
denotes mitosis cyclin, which is of our interest.
The following focusses on the human MSAC mechanism.
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2.4 Anaphase Initiation Control
2.4.1 The Mitotic Spindle Assembly Checkpoint (MSAC)
Chromosomes segregation of newly replicated sister chromatids into daughter
cells during anaphase is a critical event of mitosis. MSAC ensures the correct
segregation of chromosomes by restraining cell cycle progression from entering
anaphase until all chromosomes have made proper bipolar attachments to the
mitotic spindle and are aligned at the metaphase plate (for review see Musac-
chio and Salmon, 2007). Incorrect chromosome segregation may lead to cell
death (Weaver and Cleveland, 2005; Heald, 2006) and aging (Baker et al., 2004),
may also generate aneuploidy (Kim and Kao, 2005; Steuerwald, 2005; Mondal
and Roychoudhury, 2003). Since deviation from euploidy is seen in 70-80% of
all types of human cancers, errors in DNA segregation might facilitate tumori-
genesis (Iwanaga et al., 2002; Kops et al., 2005b; Michel et al., 2004; Sotillo
et al., 2007) and possibly contribute to cancer (Compton, 2006; Gupta et al.,
2003; Mondal et al., 2007a) Thus, the MSAC mechanism guards the fidelity of
chromosome segregation. Figure 2.4 illustrates how the MSAC mechanism seems
to works. In early metaphase, those chromosomes not attached to the spindle,
generate a signal that inhibits the transition from metaphase to anaphase. Once
all kinetochores achieve bipolar attachment to the spindle’s microtubules (in
late metaphase) the MSAC is switched off and anaphase ensues. The Anaphase
Promoting Complex (APC) is the target of the MSAC. It becomes active only
after the attachment of the last kinetochore. Cdc20 is the co-activator of APC at
the metaphase to anaphase transition. APC:Cdc20 mediated ubiquitination leads
to activation of the separase, which cleaves the cohesins that maintain the linkage
between sister chromatids (Peters, 2002), leading to sister chromatid separation
and anaphase onset. Ubiquitination and degradation of cyclin B inactivates Cdk1,
thereby permitting exit from mitosis (Nasmyth, 1993; Taylor, 1999).
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Figure 2.4: The MSAC , is the major cell cycle control mechanism in mitosis.
It delays the transition from metaphase to anaphase until all chromosomes are
correctly aligned at the metaphase spindle equator. In early metaphase, the chro-
mosomes are not attached to the spindle of microtubules, while in late metaphase
most chromosomes are attached. Once all kinetochores are attached, anaphase
initiation is rapid. The subscript n denotes the number of chromosomes (e.g.
n = 46 for human)
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2.4.2 Experimental Studies on the MSAC
MSAC is a complex mechanism the elucidation of which is of high importance for
cell biology and medical research. The following section summarizes recent progress
toward the understanding of the functions of the MSAC , as well as the mechanisms
by which it activates the APC/C, and its regulation by phosphorylation and by
association with its binding proteins.
Core Components of the MSAC
The core proteins involved in MSAC (Minshull et al., 1994) include MAD (“Mitotic
Arrest Deficient”; Mad1, Mad2, and Mad3 (in humans: BubR1)) (Li and Mur-
ray, 1991) and BUB (“Budding Uninhibited by Benzimidazole”; Bub1, and
Bub3) (Hoyt et al., 1991), all of which are conserved among eukaryotes. A detailed
list of the characteristics and proposed functions of the MSAC core proteins in
different organisms is shown in Table 2.2.
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Cdc20
The molecular understanding of the cell cycle began when Lee Hartwell and
coworkers isolated Cell Division Cycle 20 homolog (Cdc20) mutants of S. cerevisiae
that, despite continued cell growth, failed to execute or complete key cell-cycle
events, such as DNA replication or mitosis (Hartwell et al., 1970).
Among the original Hartwell mutant collection were the Cdc20 mutants that
arrest cell division in mitosis and fail to initiate anaphase and chromosome
segregation (Hartwell et al., 1973). Cdc20 is a highly conserved WD40-repeat
protein (Prinz et al., 1998; Pfleger and Kirschner, 2000a). Orthologs of Cdc20
were then discovered in various organisms (see Tables 2.3), including mammals
and Drosophila (Weinstein et al., 1994; Dawson et al., 1995). In Drosophila, the
Cdc20 ortholog, Fizzy, was shown to be required for the degradation of mitotic
cyclins A and B (Dawson et al., 1995). However, the biochemical functions of
Cdc20 remained obscure until the discovery of the Anaphase Promoting Com-
plex/Cyclosome (King et al., 1995; Sudakin et al., 1995). (for review see Yu, 2007).
Two main species, Mad2 and BubR1, can bind and sequester Cdc20.
APC
The downstream target of the MSAC is the Anaphase Promoting Complex/
Cyclosome (APC/C or APC; an E3 ubiquitin ligase). APC is a multisubunit
enzyme conserved from yeasts to humans, which is first identified independently
by King et al. (1995) and Sudakin et al. (1995). The APC is composed of at least
thirteen different subunits (see Table 2.3) which form two sub-complexes joined
by the Apc1 subunit (see Figure 2.5). They remain tightly associated throughout
the cell cycle.
APC activity is also strictly dependent on one of several co-activator proteins (see
Table 2.3) that associate with APC during specific periods of the cell cycle. The
best studied of these are Cdc20 and Cdh1, which are encoded by all known
eukaryotic genomes. Additional meiosis-specific APC co-activators have been
identified in yeasts and Drosophila.
25
2. MITOSIS TRANSITION CONTROLS
Figure 2.5: The APC subunits, The APC is composed of two sub-complexes joined
by Apc1. This figure has been re-drown and modified from Peters (2006).
APC activity at metaphase-to-anaphase transition depends on the co-activator
Cdc20. At the exit from mitosis, its activity depends on the co-activator Cdh1.
Note that all APC co-activators contain a C-terminal WD40 domain1 that is
predicted to fold into a propeller-like structure, and that is now believed to
recognize APC substrates by interacting with specific recognition elements in
these substrates, called D2- (Glotzer et al., 1991), and KEN3-boxes (Pfleger and
Kirschner, 2000b). Both Cdc20 and Cdh1 can recognize APC substrates that
contain the D-box, but Cdh1 can also interact with a second motif, the KEN-box,
thereby broadening the substrate specificity of the APC (Buschhorn and Peters,
2006; Pfleger et al., 2001; Eytan et al., 2006; Yamano et al., 2004; Pfleger and
Kirschner, 2000a; Burton and Solomon, 2007; Chang et al., 2004).
The APC becomes active as APC:Cdc20 at the onset of anaphase just after
MSAC is silenced. The APC:Cdc20 has two main functions:
 First, it catalyzes the ubiquitination of Securin which binds and inhibits the
protease Separase (May and Hardwick, 2006). Subsequently, the Separase
cleaves the cohesin subunit Scc1, which breaks the Cohesin ring (species details
1WD40 domain: A propeller-shaped protein domain that is composed of sequence repeats
that are 40-amino-acid residues long and contain tryptophan (W) and aspartate (D) residues
in conserved positions. In most cases, seven WD40 repeats fold into a seven-bladed propeller
structure.
2Destruction-box: A sequence element (consensus RXXLXXXN) that was first discovered
in the N terminus of mitotic cyclins that is required for their destruction. D-boxes can be
recognized by APC:Cdc20 and by APC:Cdh1f. Where x is any amino acid
3KEN-boxes: A sequence element (consensus KEN) that is present in many APC substrates.
KEN-boxes are preferentially, but not exclusively, recognized by APC:Cdh1.
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are summarized in Table 2.3 and Table 2.4).
 Second, APC:Cdc20 is responsible for the first phase of Cyclin B proteolysis
that occurs when cellular levels of the Cyclin B are high. Then the activated
APC:Cdh1 mediates the second phase of Cyclin B destruction and triggers
mitotic exit (Tan et al., 2005; Yeong et al., 2000).
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2. MITOSIS TRANSITION CONTROLS
Mad2 Function in Sequestering Cdc20
Mad1 forms a tight 2:2 complex with Mad2 (Sironi et al., 2001b, 2002). The binding
of Mad2 to Mad1 triggers a conformational change of Mad2, in a similar way as
does Cdc20 binding. Mad2 binds to Mad1 and Cdc20 in the same pocket with
similar affinities (Luo et al., 2002; Yu, 2006). Mad2 can adopt two conformations:
O-Mad2 and C-Mad2 (for “Open” and “Closed” respectively), which differ in
the structure of its 50 residue C-terminal segment (Luo et al., 2002; Luo and Yu,
2005). The O-Mad2 is the physiological state of cytosolic Mad2 in the absence
of Mad1 or Cdc20 (Luo et al., 2004; DeAntoni et al., 2005a). O-Mad2 refolds to
C-Mad2 when bound to kinetochore receptor Mad1 or APC activator Cdc20 (Luo
et al., 2002, 2000a). p31comet is a negative regulator of the spindle checkpoint. It
prevents further Mad2 turnover on Mad1 and neutralizes the inhibitory activity
of Cdc20-bound Mad2, leading to activation of the APC followed by degradation
of Securin and Cyclin B (Habu et al., 2002; Xia et al., 2004; Mapelli et al., 2006).
Recently, intensive studies led to an improved understanding of Mad2 - Cdc20
binding. Accordingly, two alternative mechanistic models were proposed: the
“Exchange” (Luo et al., 2004) and the “Template” model (DeAntoni et al., 2005a; re-
viewed by Le´na´rt and Peters, 2006; Nasmyth, 2005; Hardwick, 2005; Hagan and
Sorger, 2005).
 In the Exchange model (see Figure 2.6), Mad1 recruits O-Mad2 at the kineto-
chore and transforms its conformation from O-Mad2 to C-Mad2. Then, C-Mad2
dissociates from Mad1 and binds Cdc20. This model was criticized because it
is unable to explain additional experimental data (DeAntoni et al., 2005a,b;
Vink et al., 2006; Mapelli et al., 2006) and assumes that Mad1 competes with
Cdc20 for Mad2 binding.
 According to the alternative Mad2 Template model (see Figure 2.6), Mad1 and
C-Mad2 form a stable 2:2 complex at unattached kinetochores (DeAntoni et al.,
2005a). This quadromer complex then, binds additional molecules of O-Mad2
through formation of conformational heterodimers between the C-Mad2 subunit
of the Mad1:C-Mad2 complex and O-Mad2. Upon Mad1:C-Mad2 binding, O-
Mad2 adopts an intermediate conformation (O-Mad2*) that can quickly and
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Figure 2.6: Schematic drawing of the Mad2 Template and the Mad2 Exchange
models. The Template model (upper part of the figure) assumes that Mad1
and C-Mad2 form a stable core complex at unattached kinetochores. This core
then binds additional molecules of O-Mad2 through formation of conformational
heterodimers between the C-Mad2 subunit of the Mad1:C-Mad2 complex and
O-Mad2. Cdc20 binding to this complex leads to the conversion of O-Mad2 to
C-Mad2 resulting in the formation of Cdc20:C-Mad2, which in turn is assumed
then to dissociate off Mad1:C-Mad2. Upon Mad1:C-Mad2 binding, O-Mad2
adopts an intermediate conformation (O-Mad2*) that can quickly and efficiently
bind Cdc20 and switch to the C-conformation. The Exchange (lower part of the
figure) assumes that Mad1 recruits open Mad2 (O-Mad2) at the kinetochore and
transforms its conformation from O-Mad2 to closed Mad2 (C-Mad2). C-Mad2
then dissociates from Mad1 and binds Cdc20.
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efficiently bind Cdc20 and switch to the C-conformation. The binding of Cdc20
to this complex leads to the conversion of O-Mad2 to C-Mad2, resulting in the
formation of C-Mad2:Cdc20 which then dissociates from Mad1:C-Mad2 (Fang,
2002). The Template model describes Mad2:Cdc20 complexation, which is the
seeding reaction of MCC (M itotic Checkpoint Complex) formation.
There are still open questions related to the role of Mad2 that are critical to
understanding the MSAC mechanism. These questions will be discussed in the
conclusion section of this chapter as well as in chapter 3. In the following section,
MCC formation will be analyzed.
MCC Formation
The highly conserved proteins Mad2 and BubR1 are essential for Cdc20 binding.
They form the Mitotic Checkpoint Complex (MCC). In HeLa1 cells, MCC contains
Mad2, Bub3, BubR1 and Cdc20 in apparently equal stoichiometries (Sudakin
et al., 2001). A similar complex was identified in budding (Hardwick et al., 2000)
and fission (Millband and Hardwick, 2002) yeasts and in Xenopus (Chung and
Chen, 2003).
Bub3 associates with BubR1 (Taylor et al., 1998a; Sudakin et al., 2001). This
interaction is constitutive and is required for the localization of BubR1 to the kine-
tochores during mitosis. In prometaphase, CENP-E activates the kinase activity
of BubR1 at unattached kinetochores. It is unclear whether BubR1 activation is
required for MSAC function (Chen, 2002a; Mao et al., 2003). The kinase activity
of BubR1 might not be required in the MCC, however, it might control other
aspects of kinetochore signaling or chromosome alignment (Ditchfield et al., 2003;
Lampson and Kapoor, 2005) (reviewed by Musacchio and Salmon, 2007). BubR1
activity is switched off upon microtubule attachment (Mao et al., 2005; Braunstein
et al., 2007). BubR1 cannot bind Mad2 directly (Fang, 2002). Moreover, BubR1
does not form a ternary complex with Mad2 and Cdc20. Two Cdc20 binding sites
1HeLa cell: cancerous cell belonging to a strain continuously cultured since its isolation in
1951 from a patient suffering from uterine cervical carcinoma. The designation HeLa is derived
from the name of the patient (Henrietta Lacks (August 18, 1920 October 4, 1951)). HeLa cells
have been widely used in laboratory studies.
32
2.4 Anaphase Initiation Control
were identified on BubR1 (Bolanos-Garcia et al., 2005; Davenport et al., 2006).
Binding of the N-terminal region of BubR1 to Cdc20 requires prior binding of
Mad2 to Cdc20 (Davenport et al., 2006). The other site (between residues 490 and
560) can bind Cdc20 tightly regardless of Mad2 being bound to Cdc20 (Davenport
et al., 2006). Thus, BubR1 can form a ternary complex with Bub3 and Cdc20
which however has no inhibitory activity at the APC (unpublished data by Sudakin
et al., 2001). In addition, in vivo inhibition of Cdc20 for mitotic function is a
two-step process in which prior binding of Mad2 to Cdc20 is required to make
Cdc20 sensitive for BubR1 binding (Davenport et al., 2006).
Localization of all MSAC proteins at unattached kinetochores in mitosis provides a
catalytic platform and contributes to MCC formation. The MCC is also detectable
in normal metaphase-arrested cells in which the MSAC is inactive. This indicates
that MCC formation does not require checkpoint activation (Poddar et al., 2005).
Moreover, the MCC is also detectable in checkpoint defective cells (Poddar et al.,
2005; Fraschini et al., 2001). A detailed study (Meraldi et al., 2004) proposes
that cytosolic Mad2-BubR1 is essential to restrain anaphase onset early in mitosis
when kinetochores are still assembling. These arguments support the idea that the
MCC (and its sub-complexes) might form in a kinetochore-independent manner (for
review see Musacchio and Salmon, 2007).
The MCC binds to and inhibits the APC and is believed to be essential for
MSAC function (Musacchio and Salmon, 2007). However, MCC inhibits only
the mitotic and not the interphase APC (Pinsky and Biggins, 2005). The
interaction between APC and MCC is quite labile in the absence of unattached
kinetochores (Sudakin et al., 2001). How the MCC inhibits APC activity is poorly
understood (Musacchio and Salmon, 2007). The MCC might bind to the APC as a
pseudo-substrate due to a KEN-box motif in BubR1. This indicates that the MCC
needs to disassemble from the APC at metaphase to elicit anaphase (Morrow et al.,
2005; Fang, 2002). Bub1 and Aurora-B kinase contribute directly to the formation
of a complex of the MCC with the APC (Morrow et al., 2005). Unattached
kinetochores might sensitize the APC to inhibition by the MCC (Sudakin et al.,
2001; Chan et al., 2005; Doncic et al., 2005; Sear and Howard, 2006).
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In addition to kinetochore attachment, tension is important for MSAC inactivation
(Nicklas et al., 1995; Nicklas, 1997). For example, if both sister kinetochores attach
to microtubules from the same pole, not enough tension is generated and micro-
tubule kinetochore attachment is destabilized to correct the problem (Musacchio
and Salmon, 2007). This destabilization depends on Aurora-B kinase (Hauf et al.,
2003; Pinsky and Biggins, 2005; Tanaka et al., 2002; Lampson et al., 2004). For
sub-complex details see Table2.5.
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Additional Components of the MSAC
In addition to the four MCC proteins, the MSAC also involves several other
proteins that also are involved in essential aspects of this mechanism. Among
these additional components are Aurora-B and the “Multipolar spindle-1” pro-
tein (Mps1). These components are required for MSAC signal amplification and
MCC formation (see Table 2.6). Moreover, several other proteins have recently
been identified in higher eukaryotes that are also involved in carrying out essential
aspects of the MSAC mechanism e.g., localization or biochemical signaling: “Rough
Deal” (Rod) (May and Hardwick, 2006; Buffin et al., 2007), ZW10 (Zeste White
10) (Saffery et al., 2000a,b; Chan et al., 2000; Scholey et al., 2003; Raff et al.,
2002), Zwilch (Williams et al., 2003; Karess, 2005) , Zwint-1 (Kops et al., 2005a;
Wang et al., 2004a) the RZZ complex (Karess, 2005), CENP-E (“Centromere
associate Protein E”, a member of the kinesin superfamily), and protein kinases
like “Mitogen Activated Protein Kinase” (MAPK), CDK1, and cyclin-B.
Several core checkpoint proteins are recruited to unattached kinetochores in
prometaphase including Mad1 (Campbell et al., 2001; Chung and Chen, 2002),
Mad2 (Fang et al., 1998a; Lampson and Kapoor, 2005), BubR1 (Morrow et al.,
2005; Hoffman et al., 2001), Bub1 (Taylor et al., 1998a; Chen, 2002b), Bub3 (Taylor
et al., 1998a; Howell et al., 2004), and Mps1 (Stucke et al., 2004, 2002) (Fig-
ure 2.7). Obviously, the kinetochores serve as a platform for complex formation (cf.
Figure 2.8). The Cdc20:Mad2 and Mad1:Mad2 complexes form in the absence of
other proteins in vitro (BubR1 or Bub3 are dispensable) (Chung and Chen, 2002;
Hwang et al., 1998; Martin-Lluesma et al., 2002; Luo et al., 2002; Fraschini et al.,
2001). Upon microtubule attachment, many of these proteins deplete from the
kinetochores (see for example Lampson and Kapoor, 2005; Wassmann et al., 2003;
Shannon et al., 2002).
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2. MITOSIS TRANSITION CONTROLS
Figure 2.7: A hierarchical network of localization pathways. This figure has been
re-drown modified from Liu et al. (2006), new species has been added like, Spindly,
Bub3, and Dynein.
Biochemical Signaling
UbcH10 increases both, Cdc20 ubiquitination and the dissociation of Cdc20
from Mad2 and APC Reddy et al. (2007). Conversely, depletion of UbcH10
from HeLa cells decreases APC-mediated ubiquitination of Cdc20, stabilizes the
Mad2-Cdc20 interaction, and delays anaphase initiation (Reddy et al., 2007). In
an accompanying study, Stegmeier et al. (2007) have identified the ubiquitin-
specific protease USP44 as a spindle checkpoint component through an RNA
interference (RNAi) screen. Human cells depleted for USP44 by RNAi do not
undergo mitotic arrest in the presence of spindle poisons. The checkpoint bypass
of USP44 RNAi cells depends on APC, although Mad2 and BubR1 are localized
normally in the kinetochores. Thus, in APC inhibition, USP44 acts downstream
of Mad2 in APC inhibition. Furthermore, USP44 antagonizes APC-mediated
ubiquitination of Cdc20 in vivo. Recombinant USP44 directly deubiquitinates
Cdc20 in vitro. This study indicates that USP44 reduces Cdc20 autoubiquitination
and protects the Cdc20:Mad2 checkpoint complexes from disassembly. Griffis
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2.4 Anaphase Initiation Control
Figure 2.8: Structural features in the regulation of mitotic progression from
metaphase to anaphase defining the model relations. The left part of the figure
(unattached case) has been re-drown modified from Musacchio and Salmon (2007)
and new species like Spindly and Dynein have been integrated. Before the
attachment most species recruited to the kinetochore. The right hand port of
the figure presented the kinetochore after attachment to the spindle microtubule.
After the attachment, many species deplete from the kinetochore.
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2. MITOSIS TRANSITION CONTROLS
et al. (2007) have recently identified a new protein, called “Spindly”. After the
depletion of Spindly, dynein cannot target to kinetochores, and, as a result, cells
arrest in metaphase with high levels of kinetochore-bound Mad2 and RZZ. They
also identified a human homologue of Spindly that serves a similar function that
accumulates on unattached kinetochores and is required for silencing the MSAC .
p31comet (formerly CMT2) is a negative regulator of the spindle checkpoint. It
prevents further Mad2 turnover on Mad1 and neutralizes the inhibitory activity
of Cdc20-bound Mad2, leading to activation of APC (Habu et al., 2002; Xia et al.,
2004; Mapelli et al., 2006). For details see Table 2.7.
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2. MITOSIS TRANSITION CONTROLS
2.4.3 Recent Models of the MSAC
For the cell cycle in general there exists already a large number of models, ranging
from relative simple, low-dimensional models (Tyson, 1991; Goldbeter, 1991) to
complex models taking into account a large number of molecular species (Chen
et al., 2004).
Because most experimental studies of the spindle checkpoint are recent, the
MSAC has not yet been modeled in a detailed molecular level. Doncic et al.
(2005) compared several mechanisms that could account for the inhibition of the
APCCdc20 complex in yeast. They noticed that the design of the MSAC network
is limited by physical constrains imposed by realistic diffusion constants and
the relevant spatial and temporal dimensions in the yeast cell. By designing a
simplified model of radial symmetry, they observed that amplifying the signal
through the release of a diffusible inhibitory complex can describe the checkpoint
function. Nevertheless, their model does not fully take into account the molecular
complexity. A similar approach was presented by Sear and Howard (2006). They
investigated two mechanisms for MSAC in metazoan cells:
 one involves free diffusion and sequestration of cell cycle regulators requiring a
two-stage signal amplification cascade.
 The second mechanism involves spatial gradients of a short-lived inhibitory
signal that propagates by diffusion and primarily by active transport along
spindle microtubules.
Both mechanisms might act in parallel. Mathematical modeling of cell cycle
control in budding yeast was analyzed in more details by Chen et al. (2004),
however, this work is not focused on the MSAC. A model for the exit from
mitosis (Ciliberto et al., 2005) describes the control of the checkpoint, however
it not considers BubR1 (Mad3 in yeast) and the influence of spatial distribution
and diffusion.
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2.5 Mitotic Exit control
The second critical control mechanism during mitosis is a complex regulatory
mechanism (called Exit From Mitosis (EFM)) that allows cells to leave mitosis.
2.5.1 Exit From Mitosis (EFM) Mechanism
As described above, the APC plays an important role in the ubiquitination and
destruction of both securin and cyclin B. The kinase activity of a cyclinB:Cdk1
complex promotes mitosis, whereas the destruction of the cyclin partner and loss
of kinase activity is required for EFM (Su et al., 1998).
APC:Cdc20 is responsible for the first phase of Cyclin B proteolysis that occurs
when cellular levels of the Cyclin B are high. Since MSAC is activated, Cdh1
is phosphorylated by Cdks and thereby kept inactive. After anaphase initia-
tion (MSAC inactivate), Cdh1 is dephosphorylated and thus, it is able to bind and
activate the APC (Kramer et al., 2000; Zachariae et al., 1998a). APC:Cdh1 then
ubiquitinates Cdc20 and thereby inactivates APC:Cdc20 (Pfleger and Kirschner,
2000a; Prinz et al., 1998). More precisely, APC:Cdh1 is activated once the degra-
dation of cyclin B has been initiated by APC:Cdc20 (see Figure 2.9). The second
phase of Cyclin B destruction is mediated by APC:Cdh1 which then trigger the
exit from mitosis (Tan et al., 2005; Yeong et al., 2000; Bosl and Li, 2005; Morgan,
1999; King et al., 1996; Alexandru et al., 1999).
2.5.2 Analysis of the Recent Experimental Studies of the EFM
In all eukaryotes, EFM occurs through the inactivation of the Cdk1 in complex
with mitotic cyclin. This complex is called Cdk1:cyclin B or Cdc28:Clb2 in
budding yeast (Bloom and Cross, 2007). Two main events must occur before a
cell is able to leave mitosis:
 The separation of sister chromatids
 The destruction of Cyclin B.
43
2. MITOSIS TRANSITION CONTROLS
Figure 2.9: Activation of APC by Cdc20 and Cdh1 during mitosis. MSAC is
activated at kinetochores that are not (or not fully) attached with microtubules.
It inhibits the capability of APC:Cdc20 to ubiquitylate securin and cyclin B and
thereby prevent anaphase. Once, all kinetochores are attached to microtubules,
APC:Cdc20 is responsible for activates Separase and the first phase of Cyclin B
proteolysis that occurs when cellular levels of the Cyclin B are high. Thereby
Cdh1 is dephosphorylated (activated) and thus able to bind and activate the
APC:Cdch1. Activated APC:Cdh1 then mediates the second phase of Cyclin B
destruction and triggers EFM. The upper part of this figure explain the expected
behavior of APC activity (with both Cdc20 and Cdh1)and cyclin B in mitosis.
Then, an abstract reaction scheme explain active APC functions. The lower part
of the figure explain the corresponding transition event of mitosis.
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These late mitotic events are tightly regulated to occur only after the onset of
anaphase (MSAC inactivated) and prior to cytokinesis (Wolfe et al., 2006; Nasmyth
et al., 2000). Several proteins and protein complexes are involved in these tasks;
APC, Cdc20, Cdc14, Cdh1, Cdc15, Net1, Tem, Cyclin B complex, securin, separase
and the cohesin complex. Some of these players are not observed in humans (e.g.
Net1).
During anaphase, the phosphatase Cdc14 is activated. It dephosphorylates several
targets of mitotic Cdk and promotes mitotic exit (D’Amours and Amon, 2004).
Separase plays an essential role in Cdc141 activation (Queralt et al., 2006; Sul-
livan and Uhlmann, 2003). Cdc14 dephosphorylates (and thereby activates) a
second APC co-activator called Cdh12 that promotes completion of cyclin de-
struction (Prinz et al., 1998). In higher eukaryotes, it has been shown that a
homolog of Cdc14 can dephosphorylate Cdh1 in vitro (Bembenek and Yu, 2001b).
Cdh1 dephosphorylation activates APC and forms the APC:Cdh1 complex, al-
lowing cells to progressively accumulate mitotic cyclin Clb2 (in human Cyclin
B) (Zachariae et al., 1998b; Yeong et al., 2000; Zachariae et al., 1998a; Huang
et al., 2001). Then, APC:Cdh1 ubiquitinates Cdc20, and completely degrades
Cyclin B. Additionally, APC:Cdh1 ubiquitinates other species, like Bub1 that are
not required for EFM (Qi and Yu, 2007).
The mechanism of the activation of APC:Cdh1 and EFM is well characterized
in budding yeast (Morgan, 1999). Mutations of a set of yeast genes, such as
Tem1, Lte1, Cdc14, and Cdc15 stabilize mitotic cyclin Clb2p and cause late
anaphase arrest, indicating that they are required for the EFM (Morgan, 1999;
Jaspersen et al., 1998; Shou et al., 1999; Visintin et al., 1999). During most
part of the cell cycle, Cdc14 is sequestered in the nucleolus due to its association
with the regulatory subunit Net1 (also called Cfi1) (Shou et al., 1999; Visintin
et al., 1999). The release of Cdc14 from the nucleolus and its accumulation in
1hCdc14A is the human homologue of Cdc14 (Lanzetti et al., 2007; Krasinska et al., 2007;
Vazquez-Novelle et al., 2005). hCdc14A protein is 64% identical to yeast Cdc14 (Li et al., 1997a).
2hCdc14A was shown to dephosphorylate Cdh1 and reconstitute active APC:hCdh1 in
vitro (Bembenek and Yu, 2001a). Additionally, human Cdc14 phosphorylates Cdc25 in vitro (Es-
teban et al., 2006). The later has important roles in other cell cycle phases.
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the nucleus (and partially in the cytoplasm) during anaphase is thought to be
important for activating APC:Cdh1 (Shirayama et al., 1999).
2.5.3 Recent Models of the EFM
Be´la Nova´k and colleagues have proposed several models for EFM in budding
yeast. Queralt et al. (2006) presented a new mathematical model for EFM focused
only on the cell cycle transition from a stable state of high Cdk activity in mitosis,
via anaphase and mitotic exit, to a stable state of low Cdk activity in G1. This
transition corresponds to the window of the cell cycle that was analyzed by
experiments in which cells arrested in metaphase because of Cdc20-deprivation,
are able to enter in anaphase by re-addition of Cdc20 or by over-expression of
separase. They described a wiring diagram of EFM and developed a quantitative
model based on nonlinear differential equations. The model was analyzed by
numerical simulations. The kinetic parameters were chosen to fit the experimental
observations.
Toth et al. (2007) present a two dimensional model for the EFM in budding yeast.
They use phase-plane analysis, which reveals two underlying bistable switches
in the regulatory network. One bistable switch is caused by mutual activation
(positive feedback) between Cdc14 activating MEN and Cdc14 itself. The mitosis-
inducing Cdk1 activity inhibits the activation of this positive feedback loop and
thereby controlling this switch. The other irreversible switch is generated by a
double-negative feedback (mutual antagonism) between mitosis inducing Cdk1
activity and its degradation machinery (APC:Cdh1). The Cdc14 phosphatase
helps turning this switch in favor of APC:Cdh1. Both of these bistable switches
have characteristic thresholds, the first one for Cdk1 activity, and other for Cdc14
activity. The same authors show that the physiological behaviors of certain cell
cycle mutants are suggestive for those Cdk1 and Cdc14 thresholds.
We built an integrative mathematical model for MSAC and EFM mechanism
(M. Palm, 2008). Our model overlaps with the model developed by Toth et al.
(2007).And will be introduced in detail in Chapter 7.
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2.6 Concluding Remarks
Our focus in this chapter was on identifying open questions related to two different,
still connected mitosis transition control mechanisms, namely, the Mitotic Spindle
Assembly Checkpoint (MSAC) and Exit From Mitosis (EFM) mechanisms.
These mechanisms involve a rather large number of biochemical species of ele-
ments, together with their corresponding interactions. Since of these elements
serve multiple functions, in addition. Empirical data have proved fruitful in the
understanding of these mechanisms, in the context of mitosis, a fact well docu-
mented by an increasing number of open questions. Yet, such data are typically
limited by the complexity of such mechanisms.
The following are examples of open questions that are of most importance in this
context. We know that both Mad2 and BubR1 sequester Cdc20, but how do these
three elements interact? The Template model seems to explain some empirical
data more accurately than the Exchange model does, but the question why this
is so remains elusive. Is there any amplification phenomenon in the template
model? MCC is formed in different organisms, but is MCC formation kinetochore
dependent or independent? Moreover, MCC inhibits APC, but how? How an
MCC:APC complex falls apart after attachments? How biochemical signals as
p31comet and dynein actually work? How can we ponder the roles of localizations
and diffusion in the context of MSAC ? Eventually, how does MSAC operate
throughout the entire process of mitosis? These questions, as examples, relate to
the MSAC mechanism, and comparable questions can be made in relation to the
EFM mechanism.
We propose that theoretical accounts of mitosis transition controls based on mod-
eling, simulation, and cross-disciplinary research (In-Silico) will be of significant
help for better understanding of such a complex phenomenon as mitosis. This
might well be an eye-opening trip a cross disciplines, a perspective belonging to
the so called new science of Systems Biology. We shall refer to our work as to
“Systems Biology of Mitosis”. In the next chapter, we will introduce modeling
approaches and classifications for systems biology. Some details and basic concepts
will be presented for non modelers.
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Chapter 3
Modeling Mad2 Function in
Sequestering Cdc20
“Music is the pleasure the human mind experiences from
counting without being aware that it is counting”.
Gottfried Leibniz (1646 1716)
“Mathematics is the handwriting on the human consciousness
of the very Spirit of Life itself”.
Claude Bragdon (1866-1946)
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3.1 Summary
For successful mitosis, metaphase has to be arrested until all centromeres are
properly attached. The onset of anaphase, which is initiated by activating the
APC, is controlled by the spindle assembly checkpoint MSAC . Mad2, which
is a constitutive member of the MSAC , is supposed to inhibit the activity of
the APC by sequestering away its co-activator Cdc20. Mad1 recruits Mad2 to
unattached kinetochores and is compulsory for the establishment of the Mad2
and Cdc20 complexes. Recently, based on results from in vivo and in vitro
studies, two biochemical models were proposed: the Template and the Exchange
model. Here, we derive a mathematical description to compare the dynamical
behavior of the two models. Our simulation analysis supports the Template
model. Using experimentally determined values for the model parameters, the
Cdc20 concentration is reduced down to only about half. Thus, although the
Template model displays good metaphase-to-anaphase switching behavior, it
is not able to completely describe MSAC regulation. This situation is neither
improved by amplification nor by p31comet inhibition. We speculate that either
additional reaction partners are required for total inhibition of Cdc20 or an
extended mechanism has to be introduced for MSAC regulation.
3.2 Introduction
To address the question, how Cdc20 concentration relates to anaphase onset and
how it is regulated, we investigated the role of Mad1 in eliciting the formation of the
Cdc20:Mad2 complex on the basis of two biochemical models, the exchange (Luo
et al., 2004) and the template (DeAntoni et al., 2005a) model. To this end, we
derived the reaction equations from the description in (Luo et al., 2004; DeAntoni
et al., 2005a). Using standard principles of chemistry and thermodynamics, we
converted the reaction equations into non-linear ordinary differential equations
for the concentrations of the reactants. To simulate their dynamics in the course
of time, the differential equations were integrated for different values of the
kinetic constants involved. To find a behavior in concordance with experimental
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results, we employed a minimization procedure. The purpose of this chapter is
threefold. First, we show how to derive a mathematical model for the biochemically
described Exchange and Template models. Then, as the main purpose, we
compare the two models by mathematical simulations and show that the Exchange
model is not able to realistically describe the metaphase-to-anaphase transition.
Though the Template model in principle can show correct switching behavior
for this transition, it is not able to sequester away Cdc20 completely whenever
physiologically realistic kinetic constants are used. Therefore, in a third step,
we investigate six further extensions of the Template model, based on recently
described biochemical amplification and inhibition effects, especially considering
the role of p31comet . As total inhibition of Cdc20 activity during metaphase is
the basis of most models for metaphase-to-anaphase transition (Ibrahim et al.,
2007; Toth et al., 2007; Queralt et al., 2006), it is an important question, whether
Mad2 is able to fully Cdc20 sequester (inhibition) or additional reaction partners
are required or an extended MSAC regulation mechanism has to be introduced?
3.3 Methods: Definition and Simulation of the
Models
For each model, we describe briefly the basic biochemical pathways and ex-
perimental findings. These experimental foundations are turned into chemical
reaction equations. In some cases, reactions depend on the attachment of the
microtubules to the kinetochore, which is described by a switching parameter
u: before attachment, we set u = 1; and after attachment, u = 0. Formation
of the Mad1:C-Mad2:OMad2* complex in the classical Template model is an
example for this dependence (see Eq. (3.6)). The corresponding kinetic parameter
αT is therefore multiplied by u. Biochemically, the switching parameter u may
represent the function of dynein, which after microtubule attachment removes the
Mad1:C-Mad2 2:2 complex from the kinetochore site.
The reaction equations are converted into non-linear ordinary differential equations
(ODEs) using the mass action kinetics (c.f. Appendix B B.1-B.5). Starting from
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initial concentrations for all reaction partners taken from literature (cf. Table 3.1),
the ODEs are integrated until steady state is reached before attachment (using
u = 1). After switching u to 0, the equations are again integrated, until steady
state is reached. The minimum concentration of Cdc20 before attachment and the
recovery after attachment (level of Cdc20 increase and recovery time) are criteria
to compare the models. As far as documented in the literature, experimental
values are used for the kinetic constants. In all other cases, we select representative
values for each parameter (cf. Table 3.1) exemplifying its whole physiologically
possible range. The resulting concentration curves show the influence of the kinetic
parameter on the behavior of the model. It can be clearly seen that the variation
of the curves depends in a continuous manner on the variation of the parameters.
Their influence on the behavior of the models is described in detail in the respective
sections. In a more global approach, we fit optimal values to the model parameters
by minimizing a Cdc20 concentration objective functional describing a minimal
Cdc20 concentration before and a maximal concentration after switching (see
Appendix B B.6). Minimization was performed by statistical approaches by
selecting randomly starting values within the whole range of parameters. For the
Cdc20 concentration functional, a minimal solution is in general not unique, as can
be seen from the graphs with the example parameter settings. On the other hand,
due to the continuous behavior of the system in dependence of the parameters, in
some cases parameters tend to an asymptotic, often physiologically unrealistic,
value. In other cases, the velocity of Cdc20 recovery after switching can help to
define a possible parameter set. The details are explained in the respective model
sections.
3.4 Biochemical Basis of the Models
The biochemical basis of the models are the binding kinetics of Mad1, Mad2, and
Cdc20. Mad1 forms a tight 2:2 complex with Mad2 (Sironi et al., 2001a). Binding
of Mad2 to Mad1 triggers a conformational change of Mad2, in a similar way as
does Cdc20 binding: Mad2 binds to Mad1 and Cdc20 in the same pocket with
similar affinities (Luo et al., 2002). Mad2 can adopt two conformations, O-Mad2
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and C-Mad2, differing in the structure of its 50 residue C-terminal segment (Luo
et al., 2002). The O-Mad2 is the physiological state of cytosolic Mad2 in the
absence of Mad1 or Cdc20 (Luo et al., 2004). O-Mad2 refolds to C-Mad2 when
bound to the kinetochore receptor Mad1 or the APC activator Cdc20 (Luo et al.,
2004). Upon microtubule attachment, Mad1 (Campbell et al., 2001) remains
detectable at kinetochores whereas Mad2 (Lampson and Kapoor, 2005) depletes
from the kinetochores.
3.5 The Exchange Model
In order to explain the formation of the Mad1:Cdc20 complex, Luo et al. (2004)
suggested the Mad2 Exchange model, based on a series of in vitro and in vivo
experiments. It assumes that Mad1 recruits open Mad2 (O-Mad2) at the kineto-
chore and transforms its conformation from open Mad2 (O-Mad2) to closed Mad2
(C-Mad2). C-Mad2 then dissociates away from Mad1 and binds Cdc20. This
model portrays Mad1 as a catalyst of the structural transition of O-Mad2 into
C-Mad2. The reaction rules governing the Exchange model are (cf. Figure 3.1):
O-Mad2
k1−−−⇀↽ −
k−1
C-Mad2 (3.1)
Mad1 + O-Mad2
αE .u−−−−⇀↽ −
k−2
Mad1:C-Mad2 (3.2)
Mad1:C-Mad2
k3−−−⇀↽ −
k−3
C-Mad2 + Mad1 (3.3)
C-Mad2 + Cdc20
kE−−−→ Cdc20:C-Mad2 (3.4)
Cdc20:C-Mad2
ηE−−−→ Cdc20 + O-Mad2 (3.5)
which lead to the set of time dependent nonlinear ODEs listed in Appendix B B.1,
Eqs. (B.1)-(B.6).
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Figure 3.1: Schematic reaction network of the Exchange model. In the Exchange
model (Luo et al., 2004), it is assumed that Mad1 recruits open Mad2 (O-Mad2)
at the kinetochore and transforms its conformation from O-Mad2 to closed Mad2
(C-Mad2). C-Mad2 then dissociates from Mad1 and binds Cdc20. This model
portrays Mad1 as a catalyst of the structural transition of O-Mad2 into C-Mad2.
Already this purely biochemical description gave rise to several criticisms (Le´na´rt
and Peters, 2006; Hardwick, 2005). Especially the question remained, why and
how Mad2 first binds (as O-Mad2) to Mad1, but then dissociates off (as C-
Mad2) (DeAntoni et al., 2005b).
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The only parameter dependent on the kinetochore attachment status is αE which
therefore is multiplied by the switching parameter u. The reaction scheme contains
the background reaction for O-Mad2 conversion to C-Mad2 (Eq. (3.1)) with very
low rates k1 and k−1 (Luo et al., 2004). For αE, k−2, k3, and k−3 we used
quantitative experimental data from (Luo et al., 2004) (see Table 3.1). The
remaining two parameters kE and ηE were varied within a realistic range (Luo
et al., 2004; DeAntoni et al., 2005a; Fang, 2002): kE between 10
5M−1s−1and
109M−1s−1and ηE between 3 ∗ 10−5s−1and 10−2s−1. When analyzing this set of
ODEs, we found that only for very small ηE (3 ∗ 10−5s−1) the initial Cdc20
concentration is clearly reduced to about half the initial value (Figure 3.2a) while
for the higher values of ηE (10
−2s−1) the Cdc20 concentration hardly changed
(Figure 3.2d). Our data indicate that the switching of u from 1 to 0 has little
influence on Cdc20 concentration, smaller ηE (Figure 3.2 a) showing slightly larger
effects than larger ηE (Figure 3.2 d). A large influence of u on Cdc20 concentration,
however, is required for checkpoint function. While the MSAC is activated, the
concentration of Cdc20 should be low, and should switch to large values when the
kinetochores are attached. The Exchange model does not describe this behavior.
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Figure 3.2: The dynamical behavior of the Exchange model with different values of
k4 and ηE. Color lines represent different values of k4, which is without influence
on the model behavior, as all line coincide. Switching of u from 0 to 1at time
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3.6 The Template Model
In the Exchange model it remained unclear, how Mad2 first binds to Mad1 and
then dissociates off by just adopting another conformation. In an experimental
study, (DeAntoni et al., 2005a) provided information about the detailed reaction
mechanism, which was finally condensed into the Mad2 Template model. It
assumes that Mad1 and C-Mad2 form a stable core complex at unattached
kinetochores (DeAntoni et al., 2005a). This core then binds additional molecules
of O-Mad2 through formation of conformational heterodimers between the C-
Mad2 subunit of the Mad1:C-Mad2 complex and O-Mad2. Cdc20 binding to
this complex leads to the conversion of O-Mad2 to C-Mad2 resulting in the
formation of Cdc20:C-Mad2, which in turn is assumed then to dissociate off
Mad1:C-Mad2 (Fang, 2002). Upon Mad1:C-Mad2 binding, O-Mad2 adopts an
intermediate conformation (O-Mad2*) that can quickly and efficiently bind Cdc20
and switch to the C-conformation (see Figure 3.3). The reaction rules covering
the Template model are (cf. Appendix B B.2 for ODEs):
Mad1:C-Mad2 + O-Mad2
αT .u−−−−⇀↽ −
βT
Mad1:C-Mad2:O-Mad2 ∗ (3.6)
Mad1:C-Mad2:O-Mad2 ∗ + Cdc20
γT .u−−−−→ Cdc20:C-Mad2 + Mad1:C-Mad2
(3.7)
Cdc20:C-Mad2
ηT−−−→ O-Mad2 + Cdc20 (3.8)
The kinetic constants αT , βT , and γT depend on the attachment state of the
kinetochore and are thus multiplied by the variable u. We used quantitative
data from FRAP experiments for αT and βT (Vink et al., 2006). The remaining
two parameters γT and ηT were varied widely within realistic frames (Luo et al.,
2004; DeAntoni et al., 2005a; Fang, 2002): ηT between 5 ∗ 10−4s−1and 10−1s−1,
and γT between 10
5M−1s−1and 109M−1s−1(c.f. Table 3.1). Characteristic Cdc20
concentration curves were obtained as displayed in 3.4.
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Figure 3.3: Schematic reaction network of the Template model. In a subsequent
sophisticated experimental investigation, (DeAntoni et al., 2005a) could precise the
reaction mechanism further and developed the biochemical Template model. Here,
it is assumed that Mad1 and C-Mad2 form a stable core complex at unattached
kinetochores. This core then binds additional molecules of O-Mad2 through
formation of conformational heterodimers between the C-Mad2 subunit of the
Mad1:C-Mad2 complex and O-Mad2. Cdc20 binding to this complex leads to the
conversion of O-Mad2 to C-Mad2 resulting in the formation of Cdc20:C-Mad2,
which in turn is assumed then to dissociate off Mad1:C-Mad2 (Fang, 2002). But
even with this refined description, many questions remained open (Mapelli et al.,
2006; Nezi et al., 2006), and a decision for one of the models to be more realistic
could not be met Vink et al. (2006).
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For ηT values smaller than 10
−1s−1, we observed a clear dependence of the Cdc20
concentration on the switching parameter u with the effect being larger for larger
γT . In early mitosis (u = 1), for ηT values in the order of 10
−3s−1(clearly smaller
than 10−2s−1) and γT values larger than 106M−1s−1, the Template model sequesters
about half of the Cdc20 concentration (Figure 3.4) in quantitative agreement with
experimental findings (Luo et al., 2004; Fang, 2002). However, within this frame
of realistic parameter variations, Cdc20 is never completely inhibited as would be
required for checkpoint function. ηT determines the rate of Cdc20 concentration
recovery after u is switched to zero: small ηT values of about 10
−3s−1display slow
recovery while values of 10−2s−1and above show fast recovery (Figure 3.4).
Already Fang (2002) increased the Mad2 level 100fold (to 22.5 µM) to gain
maximal Cdc20 inhibition. In our Template model simulation, an 8fold increase
of free Mad2 concentration showed complete Cdc20 disappearance for small ηT
(< 10−1s−1) and large γT (> 106M−1s−1) (see Figure 3.5). In addition, the rate
of Cdc20 recovery becomes fast for larger values of ηT . However, this Mad2
concentration is far above experimentally observed values (Fang, 2002).
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Figure 3.4: The dynamical behavior of the Template model with different values
of γT and ηT . Figures a, b, c, and d for physiological data (see text), for increase
Mad2 see Figure 3.5. Switching of u from 0 to 1 at time 2000 s
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Figure 3.5: The dynamical behavior of the Template model with different values
of γT and ηT . Figures a, b, c, and d for 8folds increase of free Mad2. Switching of
u from 0 to 1 at time 2000 s
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3.7 Variations of the Template model
In the Template model, for realistic parameter ranges, Cdc20 inhibition is not
as high as anticipated. We therefore modified the model according to recent
experimental results.
3.7.1 Amplification Effects
DeAntoni et al. (2005a) hypothesized that in analogy to the reactions in Eqs. (3.6)
and (3.7) based on Mad1, Cdc20:C-Mad2 can also be formed by the reactions in
Eqs. (3.9) and (3.10) below based on Cdc20. This additional pathway for the
production of Cdc20:C-Mad2 results in a signal amplification for the MSAC since
Cdc20:C-Mad2 now is produced not only at the location of Mad1 at the kinetochore
but at a larger number of locations everywhere in the cell. To check the effect of
this additional pathway, we added two reactions (3.9-3.10) to the Template model
(see Figure 3.6 a, ODEs Appendix B B.3):
Cdc20:C-Mad2 + O-Mad2
k4−−−−⇀↽ −
k−4
Cdc20:C-Mad2:O-Mad2 ∗ (3.9)
Cdc20:C-Mad2:O-Mad2 ∗ + Cdc20 k5−−−−→ 2 Cdc20:C-Mad2 (3.10)
The Mad2 heterodimer formation at the Mad1 location is considered to be as fast
as at Cdc20, so that k4 and k5 would be as large as αT and γT , respectively. For
k4 and k5 both equal to 10
5M−1s−1, ηT = 10−3s−1and γT in the range between
105M−1s−1and 109M−1s−1. Our calculations indicate that the switching parameter
u has little to no effect on the Cdc20 concentration (Figure 3.7 b). Small k4 =
k5 = 10
3M−1s−1have vanishing influence on the model and roughly show the
Template model behavior as observed before (Figure 3.7 a). Furthermore, using
our fitting procedure for optimal parameters, the values of k4 and k5 tend to zero:
the amplification is discarded from the reaction scheme.
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a
b
Figure 3.6: Schematic reaction networks and localization: (a) the Template model
with amplification, (b) the Template model with amplification controlled by
p31comet .
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Figure 3.7: The dynamical effects of the different amplification mechanisms in the
Template model (time in s) : a and b represent the case, in which the amplification
is uncontrolled (Eqs (B.12)-(B.17), Appendix B B.3). c and d: amplification
controlled by the switching parameter u (Eqs (B.25)-(B.33), Appendix B B.5). e
and f: e and f: controlled amplification, but now with p31comet . Left column (a,
c, e): low amplification rate k4 = k5 = 10
3M−1s−1. Right column (b, d, f): high
amplification rate k4 = k5 = 10
5M−1s−1. Numerical solution of the differential
equations in Appendix B B.3, B.4, and B.5. Color lines represent different values
of γT .
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The additional amplification reactions could contribute to the model behavior,
in case the reaction Eq. (3.9) did not take place all the time, but instead would
also be controlled by the switching parameter u (k4 replaced by k4.u). With the
same parameter values as in the previous calculation (Figure 3.6 d), we obtained
Cdc20 concentrations nearly independent from γT : low Cdc20 concentrations
were reached now also for small values of γT (Figure 3.6 c). However, we have
no experimental indication for such an influence of microtubule attachment to
kinetochores on k4.
3.7.2 Inhibition Effects
Another way to vary the Template model is the introduction of the Mad2 ligand
p31comet (formerly CMT2), which is a negative regulator of the spindle checkpoint.
It prevents further Mad2 turnover on Mad1 and neutralizes the inhibitory activity
of Cdc20-bound Mad2, leading to activation of APC followed by degradation of
Securin and Cyclin B (Habu et al., 2002). Its negative effect on the MSAC is
based on its competition with O-Mad2 for C-Mad2 binding (Habu et al., 2002;
Xia et al., 2004). It forms triple complexes with C-Mad2 and either Mad1 or
Cdc20 (Xia et al., 2004). If p31comet is activated at microtubule attachment to the
kinetochores, it might be a cellular factor contributing to the checkpoint switching
behavior. Therefore, we introduced an additional reaction 3.11 into the Template
model reactions (3.6-3.8) describing the effect of p31comet (ODEs Appendix B B.4):
Mad1:C-Mad2 + p31
δT .v−−−−⇀↽ −
ζT
Mad1:C-Mad2:p31 (3.11)
The activation of p31comet is taken care of by the introduction of the switching
parameter v which is equal to zero until the kinetochores are attached and switches
to one afterwards. In fact, the function of the switching parameter u can be totally
replaced by p31comet inhibition, as the p31comet system with u = 1 all the time
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shows the same dynamic results as the unmodified Template model (Figure 3.4).
Combining both effects (u and v switching) still show the same dynamics.
3.7.3 Amplification plus Inhibition Effects
Including both, amplification and p31comet inhibition, into the Template model, we
obtain the chemical reaction scheme (see Figure 3.6 b), consisting of Eqs. (3.6-3.8),
(3.9-3.10), and an additional equation (3.12), (ODEs Appendix B B.5):
Cdc20:C-Mad2 + p31
ξT .v−−−−⇀↽ −
σT
Cdc20:C-Mad2:p31 (3.12)
For u = 1 before and after attachment (all the time), the model behavior is
not influenced before switching (v = 0). After switching (v = 1), for low ξT =
103M−1s−1, the new additional reaction mechanism is slightly less effective in
Cdc20 recovery, whereas for high ξT = 10
5M−1s−1, Cdc20 cannot recover since it
is incorporated into the triple complex with C-Mad2 and p31comet . Combining u
and v switching does not change the dynamics.
3.8 Discussion
The mitotic checkpoint proteins Mad1, Mad2 and Cdc20 play an essential role in
cell cycle control by contributing to the regulation of the MSAC mechanism (DeAn-
toni et al., 2005a). Their interactions have been studied experimentally (e.g. (Luo
et al., 2004; DeAntoni et al., 2005a; Fang, 2002)) resulting in two alternative
models describing their behavior, the “Exchange model” (Luo et al., 2004) and
the “Template model” (DeAntoni et al., 2005a). Recently, experimental data
questioned the validity of the Exchange model while they supported the Template
model (Mapelli et al., 2006; Nezi et al., 2006; Vink et al., 2006). Here, the two
models were described by sets of chemical reactions, which were transformed into
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Model Parameters
Parameters References
Species initial concentrations
[Cdc20]= 2.2 ∗ 10−7M (Tang et al., 2001; Fang, 2002; Howell et al., 2000a)
[Mad1]= 0.5 ∗ 10−7M (Tang et al., 2001; Fang, 2002; Howell et al., 2000a)
[O-Mad2]= 1.5 ∗ 10−7M (Tang et al., 2001; Fang, 2002; Howell et al., 2000a)
[C-Mad2]= 0.1875 ∗ 10−7M (Tang et al., 2001; Fang, 2002; Howell et al., 2000a)
[Mad1:C-Mad2]= 0.5 ∗ 10−7M (Tang et al., 2001; Fang, 2002; Howell et al., 2000a)
[p31comet ] = 10 ∗ 10−7M (Xia et al., 2004; Mapelli et al., 2006)
Other species are zero
Template model
αT = 5 ∗ 105 M−1s−1 (Vink et al., 2006)
βT = 0.2 s
−1 (Vink et al., 2006)
δT = 1.7 ∗ 106 M−1s−1 (Vink et al., 2006)
ζT = 0.037 s
−1 (Vink et al., 2006)
k4 = 10
3, 105 M−1s−1 This study
k−4 = 0.03 s−1 This study
k5 = 10
3, 105 M−1s−1 This study
γT = 10
5, 106, 107, 108, 109 M−1s−1 This study
ηT = 5 ∗ 10−4, 10−3, 10−2, 10−1s−1 This study
Exchange model
k1 =3 ∗ 10−5 s−1 (Luo et al., 2004)
k−1=5.2 ∗ 10−6 s−1 (Luo et al., 2004)
αE=4 ∗ 103 M−1s−1 (Luo et al., 2004)
k−2=1.5 ∗ 10−2 s−1 (Luo et al., 2004)
k3 =2.8 ∗ 10−4 s−1 (Luo et al., 2004)
k−3=23 M−1s−1 (Luo et al., 2004)
kE =10
5, 106, 107, 108, 109M−1s−1 This study
ηE=3 ∗ 10−5, 5 ∗ 10−4, 10−3, 10−2s−1 This study
Table 3.1: Kinetic data. Species initial concentrations and parameters value for
models.
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sets of nonlinear ordinary differential equations (ODEs). The ODEs quantita-
tively display the dynamic behavior of the models. Where experimental results
were available, parameters were chosen according to these data. The unknown
systems parameters were optimized according to the known behavior of the Cdc20
concentration at the metaphase to anaphase transition (Appendix B B.6).
The Exchange model was suggested by Luo et al. (2004) in order to explain
their experimental data. This model however had been criticized because it is
unable to explain additional experimental data from other groups (Musacchio and
Salmon, 2007; Mapelli et al., 2006; Nezi et al., 2006; Vink et al., 2006) and since
it assumes that Mad1 competes with Cdc20 for Mad2 binding. We identified an
additional weakness of the Exchange model: it is hardly able to show switching
kinetics. This property is model inherent since those reactions involving Cdc20
are kinetochore uncontrolled and are not influenced by microtubule attachment.
Moreover, the steady state is reached very slowly (about 100 times slower than
in the Template model). In addition, when applying experimentally determined
parameter values, the Exchange model is not able to sequester Cdc20 sufficiently
as would be required for MSAC regulation. Even a free parameter optimization
did not result in a satisfying model switching behavior.
In contrast, the behavior of the Mad2 Template model (DeAntoni et al., 2005a) is
in accordance with experimental observations (Fang, 2002; Mapelli et al., 2006;
Vink et al., 2006) and shows robust switching behavior. However, the Cdc20
concentration is only reduced down to about half when experimentally determined
values are used for the model parameters. This observation is in agreement with
Fang (2002), and Luo et al. (2004) in HeLa cells. Complete sequestering of Cdc20
is obtained for higher Mad2 concentrations, as observed by Fang (for a 100fold
higher Mad2 concentration). When increasing the free Mad2 concentration 8fold
in the Template model, we found complete reduction of Cdc20 concentration.
However, there is no experimental indication for such a high Mad2 concentration
in HeLa cells. Thus, although showing robust switching behavior when using
experimentally determined parameter values, the Template model as listed is
unable to result in complete inhibition of Cdc20. This conclusion is in agreement
with statements of Fang (2002). Contributions from additional reaction partners
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are required for complete Cdc20 sequestering. Such a reaction partner seems to be
the checkpoint protein BubR1 which also binds Cdc20 (Fang, 2002; Sudakin et al.,
2001; Tang et al., 2001) and cooperates to form the mitotic checkpoint complex
MCC (Sudakin et al., 2001).
Mad2 heterodimers can bind to either Mad1 or Cdc20 (DeAntoni et al., 2005a,b).
Thus, C-Mad2:Cdc20 complexes can be formed not only at Mad1 kinetochore
sites but in the whole cell, amplifying complex formation. To investigate the
amplification mechanism, we extended the Template model by the appropriate
reactions. When the newly introduced reaction rates are small, these reactions
do not contribute to the model behavior. If however the rates are high, there is
hardly any Cdc20 recovery after switching since these amplification reactions are
not influenced by mitotic progression. Thus, these additional reactions do not
improve Template model behavior.
The checkpoint inhibitor p31comet competes with O-Mad2 for C-Mad2 binding,
thus preventing the binding of O-Mad2 to C-Mad2 (Mapelli et al., 2006; Habu
et al., 2002; Ciliberto et al., 2005). It binds to the surface of C-Mad2 opposite to
Mad1 and Cdc20 (Mapelli et al., 2006; Vink et al., 2006), forming triple complexes
with these proteins. If p31comet is activated at metaphase to anaphase transition,
our model calculations clearly show that p31comet is able to introduce switching
behavior into the model and would be even able to replace the function of the
switching parameter u: The Template model behavior is very similar when u is
removed and p31comet reactions are added to the model. The situation is slightly
different in the presence of the amplification reactions. Now, removing u and
introducing the p31comet reactions, we found no improved Cdc20 recovery for small
reactions rates ξT , however, strongly reduced recovery for large ξT rates. In order
to distinguish between these two cases, additional experimental kinetic data are
required for p31comet reactions. In general we observe that p31comet is not sufficient
for full MSAC regulation. This finding is particularly interesting, because it was
shown in a very general model that amplification reactions might be necessary
to promote the final signal from the last attaching kinetochore for anaphase
onset (Doncic et al., 2005; Sear and Howard, 2006). In (Doncic et al., 2005),
p31comet is explicitly mentioned as a candidate for this information transmission.
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The switching parameter u represents the function of dynein which after micro-
tubule attachment removes the Mad1:C-Mad2 2:2 complex from the kinetochore
site. It might also represent potential additional functions which contribute to
switching behavior. When both, u and p31comet , are included in the reaction
scheme, the general behavior of the system is not improved over those systems
including only u or only p31comet . We observed an improvement however, when
the reaction Eq. (3.9) becomes controlled by u. Now, before attachment, low
concentrations for Cdc20 were observed even for low values of γT , and after at-
tachment Cdc20 recovers fast independent of γT values, showing an considerably
improved regulation behavior. However, we have no experimental indication for a
mitotic control of reaction Eq. (3.9).
3.9 Conclusion
Taken together we conclude, that the presented Exchange model is not describing
checkpoint function. The Template model is clearly superior and shows robust
switching behavior. However, applying experimentally determined parameter
values to this model, Cdc20 is not sequestered completely. Additional reaction
partners would be required for total inhibition of free Cdc20. BubR1 would be
a potential candidate for this function. Thus, as a next step (Chapter 4), MCC
formation including BubR1 and Cdc20 will be included into the quantitative
analysis.
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Chapter 4
Modeling MCC assembly
“The best model of a cat is another cat or, better, the cat itself”.
Norbert Wiener (1894 - 1964)
“One of the deepest functions of a living organisms is to
look ahead... to produce future”.
Francois Jacob (1974 -)
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4.1 Summary
BubR1 binds Cdc20 within two seemingly different contexts. In the first con-
text, it forms an isolated complex with Cdc20, whereas in the second it is part
of a larger complex of proteins (BubR1, Cdc20, Mad2, Bub3) called “Mitotic
Checkpoint Complex”, or MCC. We incorporated both contexts in two different
models, and found that Cdc20 can be fully sequestered by BubR1 neither in the
first nor in the second context. Moreover, it has been postulated that MCC for-
mation can be either Kinetochore-independent (KIM) or Kinetochore-dependent
(KDM) (e.g., Musacchio and Salmon, 2007). We found that only the Kinetochore-
dependent model can -partially- account for the availability of Cdc20 both before
and after the attachment of all chromosomes.
We observed that for the models analyzed, effective MCC formation cannot be
combined with complete Cdc20 sequestering. Instead, the MCC might bind and
completely block the APC. The MSAC might function by an MCC:APC complex
rearrangement.
4.2 Molecular biological basis of MCC models
Sudakin et al. (2001) analysed and described the MCC in HeLa cells. It contains
Mad2, Bub3, BubR1 and Cdc20 in apparently equal stoichiometries. A similar
complex was identified in budding (Hardwick et al., 2000) and fission (Millband and
Hardwick, 2002) yeasts and in Xenopus (Chung and Chen, 2003). Bub3 associates
with BubR1 (Sudakin et al., 2001; Taylor et al., 2004, 1998a). This interaction
is constitutive and is required for the localization of BubR1 to the kinetochores
during mitosis. In prometaphase, CENP-E activates the kinase activity of BubR1
at unattached kinetochores (Mao et al., 2003, 2005; Chan et al., 1998). It is
unclear whether the BubR1 activation is required for MSAC function (Mao et al.,
2003; Chen, 2002b): the kinase activity of BubR1 might not be required in
the MCC, however, it might control other aspects of kinetochore signaling or
chromosome alignment (Ditchfield et al., 2003; Lampson and Kapoor, 2005)
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(reviewed in Musacchio and Salmon (2007)). BubR1 activity is switched off upon
microtubule attachment (Mao et al., 2005; Braunstein et al., 2007).
The binding properties of BubR1 are controverse. BubR1 cannot bind Mad2
directly (Fang, 2002). Though it was reported that BubR1 does not form a ternary
complex with Mad2 and Cdc20 (Bolanos-Garcia et al., 2005; Davenport et al.,
2006), for fission and budding (Burton and Solomon, 2007; King et al., 2007) yeasts
such complexes (with Mad3) were found when investigating the highly conserved
KEN boxes. Two Cdc20 binding sites were identified on BubR1 (Bolanos-Garcia
et al., 2005; Davenport et al., 2006): Binding of the N-terminal region of BubR1
to Cdc20 requires prior binding of Mad2 to Cdc20 (Davenport et al., 2006). The
other site (between residues 490 and 560) can bind Cdc20 tightly regardless of
Mad2 being bound to Cdc20 (Davenport et al., 2006). Thus, BubR1 can form a
ternary complex with Bub3 and Cdc20 which however has no inhibitory activity
at the APC (unpublished data (Sudakin et al., 2001)).
During prometaphase, Cdc20 and all MSAC proteins concentrate at unattached
kinetochores (Cleveland et al., 2003; Maiato et al., 2004), like Mad1 (Campbell
et al., 2001; Chung and Chen, 2002), Mad2 (Fang et al., 1998a; Lampson and
Kapoor, 2005), BubR1 (Morrow et al., 2005; Hoffman et al., 2001), Bub1 (Taylor
et al., 1998a; Chen, 2002b), Bub3 (Taylor et al., 1998a; Howell et al., 2004), and
Mps1 (Stucke et al., 2004, 2002). Kinetochore localization of Cdc20 and of its
binding partners in the MCC is dynamic. Localization of all MSAC proteins at
unattached kinetochores in mitosis provides a catalytic platform and contributes
to MCC formation (Kallio et al., 2002a; Howell et al., 2000b; Shah et al., 2004).
The MCC is also detectable in normal metaphase-arrested cells in which the
MSAC is inactive. This indicates that MCC formation does not require check-
point activation (Poddar et al., 2005). Moreover, the MCC is also detectable in
checkpoint defective cells (Poddar et al., 2005; Fraschini et al., 2001). A detailed
study (Meraldi et al., 2004) proposes that cytosolic Mad2-BubR1 is essential to
restrain anaphase onset early in mitosis when kinetochores are still assembling.
These arguments support the idea that the MCC (and its subcomplexes) might
form in a kinetochore-independent manner (for review see Musacchio and Salmon
(2007)). We thus distinguish two dynamical models (see Figure 4.1): a kinetochore
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dependent model (KDM), and a kinetochore independent model (KIM). In the
following, we define the chemical reaction equations based on empirical results
and analyse their properties.
4.3 Mathematical modeling of the MCC
We analyse different models for MCC function considering in particular the role
of the attachment status of the kinetochore. For each model, we describe the
reaction equations in the usual biochemical notation specifying kinetic constants
and assuming mass action rules to derive the differential equations for the con-
centrations as functions of time. Some of the reactions are independent of the
kinetochore attachment status, others are mediated in some way by attachment or
non-attachment, respectively. The most prominent equation will be the formation
of the MCC complex
Cdc20:C-Mad2 + Bub3:BubR1
kF−−⇀↽ −
k−F
MCC
which, in the “kinetochore dependent model” (KDM), proceeds only, when the
kinetochore is unattached, whereas in the “kinetochore independent model” (KIM)
it proceeds all the time independently of the attachment status. Therefore, in the
KDM, we set kF := k4 · u, where u is a switching parameter, which is set to u = 1
as long as the kinetochore is unattached and switches to u = 0 when it attaches.
The backward reaction with kinetic parameter k−F := k−4 proceeds all the time.
In the KIM, on the contrary, we assume no dependency of the forward reaction on
the attachment status and set kF := k4. In general, more than one equation will
be affected by the kinetochore attachment status, and they will be all regulated by
u. We do not consider down or upregulation by a certain percentage, in agreement
with experimental findings (Vink et al., 2006; Musacchio and Salmon, 2007). For
regulation of reactions proceeding with attached kinetochores only, we use the
factor v = 1− u, as is the case in the model with p31comet contribution.
Biochemically, the switching parameter u represents the function of dynein, which
after microtubule attachment removes the Mad1:C-Mad2 2:2 complex from the
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kinetochore site. It might also represent potential additional functions which
contribute to switching behavior.
From the reaction equations, ordinary differential equations (ODEs) are derived
using mass action kinetics. For a set of given initial concentrations for all reaction
partners, the ODEs are integrated until steady state is reached before attachment
(phase 1). Then u switches from 1 to 0 and the resulting set of equations is again
integrated until steady state is reached (phase 2). For consistency and comparabil-
ity of all models we use the same initial concentrations (c.f. Table 4.1). The actual
values are chosen according to data from the literature. When only a certain
range was known, we have used different starting values for our computations, but
we did not find qualitatively differing trajectories. The kinetic constants are also
taken from literature as far as they are known (Table 5.2). For all other constants
(k2, k3, k5, k7, k8, see Table 5.2), several computations with values representing the
whole physiologically reasonable parameter range are compared. The trajectories
are discussed in corresponding figures. They all show a continuous dependence
of the parameters used. Criteria for comparison of the ability of the model to
show acceptable switching behaviour are the level of MCC depletion and Cdc20
increase and the recovery time after the metaphase to anaphase transition.
4.4 Dynamics of different MCC models
4.4.1 Kinetochore dependent MCC model (KDM)
The Template model (DeAntoni et al., 2005a) for the Cdc20:C-Mad2 complex
formation can be regarded as a seeding reaction to MCC assembly. In our recent
mathematical description and simulation analysis of the Template model (Chap-
ter 3), we found that for realistic Mad2 concentrations, Cdc20 cannot be se-
questered completely in the cell by Mad2 alone. In addition to binding to Mad2,
Cdc20 also binds to BubR1 (Bolanos-Garcia et al., 2005; Davenport et al., 2006;
Chen, 2002b; Fang, 2002) and it might be this protein which sequesters the
remaining part of Cdc20. We therefore added to the reaction equations of the
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Figure 4.1: Schematic networks of MCC models. Black lines represent the
kinetochore dependent (KDM) and the kinetochore independent (KIM) models.
The KDM is obtained for u inside the green circles being = 1 for phase 1 before
kinetochore attachment, and = 0 for phase 2 after attachment. In the KIM, in
contrast, u inside the green circles is = 1 in both phases. The red lines represent
the amplification reactions as defined in section 4.4.3. For biochemical details see
text.
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Template model (Eqs. (4.1)-(4.3), Chapter 3) those reaction equations describing
the interaction with BubR1. The reaction scheme is presented in Figure 4.1 and
the reaction rules (4.1)-(4.6) are listed below. The BubR1 reaction equations
(4.4) for MCC formation and (4.5) for complexation with Bub3 and Cdc20 were
deduced from experimental work (Sudakin et al., 2001; Davenport et al., 2006;
Fang, 2002). Reaction (4.6) and its low rate were mentioned by Musacchio and
Salmon (2007) (see also Fang (2002); Davenport et al. (2006)).
Mad1:C-Mad2 + O-Mad2
k1·u−−−⇀↽ −
k−1
Mad1:C-Mad2:O-Mad2 ∗ (4.1)
Mad1:C-Mad2:O-Mad2 ∗ + Cdc20 k2·u−−−→ Cdc20:C-Mad2 + Mad1:C-Mad2 (4.2)
Cdc20:C-Mad2
k3−−−→ O-Mad2 + Cdc20 (4.3)
Cdc20:C-Mad2 + Bub3:BubR1
k4·u−−−⇀↽ −
k−4
MCC (4.4)
Cdc20 + Bub3:BubR1
k5·u−−−⇀↽ −
k−5
Bub3:BubR1:Cdc20 (4.5)
Cdc20 + O-Mad2
k6−−−→ Cdc20:C-Mad2 (4.6)
The corresponding differential equations are listed in Appendix A, Eqs. (C.1)-
(C.8). The first two reactions (4.1) and (4.2) are kinetochore controlled and
therefore the rates are multiplied by the switching parameter u. In the reaction
scheme we assume that also the BubR1 forward reactions (4.4) and (4.5) are
kinetochore dependent so that also rates k4 and k5 are multiplied by u. Most
concentrations and rates of this reaction scheme were taken from literature (listed
in Table 4.1 and Table 5.2). For k4 we chose a high rate of 10
7 M−1s−1 similar to
k1 and k2 since only for high values of k4 high amounts of MCC would be formed.
Nevertheless, we analysed the consequences of lower values of k4 (see below). k5
should be considerably smaller than k4 and was chosen to be 10
4 M−1s−1. Below,
also the influence of larger values of k5 was studied. The backward reactions k−4
and k−5 should be slow and in the range of the experimental values of k−1; we
put k−4 = 0.02 s−1 and k−5 = 0.2 s−1 (see Table 5.2). For these kinetic data,
we calculated the time-dependent values of all species concentrations. Here we
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focus our discussion on the dynamics of the Cdc20 and MCC concentrations. In
Figure 4.2, the Cdc20 concentration is plotted for three different values of k3
and five different values of k2. With increasing values of k3, we observed faster
switching behavior. For k3 = 0.01 s
−1, switching is already considerably fast,
consistent with the findings for the Template model. k2 hardly influenced the
Cdc20 concentration when being larger than 107 M−1s−1. For no parameter value
combination of k2 and k3 could Cdc20 be sequestered completely. Instead, for low
values of k3 and high values of k2, Cdc20 concentration was reduced to slightly
more than half and other parameter value combinations reduced it even less. The
MCC shows fast switching behavior in all cases considered (see Figure 4.2).
In Figure 4.3a, we show the time course of the concentrations of all eight species
in the model for the physiologically relevent parameters k2 = 10
7M−1s−1 and
k3 = 0.01s
−1. It is interesting to note that [Bub3:BubR1] does not decay to zero
to sequester more Cdc20 into MCC. There is also virtually no Bub3:BubR1:Cdc20
formed. Instead, about 15% of the Bub3:BubR1 concentration remains freely
floating in the cell plasma. Another interesting feature is exhibited by the
Mad1, Mad2, and Cdc20 dynamics. As there is virtually no Mad1:C-Mad2:O-
Mad2* formed, this complex shows its property as short living intermediate
in the reactions (4.1) and (4.2), clearly catalysed by Mad1:C-Mad2, staying at
constant concentration of 0.5 · 10−7 M and transforming O-Mad2 plus Cdc20 into
Cdc20:C-Mad2. Immediately after switching at 2000 s, the MCC releases at a
fast rate Cdc20:C-Mad2, which first increases, but shortly afterwards decays into
its components.
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Figure 4.2: Kinetochore dependent MCC model (KDM). For three different
k3−values, the time evolution within phase 1 before attachment (0-2000 s) and
within phase 2 after attachment (2000-4000 s) of Cdc20 (a1-c1) and MCC (a2-
c2) are shown for five different k2−values (colored lines). Solutions are nearly
independent of k2 for k2 ≥ 107 M−1s−1. Whereas switching behaviour for MCC
is satisfactory for any k3, Cdc20 recovery time becomes short enough only for
k3 ≥ 0.01 s−1.
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a) Kinetochore dependent model (KDM)
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b) Kinetochore independent model (KIM)
Figure 4.3: Species concentrations for KDM (a) and KIM (b). For k2 = 10
7M−1s−1
and k3 = 0.01s
−1, the time evolution of all eight species in the MCC assembly
models are shown before (phase 1, t = 0− 2000 s) and after attachment (phase
2, t = 2000 − 4000 s). Bub3:BubR1 is noy totally used up to sequester Cdc20.
Mad1:C-Mad2 shows its function as a catalyzer for Cdc20:C-Mad2 production.
Time evolution is identical in KDM (a) and KIM (b) before t = 2000 s, but
quantitatively and qualitatively ([Cdc20:C-Mad2]) different after that. Details see
text.
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4.4.2 Kinetochore independent MCC model (KIM)
The line of biochemical reactions placing MCC formation under the control
of the kinetochore are not clear (reviewed by Musacchio and Salmon (2007)).
MCC formation might be kinetochore independent (Poddar et al., 2005; Fraschini
et al., 2001; Meraldi et al., 2004). We therefore analysed a modified kinetochore
independent model in which the reaction equations (4.4) and (4.5) are now replaced
by u–independent equations (4.7) and (4.8) (see Figure 4.1):
Cdc20:C-Mad2 + Bub3:BubR1
k4−−⇀↽−
k−4
MCC (4.7)
Cdc20 + Bub3:BubR1
k5−−⇀↽−
k−5
Bub3:BubR1:Cdc20 (4.8)
The resulting differential equations are the same as in Appendix A, Eqs. (C.1)-
(C.8), except for the kinetic constants k4 · u and k5 · u, which have to be replaced
by k4 and k5, respectively. Using the same initial concentrations (Table 4.1)
and rate values (Table 5.2) as above we calculated the time dependent model
behavior. Of course, until kinetochore attachment, both, time dependence and
concentrations are unchanged since u = 1. After attachment, however, we found
very slow switching and Cdc20 and MCC concentration changes only for larger
k3. Even for large k3, Cdc20 recovery and MCC depletion were not complete (see
Figure 4.4). The quantitative failure of this reaction model indicates that the
BubR1 reactions are kinetochore controlled.
As already done for the KDM, we show the concentration over time curves for all
eight species in the KIM for k2 = 10
7M−1s−1 and k3 = 0.01s−1 in Figure 4.3b. The
characteristic features of the catalyzing reactions (4.1) and (4.2) involving Mad1
remain the same, but there is a drastic qualitative change in the concentration
dynamics of Cdc20:C-Mad2, which decreases immediately after switching, because
without kinetochore control it still restores MCC (Eq. 4.7) besides decaying into
its components (Eq. 4.3). There is thus not only a quantitative change resulting
in a slower dynamics, but also a qualitative change in the time evolution of the
trajectory of [Cdc20:C-Mad2].
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Figure 4.4: Kinetochore independent MCC model (KIM). Same representation as
in Figure 4.2. Concentration curves in phase 1 before attachment (0-2000 s) are
identical to those in Figure 4.2, whereas in phase 2 after attachment (2000-4000
s) the parameter u (in the green circle in Figure 4.1) is still set to u = 1 (no
kinetochore control). As a consequence, switching is very slow. Furthermore,
Cdc20 recovery and MCC depletion levels are poor.
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4.4.3 Amplification effects
DeAntoni et al. (2005a) hypothesized that in analogy to the reactions based on
Mad1 (Eqs. (4.1) and (4.2)), Cdc20:C-Mad2 can also be formed by reactions
catalyzed by O-Mad2 and Cdc20 in a two step mechanism as described by the two
reaction equations (4.9) and (4.10). This additional pathway for the production of
Cdc20:C-Mad2 results in a signal amplification for the MSAC since Cdc20:C-Mad2
now is produced not only at the location of Mad1 at the kinetochore but at a
larger number of locations everywhere in the cell. We checked the effect of this
assumption by adding two additional reactions to the Template model, but we
found no improvement of the Template model behavior (Chapter 3). Also here,
we added the two reaction equations (4.9) and (4.10) to the KDM and analysed
the influence of the amplification on the model (see Figure 4.1, red arrows).
Cdc20:C-Mad2 + O-Mad2
k7−−−⇀↽ −
k−7
Cdc20:C-Mad2:O-Mad2 ∗ (4.9)
Cdc20:C-Mad2:O-Mad2 ∗ + Cdc20 k8−−−→ 2 Cdc20:C-Mad2 (4.10)
When calculating the time-dependent Cdc20 and MCC concentrations, we observed
hardly any change for small values of k7 and k8 (see Figure 4.5, a1-a2) compared
to the KDM (Figure 4.2, b1-b2). This result was expected since for small rates,
reactions (4.9) and (4.10) do not contribute to the model behavior. When, however,
the rates adopt values in the realistic range (k7 = k8 = 10
6 M−1s−1, see Table 5.2),
we observed only little Cdc20 recovery after kinetochore attachment (see Figure 4.5,
b1-b2). This result is due to both reactions being independent of kinetochore
control. The MCC concentration is hardly influenced by these reactions, since
they do not contribute to MCC regulation.
It might be speculated that also the amplification reactions might be somehow
kinetochore dependent. When multiplying the rates k7 and k8 by a switching pa-
rameter u (controlled case), we observed the same model behaviour (see Figure 4.5,
c1-c2 for fast amplification reaction). as for the KDM without amplification (Fig-
ure 4.2, b1-b2). For slow amplification reactions, the concentration curves (figures
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not shown) are virtually identical to those in the uncontrolled case (Figure 4.5,
a1-a2).
4.4.4 p31comet contributions
The negative spindle checkpoint regulator p31comet is a Mad2 ligand. Its negative
effect on the MSAC is based on its competition with O-Mad2 for C-Mad2 bind-
ing (Habu et al., 2002; Xia et al., 2004; Mapelli et al., 2006; Yu, 2006). It forms
triple complexes with C-Mad2 and either Mad1 or Cdc20 (Xia et al., 2004; Vink
et al., 2006; Mapelli et al., 2006). In our analysis of the Template model (Chap-
ter 3), we added a reaction describing the effect of p31comet . We could show that,
when p31comet is activated at microtubule attachment to the kinetochores, it can
function as a cellular factor contributing to the checkpoint switching behavior:
p31comet function can replace the switching parameter u. Here, we introduced the
same p31comet reactions (4.17) and (4.18) to the KDM:
Mad1:C-Mad2 + O-Mad2
k1−−⇀↽−
k−1
Mad1:C-Mad2:O-Mad2 ∗ (4.11)
Mad1:C-Mad2:O-Mad2 ∗ + Cdc20 k2−−→ Cdc20:C-Mad2 + Mad1:C-Mad2 (4.12)
Cdc20:C-Mad2
k3−−−→ O-Mad2 + Cdc20 (4.13)
Cdc20:C-Mad2 + Bub3:BubR1
k4·u−−−⇀↽ −
k−4
MCC (4.14)
Cdc20 + Bub3:BubR1
k5·u−−−⇀↽ −
k−5
Bub3:BubR1:Cdc20 (4.15)
Cdc20 + O-Mad2
k6−−−→ Cdc20:C-Mad2 (4.16)
Mad1:C-Mad2 + p31
k7p·v−−−⇀↽ −
k−7p
Mad1:C-Mad2:p31 (4.17)
Cdc20:C-Mad2 + p31
k8p·v−−−⇀↽ −
k−8p
Cdc20:C-Mad2:p31 (4.18)
This corresponds to the differential equations Eqs. (C.18)-(C.28) in Appendix
C, where v = 1− u. Reaction equations (4.11) and (4.12) are now kinetochore
uncontrolled (no multiplication of the rates by u). However, MCC formation (4.14)
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Figure 4.5: Amplification effects. Here, k3 = 0.01. For slow (a1, a2) and fast (b1,
b2, c1, c2) amplification reaction rates, the concentration curves for Cdc20 and
MCC show fast switching behaviour in the uncontrolled (a1/2-b1/2) as well as in
the controlled (c1-c2) case, where rates k7 and k8 are multiplied by u. Only for
fast (k7 = k8 = 10
6 M−1s−1) amplification reaction rates in the uncontrolled case,
Cdc20 does not recover to the maximal level (b1).
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and the BubR1 reaction (4.15) are not linked to p31comet function, so that these
reactions remain kinetochore controlled with rates multiplied by the switching
parameter u. Thus, the reaction scheme (Eqs. (4.11) - (4.18)) remains kinetochore
dependent. We studied the influence of p31comet on the behavior of this model
and observed, as for the Template model (Chapter 3), that u in reactions (4.1)
and (4.2) can be replaced by p31comet function without changing the behavior
of Cdc20 and MCC (data not shown). In this respect, the switching parameter
u additionally represents p31comet function and further potentially unidentified
reactions by additional proteins. An example could be UbcH10 (Townsley et al.,
1997), which plays a role in checkpoint inactivation (Reddy et al., 2007). Also
other effects like protein activation, inhibition, or degradation might contribute
to u.
When keeping the original KDM (with reactions (4.1) and (4.2) controlled by u,
instead of uncontrolled (4.11) and (4.12)) and including the p31comet contribution
(Eqs. (4.17) and (4.18)), the system behaviour virtually does not change (data
not shown).
4.4.5 Maximum sequestering of Cdc20
For realistic parameter values, Cdc20 cannot be totally sequestered in the MCC
models analysed. As shown in in vitro assays (Fang, 2002), complete Cdc20
binding is obtained when the Mad2 concentration is increased to at least eight-
fold beyond experimentally measured physiological values. Figure 4.6 shows
that indeed for eight-fold higher Mad2 concentrations, the Cdc20 concentration
decreased down to zero for low values of k3 and high values of k2 in our simulation
of the KDM, while the MCC concentration slightly increased independently of
k3. The MCC concentration increased since there is more Cdc20:Mad2 available.
The concentration increase is limited due to limitations in the BubR1:Bub3
concentration.
In addition to Cdc20 reduction to zero due to high Mad2 values, Cdc20 can also
be strongly reduced for high values of k5. In this case, most of BubR1:Bub3
binds Cdc20 and removes it from the cell plasma. Figure 4.7 displays the low
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Cdc20 concentrations for low values of k3 and high values of k2 as well as the
fast switching behavior of the model. However, most of BubR1:Bub3 is used–up
for this reaction so that hardly any MCC can form (see Figure 4.7, a2, for the
lowest value of k3). For higher k3, there is virtually no MCC assembled. Thus,
for high values of k5, strong Cdc20 sequestering is combined with MCC depletion
which would leave the APC uncontrolled. On the other hand, maximum MCC
concentration was obtained for low values k5: in this case, most BubR1:Bub3
contributes to MCC formation so that hardly any BubR1:Bub3:Cdc20 can form
(data not shown).
Thus, for the assumed concentrations of [Bub3:BubR1] = 1.5 · 10−7M and [Cdc20]
= 2.2 · 10−7M (Table 4.1), MCC cannot sequester Cdc20 totally. In addition, the
formation of Bub3:BubR1:Cdc20 (Eq. 4.5) and Cdc20:C-Mad2 by the two step
catalysis (Eq. 4.1 and 4.2) and the direct reaction (Eq. 4.6) are not well suited to
sequester a considerable amount of Cdc20, as Figure 4.3a showed. We therefore
studied the effect of the initial Bub3:BubR1 concentration on the system by
increasing it 8-fold to 10.4 · 10−7 M. The result is shown in Figure 4.8. Comparing
it to Figure 4.2 with [Bub3:BubR1] = 1.3 · 10−7 M, we see a slightly better degree
of Cdc20 sequestering to about 45% of the initial concentration for all values of k3
and k2 ≥ 107. In these cases, also [MCC] attains it maximal level of about 1.3·10−7
M. The corresponding values in Figure 4.2 are depentent on k3. Also, the switching
behaviour for both Bub3:BubR1 concentrations is comparable. Altogether, we
conclude that the Bub3:BubR1 initial concentration has no major influence on
Cdc20 sequestration.
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Figure 4.6: Maximal Cdc20 sequestering through increase of free Mad2. The
dynamical behavior of the KDM showing the time evolution of [Cdc20] (a1-c1)
and [MCC] (a2-c2) for the same values of k2 and k3 as in Figure 4.2. In contrast,
here the Mad2 initial level is 8-fold increased. Cdc20 concentration decreases
to zero for low k3 and high k2, while the MCC concentration increases slightly
independent of k3.
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Figure 4.7: Maximal Cdc20 sequestering through increased BubR1 rates. The
dynamical behavior of the KDM for k5 = 10
8 M−1s−1showing low [Cdc20] for low
k3 and high k2 (a1-c1). Obviously, most of BubR1:Bub3 binds Cdc20, but hardly
any MCC can form (a2, for k3 = 0.001 s
−1). On the other hand, good switching
behaviour for Cdc20 is correlated to a low sequestering degree.
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Figure 4.8: KDM with 8-fold increased BubR1:Bub3 initial concentration. Same
representation as in Figure 4.2. The comparison shows that BubR1:Bub3 initial
concentration has no major influence on Cdc20 sequestration.
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Figure 4.9: KDM with 2-fold increased Free Mad2 initial concentration. Cdc20
got maximum sequestering only for small k3 and very high k2.
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Figure 4.10: KDM with 2-fold increased Bub3:BubR1 initial concentration. Same
representation as in Figure 4.2. The comparison shows that BubR1:Bub3 initial
concentration has no major influence on Cdc20 sequestration.
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Figure 4.11: KDM with 2-fold increased of both free Mad2 as well as Bub3:BubR1
initial concentration. This demonstrates that Cdc20 can be sequestered for very
high k2. Additionally, only the case in which MCC amount can be get about
doubling.
95
4. MODELING MCC ASSEMBLY
4.5 Discussion and Conclusions
Building on our investigation (Chapter 3) of different models for Cdc20:Mad2
complex formation, we have extended the mathematical description of the Template
model by those reaction equations, which describe Cdc20 sequestration. The major
role is played by Bub3:BubR1 and the MCC, which, in turn, blocks the APC.
We analysed MCC formation, distinguishing a “kinetochore dependent model”
(KDM) and a “kinetochore independent model” (KIM). The latter failed to
describe correct metaphase to anaphase switching. Considering the KDM under
realistic conditions, Cdc20 is not sequestered completely but instead remains
in the cell plasma to a considerable amount. Complete Cdc20 binding is either
attained for unrealistically high concentrations of Mad2 or for high rate values
of BubR1:Bub3:Cdc20 formation; the latter, however, sacrifying MCC formation
and thus APC control. The behaviour of the KDM is virtually independent of the
Bub3:BubR1 initial concentration. Amplification effects or a detailed desciption
of p31comet contribution did not improve the situation. These results indicate
that, on the basis of the reactions considered here, the MSAC regulation does not
function through Cdc20 sequestration.
Extending previous work (Sear and Howard, 2006; Doncic et al., 2005) based on
partial differential equations, Doncic et al. (2006) showed in an analysis based on
ordinary differential equations that MSAC can act through Cdc20 sequestration.
Investigating statistical error propagation in two models describing abstract
kinetochore mediated inhibition mechanisms, they exclude that Cdc20 is inhibited
solely by protein degradation. However, both mechanisms, sequestration and
degradation, can act in parallel showing almost linear behaviour in combination.
Their model includes only two species, Cdc20 and an abstract signalling complex
m which could be Mad2 or another sequestering molecule. This comes very close
to our analysis (Chapter 3) of the Template model, where we found complete
sequestering of Cdc20 as confirmed by in vitro assays (Fang, 2002), but only
for unphysiological parameter sets. The same holds true for this investigation
(Figures 4.6, c1, d1, and 4.7, a1, b1).
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Which complexes Bub3:BubR1 is able to form, is a crucial question for MCC
formation. It is a general problem of simulation studies to identify all reaction
schemes and to incorporate them with the correct reaction kinetics. In general,
our study can help to falsify assumptions, but can hardly proof the correctness
of a pathway (Popper, 1935). In our analysis, we have found that the KIM is
very unlikely to describe MCC assembly, but that the KDM could be a basis for
further pathway design.
In our model, we analysed the influence of Cdc20 sequestration on MSAC operation
(Musacchio and Salmon, 2007). In how far partial inhibition of the APC by
the MSAC is tolerable by cell cycle control, is currently unclear. As the basic
reactions, described here and previously (Chapter 3), do not lead to complete
Cdc20 sequestration, we speculate that the MCC binds and completely blocks
the APC. APC activation might then be a consequence of a MCC:APC complex
modification or rearrangement. To investigate the further reaction scheme for
checkpoint function, we have integrated the “kinetochore dependent model” (KDM)
investigated here into a model describing APC inhibition and APCCdc20 formation
after metaphase to anaphase transition, which should be the basis of more complex
investigations. The “tightness” of the APC control might be a topic of these
future studies.
Table 4.1: Initial Concentrations for Integration
Species Initial Comments and References
Concentration
[Cdc20] 2.2 ∗ 10−7M Fang (2002); Howell et al. (2000b); Tang et al. (2001)
[O-Mad2] 1.5 ∗ 10−7M Fang (2002); Howell et al. (2000b); Tang et al. (2001)
[Mad1:C-Mad2] 0.5 ∗ 10−7M Luo et al. (2004); Fang (2002); Howell et al. (2000b)
[Bub3:BubR1] 1.3 ∗ 10−7M Fang (2002); Tang et al. (2001)
[p31comet ] 1 ∗ 10−6M Xia et al. (2004); Mapelli et al. (2006)
Initial Concentrations of other species are zero.
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Table 4.2: Kinetic Parameters
Parameter Value or Range Comments and References
k1 2 ∗ 105 M−1s−1 Vink et al. (2006)
k−1 0.2 s−1 Vink et al. (2006)
k2 10
5, 106, 107, 108, 109 M−1s−1 Chapter 3
k3 10
−3, 10−2, 10−1s−1 Chapter 3
k4 10
7 M−1s−1 This study
k−4 0.02 s−1 This study
k5 10
4, 108 M−1s−1 This study
k−5 0.2 s−1 This study
k6 10
3 M−1s−1 Musacchio and Salmon (2007)
k7 10
4
(slow), 106(fast) M−1s−1 This study
k−7 0.2 s−1 This study
k8 10
4
(slow), 106(fast) M−1s−1 This study
k7p 1.7 ∗ 106 M−1s−1 Vink et al. (2006)
k−7p 0.037 s−1 Vink et al. (2006)
k8p 10
5 M−1s−1 This study
k−8p 0.3 s−1 This study
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Chapter 5
Modeling APC Control
“There is no way in which a simple substance could begin
in the course of nature, since it cannot be formed by
means of compounding”. Gottfried Leibniz (1646 - 1716)
“In mathematics you don’t understand things. You just
get used to them”. Johann von Neumann (1903 - 1957)
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5.1 Summary
We have constructed and validated for the human MSAC mechanism an in silico
dynamical model, integrating 11 proteins and complexes. The model incorporates
the perspectives of three central control pathways, namely Mad1/Mad2 induced
Cdc20 sequestering based on the Template Model (Chapter 3), MCC formation
(Chapter 4), and APC inhibition. Originating from the biochemical reactions for
the underlying molecular processes, non-linear ordinary differential equations for
the concentrations of 11 proteins and complexes of the MSAC are derived. Most
of the kinetic constants are taken from literature, the remaining four unknown
parameters are derived by an evolutionary optimization procedure for an objective
function describing the dynamics of the APC:Cdc20 complex. MCC:APC dissocia-
tion is described by two alternatives, namely the “Dissociation” and the “Convey”
model variants. The attachment of the kinetochore to microtubuli is simulated
by a switching parameter silencing those reactions which are stopped by the
attachment. For both, the Dissociation and the Convey variants, we compare two
different scenarios concerning the microtubule attachment dependent control of
the dissociation reaction. Our model is validated by simulation of ten perturbation
experiments. Only in the controlled case, our models show MSAC behaviour at
meta- to anaphase transition in agreement with experimental observations. Our
simulations revealed that for MSAC activation, Cdc20 is not fully sequestered;
instead APC is inhibited by MCC binding.
5.2 Biochemical background
Our model incorporates three MSAC -related mechanisms: the Template Model,
the (kinetochore dependent) MCC formation, and the APC inhibition. Their
biochemical details will be explained in the following.
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5.2.1 Mad2 Template Model
DeAntoni et al. (2005a) proposed the “Template Model” explaining the mechanism
of Mad2 recruitment to the kinetochore during checkpoint activation and subse-
quent transfer to sequester Cdc20. Recent work by Vink et al. (2006) and Mapelli
et al. (2006) provide additional support for the Template Model. Moreover, this
model has been confirmed by Nezi et al. (2006), and is entirely consistent with
recent Fluorescence Recovery After Photobleaching (FRAP) data (Vink et al.,
2006). The Template Model (DeAntoni et al., 2005a) is superior and more solid
than the Exchange Model (Luo et al., 2004), which we confirmed in a recent in
silico study (for comparison and details see Chapter 3).
The Mad2 Template Model is described by the reaction equations Eqs. (5.1)-(5.3)
(see chemical reaction scheme, below). It is assumed that Mad1 and C-Mad2
form a stable core complex Mad1:C-Mad2 at unattached kinetochores (DeAntoni
et al., 2005a). In our nonlinear ordinary differential equations (ODEs) model,
we assume that this process has already been completed. Therefore, there is no
free Mad1. Equation (5.1) describes how the Mad1:C-Mad2 core complex binds
additional molecules of O-Mad2 through formation of conformational heterodimers
between the C- Mad2 subunit of the Mad1:C-Mad2 complex and O-Mad2. Upon
Mad1:C-Mad2 binding, O-Mad2 adopts an intermediate conformation (O-Mad2*),
which can quickly and efficiently bind Cdc20 and switch to the C-conformation.
This process is documented by Eq. (5.2): Cdc20 binding to the complex Mad1:C-
Mad2:O-Mad2* leads to the conversion of O-Mad2* to C-Mad2 forming together
with Cdc20 the complex Cdc20:C-Mad2; Cdc20:C-Mad2 is assumed then to
dissociate off Mad1:C-Mad2 (Fang, 2002). Finally, we assume that the Cdc20:C-
Mad2 complex can dissociate into Cdc20 and O-Mad2 (Eq. (5.3)).
5.2.2 MCC Assembly
Equations (5.4) and (5.5) describe the formation of the MCC, which contains
Mad2, Bub3, BubR1 and Cdc20 in apparently equal stoichiometries (Sudakin
et al., 2001; Hardwick et al., 2000; Millband and Hardwick, 2002; Chung and Chen,
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2003). Bub3 associates quite stably with BubR1 (Sudakin et al., 2001; Taylor et al.,
2004, 1998a). This interaction is constitutive and is required for the localization
of BubR1 to the kinetochores during mitosis. Like for the Mad1:C-Mad2 complex,
we do not model the dynamics of the formation of the BubR1:Bub3 complex.
BubR1 cannot bind Mad2 directly (Fang, 2002). Moreover, BubR1 does not
form a ternary complex with Mad2 and Cdc20. Two Cdc20 binding sites were
identified on BubR1 (Bolanos-Garcia et al., 2005; Davenport et al., 2006). Binding
of the N-terminal region of BubR1 to Cdc20 requires prior binding of Mad2 to
Cdc20 (Davenport et al., 2006). Consistently, the Bub3:BubR1 complex can bind
to Cdc20:C-Mad2 in order to form the MCC (Eq. (5.4), rate constants k4 and k-4).
The other site of BubR1 (between residues 490 and 560) can bind Cdc20 tightly
regardless of Mad2 being bound to Cdc20 (Davenport et al., 2006). Thus, BubR1
can form a ternary complex with Bub3 and Cdc20 (Eq. (5.5)) which however
has no inhibitory activity at the APC (unpublished data (Sudakin et al., 2001)).
Equation (5.6) and its low rate were mentioned Musacchio and Salmon (2007)
(details are discussed in Chapter 4).
5.2.3 APC Inhibition
The MCC is considered to be essential for MSAC function, because it binds and
inhibits the APC (see Chapter 2) However, MCC inhibits only the mitotic, and not
the interphase APC (Pinsky and Biggins, 2005). The interaction between APC
and MCC is quite labile in the absence of unattached kinetochores (Sudakin et al.,
2001). How the MCC inhibits APC activity is poorly understood (Musacchio and
Salmon, 2007). The MCC might bind to the APC as a pseudosubstrate due to a
KEN-box motif in BubR1 (Fang, 2002; Morrow et al., 2005; Burton and Solomon,
2007; King et al., 2007). This indicates that the MCC needs to disassemble from
the APC at metaphase to elicit anaphase (Morrow et al., 2005; Fang, 2002). Bub1
and Aurora-B kinase contribute directly to the formation of a complex of the MCC
with the APC (Morrow et al., 2005) (represented by k7 in Eq. (5.7)). Unattached
kinetochores might sensitize the APC for inhibition by the MCC (Sudakin et al.,
2001; Chan et al., 2005; Doncic et al., 2005; Sear and Howard, 2006) (represented
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by u in Eq. (5.7), see below). In addition to kinetochore attachment, tension
is important for MSAC inactivation (Nicklas et al., 1995; Nicklas, 1997): if both
sister kinetochores attach to microtubules from the same pole, not enough tension
is generated and microtubules kinetochore attachment is destabilized to correct
the problem (Musacchio and Salmon, 2007). This destabilization depends on
Aurora-B kinase (Hauf et al., 2003; Pinsky and Biggins, 2005; Tanaka et al.,
2002; Lampson et al., 2004). Again, these effects are subsumed by the switching
parameter u. For complex dissociation we consider two model variants:
In the “Dissociation variant”, we assume that MCC binds to APC and that this
binding is reversible (Eq. (5.7)). Free Cdc20 has to bind reversibly to APC (Eq.
(6.7a)), effectively competing with MCC.
In the “Convey variant”, we do not assume that the APC:MCC complex simply
dissociates into APC and MCC, but that the MCC complex falls apart so that
the Cdc20 contained in the MCC complex can bind to the APC (Eq. (6.7b)).
5.2.4 Control by Attachment
Several reactions in the reaction scheme are controlled by the attachment of
microtubules to the kinetochore which is realized by the factor u present in several
reaction equations (Chapter 3). Factor u represents the function of proteins like
p31comet , UbcH10, and Dynein (and its activator Spindly (Griffis et al., 2007)).
p31comet prevents further Mad2 turnover on Mad1 and neutralizes the inhibitory
activity of Cdc20-bound Mad2 (Habu et al., 2002; Xia et al., 2004; Mapelli et al.,
2006; Yang et al., 2007). Catalytically active UbcH10 can promote the release
of checkpoint proteins from APC (Reddy et al., 2007). Dynein (Howell et al.,
2001) removes the Mad1:C-Mad2 2:2 complex from the kinetochore site after
microtubule attachment. Thus, p31comet , UbcH10, and Dynein work in concert
during checkpoint inactivation.
Also the MCC:APC complex dissociation might be attachment controlled. We
therefore introduced the factor u′ in Eq. (6.7a) and Eq. (6.7b), allowing us to
compare the uncontrolled (u′= 1) with the controlled (u′= 0 before and u′= 1
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after attachment) case. The switching parameter u′ might represent the protein
function of Usp44, which deubiquitinates the APC co-activator Cdc20 both in
vitro and in vivo, and thereby directly counteracts the APC-driven disassembly of
Mad2:Cdc20 complexes (Stegmeier et al., 2007; Diaz-Martinez and Yu, 2007).
5.2.5 Chemical Reaction Scheme
In our model of the MSAC mechanism, 9 biochemical reaction equations describe
the dynamics of the following 11 species: Mad1:C-Mad2, O-Mad2, Mad1:C-
Mad2:O-Mad2*, Cdc20, Cdc20:C-Mad2, Bub3:BubR1, MCC, Bub3:BubR1:Cdc20,
APC, MCC:APC, and APC:Cdc20. Because the dissociation of the MCC:APC
complex is not known in detail, we introduce two variants for the reaction equation
for MCC:APC dissociation.
The Dissociation variant is defined by the following reaction rules (Figure 5.1, red
lines):
Mad1:C-Mad2 + O-Mad2
k1.u−−−−⇀↽ −
k−1
Mad1:C-Mad2:O-Mad2 ∗ (5.1)
Mad1:C-Mad2:O-Mad2 ∗ + Cdc20 k2.u−−−→ Cdc20:C-Mad2 + Mad1:C-Mad2 (5.2)
Cdc20:C-Mad2
k3−−−−→ O-Mad2 + Cdc20 (5.3)
Cdc20:C-Mad2 + Bub3:BubR1
k4.u−−−−⇀↽ −
k−4
MCC (5.4)
Cdc20 + Bub3:BubR1
k5.u−−−−⇀↽ −
k−5
Bub3:BubR1:Cdc20 (5.5)
Cdc20 + O-Mad2
k6−−−−→ Cdc20:C-Mad2 (5.6)
MCC + APC
k7.u−−−→ MCC:APC (5.7)
MCC:APC
k−7.u′−−−→ APC + MCC (6.7a)
APC + Cdc20
k8−−−⇀↽ −
k−8
APC:Cdc20 (5.8)
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The reaction rules defining the second variant, the Convey variant, are differ-
ent from this set by replacing the back reaction Eq. (6.7a) by Eq. (6.7b) (see
Figure 5.1, green lines):
MCC:APC
k−7.u′−−−→ APC:Cdc20 + O-Mad2 + Bub3:BubR1 (6.7b)
Both variants are controlled by the switching parameters u and u′. They represent
a signal generated by the unattached and attached kinetochores, respectively. If
the kinetochore is unattached, we set u = 1, otherwise u= 0. For instance,
formation of Mad1:C-Mad2:O-Mad2* (Eq. 5.1) can only take place as long as the
kinetochores are unattached (DeAntoni et al., 2005a).
The switching parameter u′ represents an additional hypothetical control, whose
biochemical realization is described above. For each of the two resolution pathways,
we therefore considered two scenarios: In the first, we assume that this control
does not exist by setting u′= 1. In the second, we assume that there is a control
by setting u′= 1− u. This is summarized in Table 5.1:
Model Variants
Scenario Model Reaction rules Control of MCC:APC
variants dissociation
Uncontrolled Dissociation Eqs. (5.1)-(5.7), (6.7a), (5.8) u′= 1
Controlled Dissociation Eqs. (5.1)-(5.7), (6.7a), (5.8) u′= 1−u
Uncontrolled Convey Eqs. (5.1)-(5.7), (6.7b), (5.8) u′= 1
Controlled Convey Eqs. (5.1)-(5.7), (6.7b), (5.8) u′= 1−u
Table 5.1: Model Variants, related equations, control status of MCC:APC dissoci-
ation.
5.2.6 Mathematical Treatment and Simulation
By applying general principles of mass-action kinetics, we converted the reaction
rules into sets of time dependent nonlinear ordinary differential equations (ODEs)
for the Dissociation variant (Appendix D, Eqs. (D.1)-(D.11)) and for the Convey
variant (Appendix D, Eqs. (D.12)-(D.22)).
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Figure 5.1: Schematic network of the MSAC model. The arrows describe the inter-
actions between the proteins and complexes. Red lines represent the “Dissociation
variant”, green lines represents the “Convey variant”, while the black arrows are
common to both. The switching parameter u models the effect of the attachment.
We set u= 1 for the unattached case and u= 0 for the attached case. We set
u′= 1 for the uncontrolled scenario and u′= 1− u for the controlled scenario(see
Table 5.1).
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For the rate constants ki, we selected experimentally determined values, if available
(Table 5.2). In the other cases, we selected representative values exemplifying
their whole physiologically possible range. We also fitted unspecified parame-
ters by minimizing an APC:Cdc20 concentration dependent objective functional
(Appendix D, D.3), taking into account the range of parameter values from ex-
periments (Fang, 2002; Howell et al., 2000a; Tang et al., 2001; Vink et al., 2006;
Musacchio and Salmon, 2007).
In a typical simulation, we initialized all reaction partners according to Table 5.2
and numerically integrated the ODEs until steady state was reached using u= 1
(denoting unattached kinetochores). Then we set u= 0 (kinetochores attached)
and continued integrating the ODEs until we again reached a steady state.
The minimum concentration of APC:Cdc20 before attachment and the speed of
recovery after attachment (recovery time) are criteria for MSAC function and were
analyzed to compare the models. Deduced from the biochemical data (see above),
the APC:Cdc20 concentration must be low before and the recovery must be fast
after attachment.
5.3 Results
We developed a theoretical model of the human biochemical mitotic checkpoint
at meta- to anaphase transition. As described in the literature, many proteins
contribute to checkpoint function. The key players and their interactions are
captured by the reaction equations introduced in the previous section. We
transformed these equations into ODEs and selected specific values for the initial
concentrations and rate constants from the literature and our previous publications
(summarized by Table 5.2). For only four values we could not identify specific
data in the literature. We obtained these values by optimizing the properties of
the model according to the APC:Cdc20 level: this complex level should be low in
metaphase and high in anaphase; furthermore, the switching should be fast (see
Appendix D for details). We found good behavior of the model network for the
values k7 = 10
8M−1s−1, k−7 = 0.08s−1, k8 = 5 ∗ 106M−1s−1, and k−8 = 0.08s−1.
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Model parameters
Parameters Comments and References
Species initial concentration
[Cdc20]= 2.2 ∗ 10−7M (Fang, 2002; Howell et al., 2000a; Tang et al., 2001)
[Mad2]total= 2 ∗ 10−7M (Fang, 2002; Howell et al., 2000a; Tang et al., 2001)
[BubR1:Bub3]= 1.3 ∗ 10−7M (Fang, 2002; Tang et al., 2001)
[APC]= 0.9 ∗ 10−7M (Stegmeier et al., 2007)
Other species are zero
Species concentration ratios
25% of [Mad2]total associated with (Luo et al., 2004; Fang, 2002)
Mad1, [Mad1:C-Mad2]=25%[Mad2]total
[O-Mad2]= 75%[Mad2]total
Model - Parameters
k1 = 2 ∗ 105 M−1s−1 (Vink et al., 2006)
k−1 = 2 ∗ 10−1 s−1 (Vink et al., 2006)
k2 = 10
8M−1s−1 Chapter 3
k3 = 1 ∗ 10−2s−1 Chapter 3
k4 = 10
7 M−1s−1 Chapter 3
k−4 = 2 ∗ 10−2 s−1 Chapter 3
k5 = 10
4 M−1s−1 Chapter 3
k−5 = 2 ∗ 10−1 s−1 Chapter 3
k6 = 10
3 M−1s−1 (Musacchio and Salmon, 2007)
k7 = 10
8 M−1s−1 This study
k−7 = 8 ∗ 10−2 s−1 This study
k8 = 5 ∗ 106 M−1s−1 This study
k−8 = 8 ∗ 10−2 s−1 This study
Table 5.2: Model parameters: Initial concentration and rate constants.
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5.3.1 MSAC Model Behavior
We analyzed the dynamics of the model integrating 11 proteins and complexes
of the MSAC . The literature does not provide a clear view, yet, about how
the MCC:APC complex dissociates resulting in APC activation. Therefore, we
introduced two alternative reaction pathways: In the first variant, we assume
that the MCC:APC complex dissociate into MCC and APC (reaction Eq. (6.7a)),
subsequently allowing the MCC to disassemble into its parts according to reaction
Eq. (5.4) (Dissociation variant). In the second variant, the MCC component
Cdc20 may stay in the complex with APC and only the further MCC complex
members dissociate according to reaction Eq. ( 6.7b)(Convey variant).
Figure 5.2 displays the APC:Cdc20 concentrations over time. For both, Dis-
sociation and Convey variant, we have selected the time range such that each
concentration can reach steady state. For all calculations, the concentrations and
rates of Table 5.2 were chosen including those for k7, k8, and k−8. We varied
the rate of k−7 (dissociation of MCC:APC) between 0.0008 and 0.08, because
k−7 is unknown and crucial for model behavior. For both model variants, we
distinguished 2 scenarios: in one scenario reaction Eq. (6.7a) (or Eq. (6.7b))
of the checkpoint is valid all the time (“uncontrolled”), while in the other case
this reaction is silenced until it is activated by microtubule attachment to the
kinetochore (“controlled”). This property of the controlled case is realized by
introducing the factor u′for reaction Eq. (6.7a) and Eq. (6.7b).
In the uncontrolled case, our model cannot explain the checkpoint behavior,
independently of which pathway is chosen (Figure 5.2 A-B). For the Dissociation
variant, the APC:Cdc20 concentration is low for low values of k−7, however, in
this case the switching recovery is unrealistically slow. On the other hand, for fast
switching, k−7 must be high resulting in an increased APC:Cdc20 concentration
before attachment (Figure 5.2 A-B). This behavior is even worse for the Convey
variant in the uncontrolled case (Figure 5.2 B). For low values of k−7, both
pathways behave rather similarly; for higher values of k−7 the Convey variant is
even less satisfying compared to the Dissociation variant.
109
5. MODELING APC CONTROL
The Dissociation variant The Convey variant
A B
0 1000 2000 3000 4000
0
0.2
0.4
0.6
0.8
1
x 10−7
Time (s)
[A
PC
Cd
c2
0]
 (M
)
k
−7
 
 
0.0008
0.001
0.004
0.008
0.08
0 1000 2000 3000 4000
0
0.2
0.4
0.6
0.8
1
x 10−7
Time (s)
[A
PC
Cd
c2
0]
 (M
)
k
−7
 
 
0.0008
0.001
0.004
0.008
0.08
uncontrolled (u′= 1) uncontrolled (u′= 1)
C D
0 1000 2000 3000 4000
0
0.2
0.4
0.6
0.8
1
x 10−7
Time (s)
[A
PC
Cd
c2
0]
 (M
)
k
−7
 
 
0.0008
0.001
0.004
0.008
0.08
0 1000 2000 3000 4000
0
0.2
0.4
0.6
0.8
1
x 10−7
Time (s)
[A
PC
Cd
c2
0]
 (M
)
k
−7
 
 
0.0008
0.001
0.004
0.008
0.08
controlled (u′= 1−u) controlled (u′= 1−u)
Figure 5.2: Dynamical behavior of APC:Cdc20 concentration versus time for the
Dissociation variant (A, C) and the Convey variant (B, D) each in the uncontrolled
(A, B) and the controlled (C, D) case. Calculation results are presented for different
values of the rate k7 in [s
−1], as indicated. The APC:Cdc20 concentration should be
close to zero before attachment and should rise quickly after attachment. Spindle
attachment occurs at t=2000s (switching parameter u from 1 to 0). Parameters
setting according to Table 5.1 and Table 5.2.
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In the controlled case, we introduced the factor u′(see above) regulating reaction
Eq. (6.7a) and Eq. (6.7b), and re-calculated the model. Both pathways fully inhibit
APC:Cdc20 before attachment and both show very fast switching recovery for
high k−7 values (Figure 5.2 C-D). Thus, a distinction between the two pathways
in the controlled case is not possible based on our theoretical results. We observed
that the controlled Convey variant is slightly faster (by about 5 mins) in switching
compared to the controlled Dissociation variant. This makes the Convey variant
slightly superior, however, we think that this difference is too small for a clear
preference between the two pathways. Experimental measurements have to
distinguish between these cases. Such experiments are in progress in our laboratory.
In addition to the APC:Cdc20 concentration values, we also analyzed the time-
dependent concentrations of all reaction components. We observed differences
between the two pathways in the controlled case for sub-complexes like Cdc20:C-
Mad2 and MCC (Figures 5.4 5.5).
In our simulations, the MCC completely sequesters the APC so that no free APC
is available until the microtubules are attached. Thus, Cdc20 has a dual function:
until kinetochore attachment, Cdc20 contributes to MCC formation and thus
APC inhibition, while after attachment Cdc20 acts as the APC activator. The
effect of the switching parameter u is presented in Figure 5.3, where u varied
between 1 and 0 for 101 time instead of two values 1 and 0.
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Figure 5.3: Kinetochore switching signal (u and u′) on Models Simulation. The
signal has taken for 101 increments between 0 and 1. Figures A and B for the
controlled case. Figures C and D for the uncontrolled case.
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The Dissociation variant
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Figure 5.4: Species concentration over time for the controlled Dissociation (wild
type). Spindle attachment occurs at t = 2000s (switching parameter u from 1 to
0 and u′from 0 to 1). Parameters setting according to Table 5.2.
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The Convey variant
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Figure 5.5: Species concentration over time for the controlled Convey variants
(wild type). Spindle attachment occurs at t = 2000s (switching parameter u from
1 to 0 and u′from 0 to 1). Parameters setting according to Table 5.2.
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5.3.2 Model Validation by Mutation Experiments
In order to validate our model, we tested different mutations (deletion and over-
expression) of the proteins and complexes involved, measured in different organisms
(Table 5.3).
Recent experimental studies report that deletion in different organisms of any
of Mad2 (Nezi et al., 2006; Dobles et al., 2000; Michel et al., 2001; Fang et al.,
1998b),Mad1 (Kienitz et al., 2005; Lee and Spencer, 2004; Iwanaga et al., 2007;
Hardwick and Murray, 1995; Chen et al., 1999b), Bub3 (Kalitsis et al., 2000; Taylor
et al., 1998b), BubR1 (Davenport et al., 2006; Wang et al., 2004b; Schmidt and
Medema, 2006; Hanks et al., 2004), Cdc20 (Zhang and Lees, 2001b), Bub1 (Basu
et al., 1999; Taylor et al., 1998b), or Aurora B (Kallio et al., 2002b; Biggins and
Murray, 2001; Cheeseman et al., 2002) resulted in MSAC defects like premature
sister-chromatid separation, no mitotic arrest, reduced partner binding, increase
of polyploidy, or death. Experimental details and our model predictions are in
qualitative agreement as summarized in Table 5.3: For example, over-expression
of Mad2 (He et al., 1997; DeAntoni et al., 2005a) activates the MSAC resulting in
mitotic arrest, while over-expression of Cdc20 (Hwang et al., 1998) allows cells
to exit from mitosis, however with a depolymerized spindle or damaged DNA.
Deletion of any of the APC subunits Cdc26, Apc9, Cdc6 or Doc1 disrupts complex
association (Passmore, 2004b; Boronat and Campbell, 2007) with no anaphase
initiation. We observed that deletions and/or over-expression of proteins, realized
experimentally or in our model, change checkpoint function in the same way.
For the essential checkpoint proteins, Mad2 and Cdc20, we present the mutation
effect on our model in detail in Figure 5.6 for the Convey variant. The effect is
basically the same for the Dissociation variant (Figure 5.7). For Mad2 or Cdc20
deletion, the concentrations of all model components are rather stable, that is,
they are almost not affected by microtubule attachment. However, in the case
of Mad2 deletion, the APC:Cdc20 concentration is high (Figure 5.6 A) while
for Cdc20 deletion this concentration is zero by definition (Figure 5.6 C). In the
case of Mad2 or Cdc20 over-expression, many component concentrations were
affected. In particular, for Mad2 over-expression the APC:Cdc20 concentration
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remains low before and significantly lower than in the wild type after attachment,
explaining mitotic arrest and the delay of exit from mitosis (Figure 5.6 B). In
contrast, for Cdc20 over-expression, the APC:Cdc20 concentration is high before
and after attachment (Figure 5.6 D) resulting in total checkpoint failure. Thus,
our MSAC model is able to explain the presented mutation phenotypes (Table 5.3,
Figures 5.6 5.7 5.9 5.8).
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5.4 Discussion
Although our model is able to explain checkpoint function, this explanation does
not contain details regarding the bio-molecular nature of the switching signal
represented by the abstract factor u in our model. For a general explanation of
mitosis it is desirable to replace the abstract factor u by chemical reactions of
species like p31comet , Dynein, Usp44, and/or UbcH10. These species play a role
in the signaling of the attachment to the MSAC control network we modeled here.
When further biochemical details become available, we will replace u by a network
model encompassing these species. Other additional proteins and complexes
are involved in MSAC function implicitly. These species grant localization of
outer kinetochore proteins as well as checkpoint proteins, which do not appear
in our model explicitly. Examples are Bub1 (responsible for Bub3 and BubR1
localization (Taylor et al., 1998a; Chen, 2002b; Larsen et al., 2007)) and Mps1,
an essential component of the MSAC (Hardwick et al., 1996; Stucke et al., 2002;
Palframan et al., 2006; Abrieu et al., 2001; Millband and Hardwick, 2002) required
for kinetochore localization of Mad1 and Mad2 (Vigneron et al., 2004; Liu et al.,
2003; Stucke et al., 2004; Hoffman et al., 2001; Fisk et al., 2004; Fisk and Winey,
2004, 2001; Tang et al., 2004). Considering these additional proteins and their
spatial localization would be an important next step towards a systems level model
of mitosis.
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Figure 5.6: Simulation of Mad2 and Cdc20 mutations for the controlled Convey
variant. For deletion we set the respective initial concentration 100 times lower,
and for over-expression 1000 times higher. Further setting as in Figure5.4
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Figure 5.7: Simulation of Mad2 and Cdc20 mutations for the controlled Dissoci-
ation variant. For deletion we set the respective initial concentration 100 times
lower, and for over-expression 10000 times higher. Note that Bub3 deletion has
same effect as BubR1 (data not shown), and Bub1 has the same effect as aurora
B (data not shown). Further setting as in Figure 5.2.
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Figure 5.8: Simulation of BubR1, Aurora B, Mad1, and APC (subunits) for
the controlled Dissociation variant. For deletion we set the respective initial
concentration 100 times lower. Further setting as in Figure 5.2.
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Figure 5.9: Simulation of BubR1, Aurora B, Mad1, and APC (subunits) for the
controlled Convey variant. For deletion we set the respective initial concentration
100 times lower. Further setting as in Figure 5.2.
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Chapter 6
Robustness and Stochasticity Effect
“If I feel unhappy, I do mathematics to become happy.
If I am happy, I do mathematics to keep happy.”.
Alfred Re´nyi (1921 - 1970).
“A Mathematician is someone who can take a cup of coffee and
turn it into a theory”. Paul Erdo¨s (1913 - 1996)
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6. ROBUSTNESS AND STOCHASTICITY EFFECT
6.1 Summary
Intrinsic fluctuations due to the stochastic nature of biochemical reactions can
have large effects on the response of biochemical networks. In this chapter, we
view results from stochastic differential equations to capture noise and fluctuations
effects. We have developed a “qualitative” model based on 14 proteins and
complexes to describe concentration dynamics by nonlinear ordinary differential
equations in three compartments coupled by diffusion. One kinetochore in each
compartment determines the attachment status to the spindle pole. Here, we
focus on the role of noise in the segregation surveillance process. The deterministic
differential equations are enriched by a stochastic term adding white noise of
different amplitudes. Obviously, for the known physiological parameter ranges,
noise does not disturb the checkpoint function. On the other hand, there is
a connection between diffusion and noise, that could become important when
considering a larger number of chromosomes.
6.2 Introduction
Several deterministic models have been presented for the mitosis control during
the past few months (Ibrahim et al., 2008a,b; Toth et al., 2007). When studying
the behavior of these deterministic models, it has become clear that, with the
given parameter values, the deterministic models, and in more general cell cycle
models, are not capable of reproducing the experimentally observed irregular
behavior in vitro in response to noise (Steuer, 2004).
Although most cellular processes proceed in a spatially and temporally ordered
fashion, not all noise is rejected (Rao et al., 2002). Moreover, it has become clear
that the role of intrinsic noise in cellular functions may be complex and cannot
always be treated as a small perturbation to the deterministic behavior (Steuer
et al., 2003). Different studies have explored the influence of molecular fluctuations
on complex processes and cases have been found where noise seems to be essential
for the required biological function (Steuer, 2004). In addition, this type of
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modeling is becoming increasingly important in the field of systems biology, e.g.
for modeling the cell cycle and gene regulation (Steuer, 2004; Battogtokh and
Tyson, 2004; Chen et al., 2005; Steuer et al., 2003; Kaern et al., 2005; Kepler
and Elston, 2001). Cell cycle control is subject to fluctuations from different
sources (Battogtokh and Tyson, 2004; Steuer, 2004) in a natural environment.
In this chapter, we focus on the investigation of the role of noise in a qualitative
deterministic model as it studied and mentioned in (Ibrahim et al., 2007; Lenser
et al., 2007). Here, we make use of stochastic differential equations (SDEs) to simu-
late in particular the implications of molecular fluctuations on the Mitotic Spindle
Assembly Checkpoint (MSAC ). Regarding the concentrations of [APC:Cdc20]
and [MCC:APC] as measurements for the switch triggering exit from metaphase
to anaphase, we model the dynamics of these concentrations in dependency of
attachment states of the involved kinetochores by a deterministic description of
a network of 14 proteins and protein complexes which regulate the dynamics
of [APC:Cdc20] and [MCC:APC]. Only when the last kinetochore attaches, the
APC:Cdc20 complex is allowed to form and thus starts a signalling cascade leading
to onset of anaphase. Adding white noise to the deterministic equations allows
the investigation of fluctuation effects.
6.3 The Model and its Simulation
In our model, we consider 14 proteins and protein complexes, called species here,
namely Mad2, Mad1, BubR1, Bub3, Mad2∗, Mad1∗, BubR1∗, BubR1:Bub3, APC,
Cdc20, MCC, MCC:APC, Cdc20:Mad2, and APC:Cdc20. A detailed quantitative
bio-molecular description of the reactions involved can be found in (Ibrahim et al.,
2008a). In an illustration( Figure6.1), we show the proteins, indicating also their
localization in the reaction process. Here, we summarize the reaction equations.
Three activation reactions are mediated by the kinetochore:
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Mad2
α−−⇀↽ −
k−1
Mad2 ∗ (6.1)
Mad1
β−−⇀↽ −
k−2
Mad1 ∗ (6.2)
BubR1
γ−−⇀↽ −
k−3
BubR1 ∗ (6.3)
The forward reactions with kinetic constants α, β, and γ (Table 6.1) in the
unattached state stop when the kinetochore attaches. Therefore, in the attached
state, we put α = β = γ = 0. Therefore, Mad2∗, Mad1∗, and BubR1∗ are not
any longer produced by activation at the respective kinetochore, but they are
still supplied by diffusion from other compartments with unattached kinetochores.
The backward reactions as well as all other reaction equations are not influenced
by the attachment status of the kinetochore:
BubR1 + Bub3
k4−−⇀↽ −
k−4
BubR1:Bub3 (6.4)
Mad2 + BubR1:Bub3 + Cdc20
k5−−⇀↽ −
k−5
MCC (6.5)
MCC + APC
k6−−⇀↽ −
k−6
MCC : APC (6.6)
Mad2 ∗+Mad1 ∗+Cdc20 k7−−→ Cdc20:Mad2 + Mad1 (6.7)
Cdc20:Mad2 k8−−→ Cdc20 + Mad2 (6.8)
MCC:APC Inhibitors−−−−−−→
⊥
BubR1∗
Cdc20:Mad2
APC:Cdc20 + BubR1:Bub3 + Mad2 (6.9)
APC:Cdc20
k9−−⇀↽ −
k−9
APC + Cdc20 (6.10)
Cdc20:Mad2 + BubR1:Bub3
k10−−→ MCC (6.11)
The reaction equations define ordinary differential equations for the concentrations
of the respective molecules. Mass action kinetics is assumed for reaction rules
(6.1)-(6.8) and (6.10)-(6.11). Not much is known about MCC:APC dissociation
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(6.9), so we have used a mixed inhibition function of Michaelis-Menten type:
fInh(S, I) =
V ∗ S
km ∗ (1 + I
kis
) + S ∗ (1 + I
kic
)
where S ≡ [MCC:APC] is the substrate , I ≡ [BubR1∗] + [Cdc20:Mad2] is the
inhibitor concentration, V is the forward maximum velocity, km is the forward
Michaelis-Menten constant, kis is the specific (competitive) inhibition constant,
and kic is the catalytic (noncompetitive) inhibition constant.
Here, we give examples for two of the 14 ordinary differential equations, namely
for the concentration of the complexes MCC:APC and APC:Cdc20 :
d[MCC:APC]
dt
= k6[MCC][APC]− k−6[MCC:APC]− fInh(S, I) (6.12)
d[APC:Cdc20]
dt
= fInh(S, I)− k10[APC:Cdc20] + k−10[APC][Cdc20](6.13)
The equations described so far show the evolution in time of the concentrations
of the 14 species near one kinetochore. To concentrate on the main effects, we
consider three compartments X, Y, and Z in a linear spatial arrangement, so
that molecules can only diffuse between X and Y , and between Y and Z. Each
compartment contains one kinetochore, which can be attached or not attached
to the spindle. As mentioned before, the attachment of the spindle within a
specific compartment is represented as a change of parameters α, β, and γ in that
compartment according to the values in Table 6.1 (unattached) and the value 0
(attached).
Instead of introducing spatial variables, we use Fick’s first law to describe diffusion
between compartments. In our simulation with discretized time, diffusion is then
discribed by a characteristic constant Ω =
D
l2
(Paliwal et al., 2004; Thorwarth
et al., 2005) that multiplies the concentration differences. We obtain for a species
i and reaction terms Ri,A in compartment A the following equations:
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d[i]X/dt = Ω([i]Y − [i]X) +Ri,X (6.14)
d[i]Y /dt = Ω([i]X − 2[i]Y + [i]Z) +Ri,Y (6.15)
d[i]Z/dt = Ω([i]Y − [i]Z) +Ri,Z (6.16)
Because many biological details are yet unknown, we set Ω = 1s−1, assuming
a diffusion constant of D = 0.01µm2s−1 and a distance of l = 10µm between
compartments for all substances. This estimate is based on the known diffusion
constants.
In these equations, subscripts X, Y, and Z denote the concentrations of the specific
species in the respective compartment. Hence, the complete system consists of 42
concentration functions of time as solution of a system of 42 ordinary differential
equations. Note, that attachment states of the three compartments are additional
parameters. Beginning with initial concentrations taken from literature (e.g. (Chen
et al., 2004)), the equations are integrated with all attachment parameters in
the state “unattached” (symbolized by UUU) until equilibrium is reached. Then,
attachment parameter of compartment X is turned on (UUA), and the three
activation reactions (6.1)-(6.3) in X are set to zero. After equilibrium is reached
again, attachment in compartment Y is turned on (UAA) until equlibrium is
reached. Finally, all three kinetochores are attached (AAA). These symbols are
also used in Figures 6.2–6.4, where they designate the end of the simulation time
of the respective phase.
For integration, those kinetic constants, which are documented in the literature,
are used directly, whereas for all other constants physiologically reasonable values
are substituted. This is done for many choices, and performance of the model
is optimized according to an objective function measuring the concentration of
APC:Cdc20, which should be 0 for the first three phases UUU, UUA, UAA, and
should rise to a maximal value in phase AAA within a time scale of about 3
to 5 minutes. The optimization details can be found in (Ibrahim et al., 2008a).
As a result, the values in Table 6.1 were found as optimal values for the kinetic
parameters. They are also used in our perturbation model here.
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Figure 6.1: Reaction network for one compartment. The activation reactions with
parameters α, β, and γ continue, as long as the kinetochore is unattached (left).
When the respective kinetochore attaches, α, β, and γ are set to 0. A network
of reactions leads to the formation of the MCC:APC complex (middle). These
reactions continue as long as there is at least one unattached kinetochore. This is
the consequence of the diffusion in the system, because the respective kinetochore
does not any longer supply activated Mad1∗, Mad2∗, and BubR1∗. When the
last kinetochore attaches, the APC:Cdc20 complex begins to form and leads to a
cascade of reactions cutting cohesin in the end and initiating anaphase (right).
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Kinetic parameters
α = 4.82 k−1 = 0.00752 k7 = 10.0
β = 9.92 k−2 = 0.00100 k8 = 0.00235
γ = 6.08 k−3 = 9.83 k9 = 0.00271 k−9 = 10.0
k4 = 0.412 k−4 = 3.44 k10 = 10.0
k5 = 0.00100 k−5 = 0.00100 V = 0.0197 kic = 6.84
k6 = 10.0 k−6 = 0.00100 km = 9.21 kis = 0.00100
Table 6.1: Kinetic parameters used for simulation: reaction rates for mass action
and Michaelis-Menten kinetics.
As we do not have any special information about the origin of fluctuations in
the cell cycle (Steuer, 2004; Battogtokh and Tyson, 2004), we assume random
extrinsic fluctuations, mathematically described by white noise (Rao et al., 2002;
Gillespie, 2002; Battogtokh and Tyson, 2004). For each species i in compartment
j, the stochastic Langevin-type equation has the following form:
d[i]j
dt
= C(i)j +Wi(t)
√
2 ·Ni · [i]j
where C(i)j is the original right-hand side of the deterministic equation and Wi(t)
is the (multiplicative) Gaussian white noise for species i with zero mean and unit
variance
〈Wi(t)〉 = 0, 〈Wi(t)Wi(t′)〉 = δ(t− t′).
N = Ni denotes the noise amplitude parameter, which, for simplicity, is the same
for all species.
We computed the concentration functions for several values of N. Here, we show
the results for N = 10−8 (almost no noise) and N = 10−5. We used Ω = 1 as in
the deterministic simulation, but in addition, to simulate the influence of diffusion
on the system, we used Ω = 0.01 and Ω = 0.005.
The simulations were performed using standard numerical techniques for stochas-
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tic differential equations (including the strong implicit 1.5 order Runge-Kutta
method (Kloeden and Platen, 1999a), and the explicit Runge-Kutta method of
order 1.5 (Kloeden and Platen, 1999a)). We implemented our code in (MATLAB
, Matrix Labrotory).
6.4 Results
In Figure 6.2, the concentration curves for APC:Cdc20 and MCC:APC complexes
are shown for a time period of about 12 minutes. The noise amplitude is N = 10−8.
In all simulations, steady state conditions (regarding noise, this means constant
average of concentration) are reached within less than 3 minutes in all 3 phases
(UUU, UUA, UAA) with at least one unattached kinetochore. For Ω = 1 (top),
there are no visible differences between the concentration curves for compartments
X, Y, and Z (data not shown). Diffusion is obviously fast enough to level out
the small differences induced by noise. In addition, after steady state is reached
in phase UUU, the concentrations remain at that level during phases UUA
and UAA. The graphs are almost identical to the concentration curves in the
deterministic simulation without noise ( (Lenser et al., 2007)). For Ω = 0.01
(middle), first differences appear in phases UUA and UAA as compared to UUU:
the equilibrium value is rising. Also in phase AAA, the onset of APC:Cdc20
increase and MCC:APC decrease is much faster. Also, concentration dynamics
differences between compartments X, Y, and Z become visible (data not shown).
For Ω = 0.005 (bottom), these effects become even more pronounced.
In Figure 6.3, showing the same concentration functions in the same ordering of Ω,
the noise level is much higher at N = 10−5. Whereas for Ω = 1 the overall shapes
of the curves still resemble the curves for low noise level, there is a large overshoot
of [MCC:APC] (Ω = 0.01) in phase UUU, and, for Ω = 0.005, [MCC:APC]
decays very rapidly already in phase UAA. It is also questionable, whether the
concentration reached is enough to prevent exit from metaphase to anaphase.
These effects increase for even higher N−values and disrupt mitotic control. To
give an impression of the different behaviour in the three compartments, we have
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included Figure 6.4 which shows the respective dynamics in these compartments
for N = 10−5 and Ω = 0.005.
6.5 Discussion and Conclusion
The proper segregation of sister chromatids at onset of anaphase is surveyed by the
mitotic spindle assembly checkpoint. The concentration dynamics of the complexes
APC:Cdc20 and MCC:APC determine exit from metaphase to anaphase. Our
model, describing concentration dynamics by ordinary differential equations, is
based on 14 proteins and complexes, which determine increase or decrease of
the two key complexes near a kinetochore, dependent on its attachment status.
To investigate the interaction of concentrations near different kinetochores, we
have coupled three compartments by diffusion. As for many reaction constants
only ranges, but no exact values, are known, we optimized a particular objective
function based on the expected dynamics of APC:Cdc20 concentration in (Ibrahim
et al., 2008a), where the details of this procedure can be found. The result was a
set of concentration parameters and initial values, allowing the simulation of the
deterministic model showing a correct behaviour of the spindle checkpoint and also
reproducing over-expression and deletion effects (Ibrahim et al., 2008a). The model
is based on mass action laws for all reactions except one (6.9), which is described
by a mixed Michaelis-Menten kinetic. This may be an oversimplification, because
non-linear effects may be involved. On the other hand, this argument applies to
almost all reactions considered here. It is even questionable, how diffusion can be
described correctly, as ongoing research shows that certain signalling molecules
seem to travel along one dimensional fibres. So, the formulation of the reaction
equations might be only a first step. However, for example the mixed Michaelis-
Menten kinetic, we used here, has several parameters which were optimized and
could in this way provide a description which is close to the actual reaction.
As in natural processes noise is a never neglectable ingredient, we have addressed
here the question, whether noise has a destructive influence, or, as in Steuer (2004),
is even essential for the correct function. We therefore take the same description
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by differential concentration equations for the single compartments and also the
same geometric arrangement of three compartments as in (Lenser et al., 2007).
But here, the deterministic differential equations are enriched by a stochastical
term adding white noise of different amplitudes.
We could show that the spindle checkpoint dynamics as described by our model
is stable with respect to extrinsic white noise to a rather large extend. Only
for a noise amplitude larger than N = 10−4, the function of the checkpoint is
disrupted. The influence of noise, on the other hand, is dependent on the diffusion
coefficient. Whereas diffusion in the known physiological parameter ranges is fast
enough to level out concentration differences in the distinct compartments, noise is
able to build up considerably different dynamics near different kinetochores when
the diffusion constant is decreased. This effect could become important when
considering more chromosomes, which is necessary to simulate human checkpoint
behaviour.
We did not find indications that noise is essential for the checkpoint function, in
contrast to the effects of noise in the cell cycle as a whole, where noise seems
to prevent dynamics from getting stuck in singular points (Steuer, 2004). Our
results suggest that a fast diffusion, as in the physiologically relevant parameter
ranges, helps to stabilize the system and to prevent noise to disrupt the checkpoint
function. Along these lines it will be interesting to investigate the system using
methods developed in (Levine and Hwa, 2007). They show, using a master
equation approach, that in certain metabolic networks noise is not propagated,
but has only local influence. These findings coincide with ours on a global level.
On the other hand, we did not yet investigate the influence of a single perturbation
on the system, e.g. by a concentration impulse response, as they suggest. But
this will be a challenging task for us for the future.
In the model presented here, a linear arrangement of three compartments was used.
This is only a first approximation to a more complex model for 46 chromosomes,
arranged in a two dimensional mitotic equatorial plate, where each inner kineto-
chore has six neighbors – for mathematical symmetry. The outside kinetochores
in this geometry have also connection to an outer region without any kinetochores,
which is also connected to all kinetochores via the third dimension. Presently, we
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are modeling this situation, which is much more involved. There are still debates
about the exact ranges of diffusion coefficients, and also the dimensionality is in
question. There are hints for one dimensional diffusion in certain cases, possibly
enabled by diffusion along fibres. In further investigations, we will therefore use
different diffusion constants for distinct reactants and also try to simulate different
dimensionalities. A further goal is also the investigation of the influence of the
geometry (e.g. in the mitotic equatorial plate) on the checkpoint dynamics using
partial differential equations. Here, the localization of the reactions and reactants
to the kinetochore, on the one hand side, or to the ’nucleosol’, on the other hand
side, may play an important role.
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Figure 6.2: Concentration of APC:Cdc20 (left) and MCC:APC (right) as a function
of time (8000 iterations corresponding to 12 min) in the middle compartment Y
at noise amplitude N = 10−8. The first part (orange, from time 0 to ’UUU’) of
the curves describes the phase with three kinetochores Unattached (UUU); the
second part (red, ’UUU’-’UUA’), the phase with two kinetochores Unattached
and one Attached (UUA); etc. (cf. insert). With decreasing diffusion coefficient
Ω (cf. text), the concentration differences within the 3 phases UUU, UUA, UAA,
increase more and more. Steady state is reached after at most 3 min. When all
kinetochores are attached (green curve ’UAA’-’AAA’, phase AAA), APC:Cdc20
rises immediately and MCC:APC decays.
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Figure 6.3: Concentration of APC:Cdc20 (left) and MCC:APC (right) as a function
of time (8000 iterations corresponding to 12 min) in the middle compartment Y
at noise amplitude N = 10−5. With decreasing diffusion coefficient Ω, dynamics
in the phases with one kinetochore unattached (UAA) become more and more
distinct, and in some cases a steady state equilibrium is not reached any more
within phase simulation time (3 min).
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Figure 6.4: Concentration of APC:Cdc20 (left) and MCC:APC (right) in the three
compartments X,Y,Z, at a noise amplitude of N = 10−5 for diffusion coefficient
Ω = 0.005. For these parameters, strong differences in the [APC:Cdc20] and
[MCC:APC] dynamics in the different compartments become visible.
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Chapter 7
Integrative Model of Mitosis
Transition Control Mechanisms
“Imagination is more important than knowledge...”.
Albert Einstein (1879 - 1955)
“To create a good philosophy you should renounce
metaphysics but be a good mathematician”.
Bertrand Russell (1772 - 1970)
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CONTROL MECHANISMS
7.1 Summary
Two forms of the Anaphase Promoting Complex (APC), bound to Cdc20 or
Cdh1, regulate mitosis transition. During the metaphase-to-anaphase transition,
APC:Cdc20 mediates the ubiquitination and degradation of Securin protein,
leading to the activation of Separase, dissolution of the Cohesin complex, and
chromatid separation. In addition, APC:Cdc20 mediates the first phase of Cyclin
B proteolysis. During anaphase and transition to telophase, APC:Cdh1 is turned
on and completely ubiquitinates Cyclin B, thus inactivating the CyclinB:Cdk1
mitotic kinase and triggering the exit from mitosis to cytokinesis.
Herein, we incorporated an adapted Exit From Mitosis (EFM) model that involves
the activity of APC:Cdh1 and build an integrative model that also involves the
activity of APC:Ccd20. Hence, we addressed simultaneously the functioning of
both transition control mechanisms, MSAC and EFM (see Figure 7.1). This new
model consists of 19 species and 15 reactions. It is validated by simulation of
mutation experiments. The model is described by non-linear ordinary differential
equations. The values of the kinetic parameters are derived from literature and
the remaining values of parameters are obtained with parameter optimization.
The parameter optimization will be performed with three optimization techniques,
two evolutionary and one deterministic technique; namely Covariance Matrix
Adaptation Evolutionary Strategy (CMA-ES), Differential Evolution (DE), and
the Hooke-Jeeves (HJ) algorithm, respectively.
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CONTROL MECHANISMS
7.2 Biochemical Background of the Integrative
Model
The integrative model includes two sub-models; MSAC and EFM model.
MSAC model is described as mass-action kinetics (reaction Eqs.(7.1)-(7.8))
in two model variants (see Chapter 5), the “Dissociation”(Eq. (7.D)) and
the “Convey”(Eq. (7.C)) model. The output signal of MSAC model (Anaphase
initiation) is the activation of APC by its first mitotic co-activator Cdc20 in
APC:Cdc20 complex form. The APC:Cdc20 complex has two main functions.
One is to activate Separase by ubiquitylating of Securin (Eq.(7.9)). The other
function is to proteolysis the first phase of Cyclin B (Eq.(7.10)) that occurs
when cellular levels of the Cyclin B are high. Here Cyclin B activity refers to
Cdk1:Cyclin B complex. However, APC:Cdc20 is unable to reduce Cyclin B
activity to a level low enough to complete exit from mitosis (Yeong et al., 2000).
These two reactions of APC functions are important to connect the MSAC model
with the EFM model. Both reactions are based on empirical data (e.g, Morgan,
1999; King et al., 1996; Alexandru et al., 1999; Nasmyth et al., 2000; Uhlmann
et al., 1999).
The EFM model is described by reaction Eqs.(7.11)-(7.15). Three of these reactions
are taken from the model proposed by Toth et al. (2007) for budding yeast which is
used as a basis for our Human EFM model. Reaction equation (7.11) describes the
constant production of Cyclin B. Reaction equation (7.12) describes the regulation
of a phosphatase, called Cdc14 (human homology hCdc14A, we will use Cdc14A
for simplicity now on). The inactivation of Cdc14A is considered to be mass-action
kinetics, while the activation as Michael-Menten kinetics. The activation of Cdc14
is better understood in Yeast, through two networks (Toth et al., 2007) called
FEAR (Cdc Fourteen Early Anaphase Release) (Stegmeier et al., 2002; Sullivan
and Uhlmann, 2003) and MEN (Mitotic Exit Network) (Jaspersen et al., 1998;
Lee et al., 2001; Stegmeier and Amon, 2004). The FEAR network is assumed
to be less essential than MEN because mutants in FEAR pathway show only a
delay in activation of Cdc14 while mutants of MEN block at telophase (Stegmeier
et al., 2002). In spite of this assumption, Separase plays an essential role in
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Cdc14 activation which is also a component of FEAR pathway (Queralt et al.,
2006; Sullivan and Uhlmann, 2003). Because of this function and the lack of
knowledge for Human Cdc14A regulation, we propose a Michaelis-Menten kinetic
function based on a rate limiting function of Separase as well as both parametric
FEAR and MEN pathways (reaction Eq.(7.12)). Moreover, we think such a
function can mathematically be consistent with the empirical data as we will see
in the model validation section. Active Cdc14A (Cdc14A* nomenclature will be
used from now on) dephosphorylates (and thereby activates) the second APC
co-activator, Cdh1 (a human homology is hCdh1, Cdh1 will be used from now
on) (Eq.(7.13)) (Bembenek and Yu, 2001b). We refer to phosphorylated Cdh1
by (Cdh1P). For both phosphorylation and the dephosphorylation Michaelis-
Menten kinetics are used (Toth et al., 2007). The conversion between both APC’s
activators, Cdc20 and Cdh1 is an uncatalyzed reaction and therefore described
with mass-action kinetics (Eq.(7.14)), this reaction models the exchange of Cdc20
by Cdh1 and Cdc20 degradation in single reaction. Subsequently, APC:Cdh1
promotes completion of Cyclin B destruction (Eq.7.15) (Prinz et al., 1998).
Mad1:C-Mad2 + O-Mad2
k1.u−−−−⇀↽ −
k−1
Mad1:C-Mad2:O-Mad2 ∗ (7.1)
Mad1:C-Mad2:O-Mad2 ∗ + Cdc20 k2.u−−−→ Cdc20:C-Mad2 + Mad1:C-Mad2 (7.2)
Cdc20:C-Mad2
k3−−−−→ O-Mad2 + Cdc20 (7.3)
Cdc20:C-Mad2 + Bub3:BubR1
k4.u−−−−⇀↽ −
k−4
MCC (7.4)
Cdc20 + Bub3:BubR1
k5.u−−−−⇀↽ −
k−5
Bub3:BubR1:Cdc20 (7.5)
Cdc20 + O-Mad2
k6−−−−→ Cdc20:C-Mad2 (7.6)
MCC + APC
k7.u−−−→ MCC:APC (7.7)
MCC:APC
k−7.u′−−−→ APC + MCC (7.D)
MCC:APC
k−7.u′−−−→ APC:Cdc20 + O-Mad2 + Bub3:BubR1
(7.C)
APC + Cdc20
k8−−−⇀↽ −
k−8
APC:Cdc20 (7.8)
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Separse:Securin
APC:Cdc20, k9−−−−−−−−−−−−−−−−→ Separase + waste (7.9)
Cyclin B
APC:Cdc20, k10−−−−−−−−−−−−−−−−→ waste (7.10)
k11−−−−−−−−−−−−−−−→ Cyclin B (7.11)
Cdc14A
k12−−−−−−−−−−−−−−−⇀↽ −
f(Separase;R), k−12, k−12M
Cdc14A ∗ (7.12)
Cdh1P
Cdc14A*, k13, k13M−−−−−−−−−−−−−−−⇀↽ −
Cyclin B, k−13, k−13M
Cdh1 (7.13)
APC:Cdc20 + Cdh1
k14−−−−−−−−−−−−−−−→ APC:Cdh1 + waste (7.14)
Cyclin B
APC:Cdh1, k15−−−−−−−−−−−−−−−→ waste (7.15)
7.3 Simulation
By applying general principles of mass-action as well as Michaelis-Menten kinetics,
we convert the reaction rules (Eqs.(7.1)-(7.15)) into sets of nonlinear Ordinary
Differential Equations (ODEs) for the Dissociation variant (Appendix E , Eqs.
(E.1)-(E.19)) and similarly for the Convey variant (Appendix E , Eqs. (E.20)-
(E.38)). Starting from initial concentrations for all reactions taken from literature
listed in Table 5.2, Cdh1P is assumed to be equal to the initial concentration of
Cdc20. In this manner there will be enough Cdh1 to convert all the APC:Cdc20
into APC:Cdh1.
The initial concentrations of Cdc14A and Separase:Securin are set equal to the
initial Cyclin B concentration (200nM, Moore et al. (2003)).
The product of APC:Cdc20 subjected to high initial concentration of both APC and
Cdc20 for the first few seconds should be avoided. During the first time steps APC
may be activated and will cause undesirable model behavior. This is prevented
by cutting the first step into two sub-steps. During the first 120 sec APC:Cdc20
reaction is slower 1000folds as for the relation to prophase. Afterwards MSAC is
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completely active and APC cannot be activated by Cdc20 anymore. The initial
concentration for the succeeding steps will be equal to the final concentrations of
the previous step. The ODEs are integrated until steady state is reached before
attachment (using u = 1, time is about 25 mins: Prometaphase and Metaphase).
After switching u to 0 (about 50 mins: Anaphase and Telophase), the equations
are again integrated until steady state is reached. The minimum concentration of
APC:Cdc20, APC:Chd1, Cyclin B, Cdc14A*, and Securin before attachment and
the recovery after attachment are criteria for fitness function as explained in the
following section.
7.3.1 Optimization
This objective function f(P ) compares the model behavior with current parameters
to prescribed model behavior. It assigns a quality (i.e., a positive real number)
to a given set of parameters P=(kn, n=1,...,12). In our case, the parameters
are the reaction constants. In order to fit the parameters with respect to the
observed qualitative function of the MSAC and EFM control mechanisms, 5 model
outputs will be used: APC:Cdc20, APC:Cdh1, Cyclin B, Cdc14A* and Securin.
APC:Cdc20, APC:Cdh1 and Cdc14A* have switch-like behavior. APC:Cdc20
reaches its maximum concentration of 90 nM in the first simulation phase (t< 25
mins), and APC:Cdh1 (t>25 mins) reaches the same concentration in the second
simulation phase. Cdc14A* can reach the maximum concentration (200 nM) only
after 25 mins. Cyclin B and Securin have a similar behavior (Hagting et al., 2002),
which is high in the fist simulation phase, and once APC:Cdc20 appears they will
degrade. We used a general form of the following fitness function:
f(P ) =
5∑
j=1
{W0([xj]0 − A0,j)2 +
6∑
i=1
Wi([xj]i − Ai,j)2} (7.16)
j ∈ { APC:Cdc20, APC:Cdh1, Cyclin B, Cdc14A*, Securin}
i has seven time points. i = 0 refers to the steady state of the simulation where
kinetochore is unattached (u= 1). i = 1, ..., 6 are six different time points after
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attachment (silence MSAC and EFM).
More specifically, the comparisons of the measurement occur at 25%, 50%, 60%,
70%, 80% and 100% of the simulated time after attachment. Ai,j is a ma-
trix in which each row is related to time point i, each column is related to
species element j (Table 7.1). Each element of the matrix Ai,j is fixed number
between 0 and related species maximum. W is the weight constants vector:
W = [100, 200, 250, 350, 300, 150], which focuses on some term more and by which
gives the best result.
Fitness function constant values
i Time Ai,[APC:Cdc20] Ai,[APC:Cdh1] Ai,[Cyclin B] Ai,[Cdc14A*] Ai,[securin:Separase]
0 100%F 0 0 1.0[ ]IC 0 1.0[ ]IC
1 25%S 0.9[ ]IC 0.1[ ]IC 0.75[ ]IC 0.3[ ]IC 0.75[ ]IC
2 50%S 0.8[ ]IC 0.2[ ]IC 0.5[ ]IC 0.4[ ]IC 0.5[ ]IC
3 60%S 0.5[ ]IC 0.5[ ]IC 0.35[ ]IC 0.5[ ]IC 0.35[ ]IC
4 70%S 0.3[ ]IC 0.7[ ]IC 0.15[ ]IC 0.6[ ]IC 0.15[ ]IC
5 80%S 0.1[ ]IC 0.9[ ]IC 0.05[ ]IC 0.75[ ]IC 0.05[ ]IC
6 100%S 0 1.0[ ]IC 0 1.0[ ]IC 0
Table 7.1: Fitness function constant values, F refers to the first phase and S refers
to the second simulation phase. [ ]IC represents the initial concentration for a
related species j. Ai,j refers to the comparisons of the measurements.
.
Parameter optimization was performed for the Dissociation variant of the inte-
grative model using three optimization techniques: CMA-ES (Hansen and Kern,
2004), DE (Storn and Price, 1997) and HJ (Hooke and Jeeves, 1961). All optimiza-
tion techniques were used with the same objective function. Because of the wide
parameters range (e.g. 10−12 and 1012), we used an exponential scaling, by which
parameter estimation can be efficiently and more accurately performed (Rohn
et al., 2008). The optimization algorithms in the unscaled case allow parameters
P (vector) in the range between 10−n and 10n, where n is any real number, the
scaled case considers parameters P between 0 and 1. The changed parameters P¯
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were inserted and evaluated. The relationship between P and P¯ is
P¯ = a · 10b+c·P (7.17)
where e.g., a = 1, b = −12 and c = 24 resulting in 10−12 ≤ P¯ ≤ 1012. As a result
of this scaling, search steps are larger for high parameter values and smaller for low
values, independently of the optimization procedure. This allows a optimization
procedure to investigate small parameter values with high resolution and large
parameter values with low resolution without having to internally adapt the search
step-size.
We ran the three optimization techniques 90 times in total and picked the best
fitness and model behavior. Parameter optimization with CMA-ES as well as HJ
were much faster than optimization with DE. Optimization showed that good
parameter sets could be found within the parameter ranges (Table 7.2), in which
HJ was a bit better than CMA-ES as well as DE. These local minima varied slightly.
All parameters value lie within realistic range (see for example, Chapter 5).
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Integrative model parameters
Parameters Comments and References
k1 = 2 ∗ 105 M−1s−1 Chapter 5
k−1 = 2 ∗ 10−1 s−1 Chapter 5
k2 = 10
8M−1s−1 Chapter 5
k3 = 1 ∗ 10−2s−1 Chapter 5
k4 = 10
7 M−1s−1 Chapter 5
k−4 = 2 ∗ 10−2 s−1 Chapter 5
k5 = 10
4 M−1s−1 Chapter 5
k−5 = 2 ∗ 10−1 s−1 Chapter 5
k6 = 10
3 M−1s−1 Chapter 5
k7 = 10
8 M−1s−1 Chapter 5
k−7 = 8 ∗ 10−2 s−1 Chapter 5
k8 = 5 ∗ 106 M−1s−1 Chapter 5
k−8 = 8 ∗ 10−2 s−1 Chapter 5
k9 = 1.55∗104 M−1s−1 This study
k10 = 1.6∗104 M−1s−1 This study
k11 = 1.16∗10−12 Ms−1 This study
k12 = 1.53∗103 s−1 This study
k13 = 4∗104 s−1 This study
k14 = 1.47∗109 M−1s−1 This study
k15 = 1.4∗105 M−1s−1 This study
k-12 = 5.4∗103 s−1 This study
k-13 = 2.78∗109 s−1 This study
k13M = 3.3∗10−8 M This study
k-12M = 4.56∗10−7 M This study
k-13M = 10
4 M This study
Table 7.2: Model parameters: rate constants of mass-action and Michaelis-Menten
kinetics. Last 12 parameters in bold line (k9-to-k-13M) are the result from
optimization techniques.
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7.3.2 Model Behavior
We analyzed the dynamics of the integrative model of MSAC and EFM mechanisms.
Figure 7.2 displays concentrations of the key players over time. For the Dissociation
variant, we have selected the time range such that each concentration can reach
steady state. For all species dynamic of both Dissociation as well as Convey variant
see Figure 7.3. For all integrations, the concentrations and rates of Table 7.2 were
chosen including those 12 parameters that were optimized. Before attachment (25
mins), four of these key players (APC:Cdc20, APC:Cdh1; Cdh1, Cdc14A*) are
very low, while only, Cyclin B, Securin, and Cdc14A have high concentration. Once
attachment takes place, things are changed (after 25 mins). In general, Cdc14A*,
Separase, become high gradually over time. Cyclin B and Securin are degrading
gradually once MSAC deactivates. APC:Cdc20 activates fast, degradates Securin
and the first phase of Cyclin B to be ended with very low concentration at 30mins
of its activation. Meanwhile, once Cdh1 is available, APC:Cdh1 will be formed
and increase fast. APC:Cdh1 make full degradation of Cyclin B as well as Cdc20.
153
0
50
0
10
00
15
00
20
00
25
00
30
00
35
00
40
00
45
00
0
0.
51
1.
52
x 
10
−
7
Ti
m
e 
(s)
Species concentration (M)
 
 
AP
C:
Cd
c2
0
AP
C:
Cd
h1
Cd
h1
Cd
c1
4A
*
Cd
c1
4A
Se
pa
ra
se
Cy
cli
nB
Se
pa
ra
se
Se
cu
rin
A
PC
:C
dh
1
A
PC
:C
dc
20
F
ig
u
re
7.
2:
K
ey
sp
ec
ie
s
co
n
ce
n
tr
at
io
n
ov
er
ti
m
e
fo
r
th
e
D
is
so
ci
at
io
n
.
S
p
in
d
le
at
ta
ch
m
en
t
o
cc
u
rs
at
t
=
15
00
se
c
(s
w
it
ch
in
g
p
ar
am
et
er
u
fr
om
1
to
0
an
d
u
′ f
ro
m
0
to
1)
.
P
ar
am
et
er
s
ar
e
se
tt
in
g
ac
co
rd
in
g
to
T
ab
le
7.
2.
154
7.4 Model Validation
7.4 Model Validation
The optimized parameter set and initial concentration results in the expected
model behavior. Yet, when an initial concentration or a kinetic parameter value
is changed the model behavior might change as well accordingly. In order to
validate our model, we tested different mutations (deletion and over-expression)
of the proteins and complexes involved, measured in different organisms. Model
validation will be performed for a number of species elements. That are either
part of the MSAC or the EFM mechanisms. Numerous empirical data have been
reported for mutation experiments (see Chapter 5.3.2). Our integrative model is
able to explain different mutation phenotypes. We will discuss, some mutations
of essential proteins in details, namely the APC’s activators, Cdc20 and Cdh1.
We also discuss the effect of FEAR and MEN parameter.
Cdc20 deletion might cause checkpoint failure (e.g. reduce the binding of C-Mad2
to Cdc20, cells leave mitosis and oral cancer, see for example, Hwang et al., 1998;
Mondal et al., 2007b). In different organisms Cdh1 deletion can cause delay of
Cyclin B degradation as well as EFM delay but does not block mitosis (Sudo
et al., 2001; Sigrist and Lehner, 1997; Kitamura et al., 1998; Yamaguchi et al.,
1997; Schwab et al., 1997). With respect to over-expression, Cdc20 over-expression
cause failure in MSAC function and arrests in metaphase (Zhang and Lees, 2001b;
Shirayama et al., 1999). Cdh1 over-expression data is not available yet.
For Cdc20 deletion in our model, the concentrations of the model components are
rather stable, that is, they are almost not affected by microtubule attachment.
However, in the case of Cdh1 (inactive form) deletion (100folds), the APC:Cdc20
concentration stays high and no APC:Cdh1 is presented (Figure 7.5 B) which
means Cyclin B inhibition failure, while for Cdc20 deletion (100folds) these
concentrations are approximately zero (Figure 7.5 A). In the case of Cdh1 or Cdc20
over-expression, many component concentrations were affected. In particular, for
Cdh1 over-expression (100folds) the APC:Cdc20 concentration remains low before
attachment and switches to high after attachment rather short time, which affect
Securin degradation (Figure 7.6 B). For Cdc20 over-expression (10000folds, less
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A- Dissociation Variant
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B- Convey variant
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Figure 7.3: Species concentration over time for the both Dissociation and Convey
variant (wild type). Spindle attachment occurs at t = 1500s, then MSAC becomes
silent and EFM triggers. Parameters are setting according to Table 7.2. Both
variants are equally suitable, by which the Convey variant is slightly faster).
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has no qualitative effect), the APC:Cdc20 concentration is relatively high before
attachment (Figure 7.6 A) resulting in checkpoint failure.
Mutants in FEAR pathway show only delay in activation of Cdc14 while mutants
in MEN block at telophase (Stegmeier et al., 2002). The FEAR pathway is still
essential (Queralt et al., 2006; Sullivan and Uhlmann, 2003), but maybe its full
mechanism is not yet known. In human, most FEAR as well as MEN candidates
are not yet identified. Therefore, we discuss the effect of both FEAR and MEN
pathways qualitatively as a function of separase with an additional parameter R
(see reaction Eq.(7.12)), which is defined mathematically as follows:
f(Separase;R) = [Separase] ∗ R (7.18)
where R defined as:
R = MEN ∗ (1 + FEAR
2 + FEAR
). (7.19)
Note that R is set to be the Michaelis-Menten constant k−12 (see Table 7.2). The
dependence of R on the FEAR pathway can be seen in Figure 7.4.
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Figure 7.4: FEAR pathway effect on the parameter R. FEAR effect is between 0
and 1 which has only very limited impact on R. In contrast MEN effect is linear
as defined in Eq.7.19.
157
7. INTEGRATIVE MODEL OF MITOSIS TRANSITION
CONTROL MECHANISMS
When we reduce the parameter R by inhibiting FEAR pathway, we found very
similar behavior to the wild type (see Figure 7.7 B), while when inhibiting the
effect of MEN (only reduced 10 order of magnitude), we got mitosis block (see
Figure 7.7 B). For quantitative effect of FEAR and MEN, more experimental data
is required. These can be easily integrated into our model.
7.5 Concluding Remarks
We have consolidated and validated an in silico dynamical model based on a
biomolecular reaction network (Figure 7.1). The model consists of 19 species, 15
reactions and 27 parameters. Twelve parameters are unknown and have been fitted
using two evolutionary and one deterministic optimization techniques; namely
CMA-ES, DE, and HJ algorithm, respectively. Despite the model complexity, the
network still does not contain all the biochemical interactions (e.g. FEAR and
MEN details). The reason is that most of these reactions are not yet identified in
Human. However, it can be easily integrated into our model.
The most important features are to show the interaction and dynamics of each
species over time (Figure 7.3). In particular, to capture APC functions which were
not computed in Chapter 5. APC:Cdc20 function is the activation of Separase and
dissolution of the Cohesin complex, and chromatid separation. Another function is
to degrade the first phase of mitotic Cyclin (Cyclin B:Cdk1). APC:Cdh1 function
is to fully degrade the mitotic cyclin. Our integrative model of mitosis transition
control mechanisms reproduces in detail the behavior of wild-type and mutant.
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A- Cdc20 deletion
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B- Cdh1 deletion
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Figure 7.5: Simulation of Cdc20 and Cdh1 mutations. For deletion we set the
respective initial concentration 100 times lower.
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A- Cdc20 over-expression
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B- Cdh1 over-expression
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Figure 7.6: Simulation of Cdc20 and Cdh1 mutations. For for over-expression
10000 times higher of Cdc20 while only 100 times higher Cdh1.
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A- FEAR inhibition
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B- MEN inhibition
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Figure 7.7: Simulation of FEAR or MEN pathway inhibition. Parameter R is
reduces 10 order of magnitude for MEN inhibition and 0.1 for FEAR according to
Section 7.4
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Chapter 8
Conclusion
“Every object that biology studies is a system of systems.”
Francois Jacob (1974)
“How everything is connected to everything else and what
it means for science, business and everyday life”.
Albert-La´szlo´ Baraba´si (2002)
Mitosis progression is a tightly regulated process. Eukaryotic cells, indeed, have
evolved surveillance transition control mechanisms regulating the transition from
any given stage of cell division to the next one. The so called ‘Mitotic-Spindle-
Assembly-Checkpoint (MSAC)’ and ‘Exit-From-Mitosis (EFM)’ are examples
of such mechanisms. MSAC prevents a dividing cell’s progression into anaphase
until all chromosomes are properly attached to the mitotic spindle, whereas
EFM guarantees that each of the two daughter nuclei receives a single copy
of each chromosome. In principle, MSAC controls the activity of a complex of
proteins called “Anaphase Promoting Complex”, or APC, during the transition
from metaphase to anaphase, when chromosomes are not yet attached. APC
becomes inactive after all chromosomes are attached. APC interacts with its
co-activator, a protein called “Cell Division Cycle”, or Cdc20. The function of
the ensuing complex ‘APC:Cdc20’ is twofold. First, it activates a protein called
‘Separase’, involved in breaking-up the so called ‘Cohesion ring’; this leads to
the separation of the sister chromatids. Second, APC:Cdc20 is involved in the
partial degradation of ‘Cyclin B’, a mitotic cyclin. Mitosis then progresses and
becomes the subject of the second transition control mechanism, EFM. Generally
speaking, EFM guarantees a full degradation of Cyclin B via the activity of a
complex called ‘APC:Cdh1’, formed by APC and its second co-activator, a protein
called Cdh1. After the full degradation of Cyclin B, the process of cell division
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progresses into cytokinesis. Both MSAC and EFM have complex dynamics and
involve numerous interacting elements. This is probably the reason why their
functional and topological structures remain still poorly understood. At present,
for example, no model provides a satisfactory account of how MSAC actually works.
In contrast, there are several models -all them based on data from yeast- describing
how EFM works. Still, these two mechanisms have not yet been incorporated into
a single model. We aimed to contribute towards an integrative model addressing
both MSAC and EFM in human cells.
To this end, we built-up a series of dynamic models based on empirical data,
and tested their ensuing predictions on the functioning of both MSAC and EFM.
Our in-silico approach suggests that cells are unable to completely sequester
‘Cdc20’, thereby preventing the formation of the complex ‘APC:Cdc20’. It also
suggests that it is an interaction between APC and another regulatory element of
mitosis, MCC, that explains APC’s lack of activity of during metaphase, necessary
for the progression of the ongoing process (see Chapters 5 and 4). Moreover,
previous modeling approaches to MSAC , captured by the so called “Template”
and “Exchange” models, had led to somehow contradictory views on its underlying
regulation. Intriguingly, our simulations gave partial support to only one of such
models (see Chapter 3). Finally, we simultaneously addressed the functioning
of both transition control mechanisms, MSAC and EFM, by incorporating an
adapted EFM model involving the activity of ‘APC:Cdh1’ into an integrative
model that also involves the activity of ‘APC:Ccd20’ (see Chapter 7). Our results
also stress important, additional questions. Answering these questions, however,
demands understanding how the mechanisms controlling mitosis work in three
dimensions. This requires, in turn, developing specific and suitable tools. We
currently develop a software tool called “Mitosis Arena”, in order to test network
models of mitosis embedded in a three-dimensional (3-D) framework. “Mitosis
Arena” will be available to the scientific community so that alternative models
could easily be studied within a dynamical 3-D environment. It has been designed
in accordance with standard languages, and would eventually be combined with
other Systems Biology software tools.
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Molecular biology has progressed extraordinarily by rapidly producing huge
amounts of empirical data. Yet, what is frequently missing in molecular ap-
proaches to biology is a robust account of the structure and dynamics of the
-typically complex- networks serving the various cellular functions being studied.
The emergent interdisciplinary field of “Systems Biology” studies cells as networks
of interacting molecules using an integrative approach to theory. It deals with
modeling and simulation, and involves concepts from mathematics, computer
science, physics, biochemistry, and engineering. Typically, in such studies models
are used to highlight principles, design experiments, or to act in a predictive
mode to specifically modify cellular behavior. Mitosis is an exceedingly complex
process, and molecular biologists typically characterize the activity, aggregation
and interactions of tens of cellular elements involved in mitosis, although the
relation between such interacting elements and their respective environment re-
mains still elusive. Predictions, therefore, are not straightforward. There is a
need for a system-level understating of the regulatory mechanisms involved in
mitosis. This might be of major relevance for medical research, and for a better
understating of other cellular processes, as well. We refer to the present work
as to a “Systems Biology of Mitosis”, with emphasis on human cells, simply
because we benefited from modeling and simulation approaches embedded in a
cross-disciplinary framework, in order to contribute to a deeper understanding
of mitotic regulatory mechanisms. Eventually, our “Dissociation” and “Convey”
model variants would prove fruitful in designing further laboratory experiments.
165
8. CONCLUSION
166
Appendix A
Modeling and Simulation for
Systems Biology
“Every new body of discovery is mathematical in form
because there is no other guidance we can have”.
Charles Darwin (1809-1882)
“No great discovery was ever made without a bold guess”.
Isaac Newton (1642-1727)
A.1 Prologue
“Today we increasingly recognize that nothing happens in isolation. Most events
and phenomena are connected, caused by, and interacting with a huge number of
other pieces of a complex universal puzzle. We have come to see that we live in a
small world, where everything is linked to everything else. We are witnessing a
revolution in the making as scientists from all different disciplines discover that
complexity has a strict architecture. We have come to grasp the importance of
networks” (Baraba´si, 2002).
Biological regulatory mechanisms, including mitosis, are inherently complex and
highly cross linked (as seen in Chapter 2). They cannot be understood from
reflections on the individual components (proteins, complexes etc) alone, but
should be understood through considerations involving all components at the
same time. Thus, mathematical network models formalism is used. It is a
fundamental and quantitative way to understand and analyze complex systems
and phenomena, complement to theory and experiments, and often integrate them,
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Models Classifications
Quantitative Qualitative
Deterministic Stochastic (Probabilistic)
Geometrical Physical
Static Dynamic
Descriptive Normative
Linear Non-Linear
low dimension space
...
...
Table A.1: Several model classifications in science and engineering
synthesize control, verify hypotheses, improve design, and prediction. It becomes
widespread in biology and medicine.
In a more general overview, models are either stochastic, deterministic or mixed
approaches. Many model classifications can be found in the literature where they
might differ for each field of research (e.g. Table A.1). It is rather difficult to do
such classifications for systems biology. For instance, biological systems are not
binary entities, in which something is either on or off; they could be stochastic,
subject to nonlinear behavior. Nevertheless, in this chapter we will try to give an
overview classifications of modeling for systems biology, taking into account aim(s)
and ability(ies) of a model; namely, “Network (descriptive) models”, “Algebraic
(discrete dynamical) models ”, “Time dynamical models”, and “Space dynamical
models”.
Before starting our classification, you can have an outlook on the process of
building a model (Figure A.1). Moreover, we are going to review, in particular,
for non modelers, some colligated concepts that you might need to follow this
chapter.
System: is a set of interacting or interdependent entities working together
towards some kind of process. All systems have inputs, outputs, and feedback,
and maintain a basic level of equilibrium. For example, in the human body the
heart functions to support the circulatory system, which is vital to the survival of
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Figure A.1: Models build and use. Starting from the real world system. Gather-
ing knowledge, make hypothesis, then build a model using a suitable modeling
approach. The model should capture the expected behavior and in agreement
with experimental findings. Validation like mutation experiments will explain the
solidity of the model. Intrinsic properties can lead to deeper understanding (e.g.
robustness, sensitivity of parameters, bifurcation analyzes). Ended with possible
prediction and experimental design. Solid lines refers to usual interactions, while
dash lines refers to possible interactions.
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the entire body. Scientists have examined and classified many types of systems,
following some examples:
- Isolated System - a system that has no interactions beyond its boundary layer.
Many controlled laboratory experiments are this type of system.
- Closed System - is a system that transfers energy, but not matter, across its
boundary to the surrounding environment. Our planet is often viewed as a
closed system, also mechanical systems are closed systems.
- Open System - is a system that transfers both matter and energy can cross its
boundary to the surrounding environment. People are open systems in that
they must interact with their environment in order to take in food, water, and
obtain shelter.
- Control System - a system that can be intelligently manipulated by an external
action.
Model: is a simplified description or representation of a system that may be
used to predict or explain the behavior of the system.
Ordinary Differential Equation (frequently called ODE): a differential equa-
tions1(DE) that involves only one independent variable is called ordinary differen-
tial equation.
An ODE of order n is an equation2 of the form F (t, y, y′, ..., y[n],P) = 0, where
t is the time, y is an independent variable, and P is vector of phenomenolog-
ical parameters. ODEs may have initial conditions3 or boundary conditions4.
1Differential Equation (frequently called DE): is an equation that involves the deriva-
tives of a function as well as the function itself.
2Equation(s): describe the relations between the dependent and independent variables.
An equal sign “=” is required in every equation.
3Initial Condition: Constrains that are specified at the initial point, generally time point,
are called initial conditions. Problems with specified initial conditions are called initial value
problems (IVPs).
4Boundary Condition: Constrains that are specified at the boundary points, generally
space points, are called boundary conditions. Problems with specified boundary conditions are
called boundary value problems (BVPs).
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Moreover, ODEs have properties like order1 and degree2 and could be linear3 or
homogeneous4.
Partial Differential Equation (frequently called PDE): a DE that involves
two or more independent variables is called partial differential equations. An
widespread example for systems biology is the Reaction-Diffusion systems:
∂[Ci]
∂t
= Di∇2[Ci]︸ ︷︷ ︸
Diffusion
+ Ri({[Cj]},P)︸ ︷︷ ︸
Reaction
The first term on the right hand side represent the diffusion and the second one
represent the biochemical reactions. Where [Ci] refers to the concentration of
species, ∇ is the spatial gradient. Di denotes to the constant diffusion coefficients
for species, i = 1, ..., n, t adverts the time, and P refers to phenomenological
parameters.
Stochastic Differential Equation (frequently called SDE): is a DE in which
one or more of the terms is a stochastic process, thus resulting in a solution which
is itself a stochastic process. Typically, SDEs incorporate white noise (see example
below) which can be thought of as the derivative of Brownian motion (or the
Wiener Process); however, it should be mentioned that other types of random
fluctuations are possible. We should emphasize, that SDEs can be ordinary (see
following example) or partial, which is hard to handel numerically.
1Order: The order of a differential equation is the highest power of derivative which occurs
in the equation, e.g., Newton’s second law produces a 2nd order differential equation because
the acceleration is the second derivative of the position.
2Degree: The degree of a differential equation is the power of the highest derivative term.
3Linearity: A differential equation is said to be linear if each term in the equation has only
one order of derivative, e.g., no term has both y and the derivative of y with respect to time.
Also, no derivative is raised to a power.
4Homogeneousity: A differential equation is said to be homogeneous if there is no isolated
constant term in the equation, e.g., each term in a differential equation for y has y or some
derivative of y in each term.
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For each species i, the stochastic Langevin-type equation (a well known example
type of SDEs) has the following form:
d[Ci]
dt
= RH({[Cj]},P) +Wi(t)
√
2 ·Ni · [Ci]
where RH is the original right-hand side of the deterministic equation and Wi(t)
is the (multiplicative) Gaussian white noise for species i with zero mean and unit
variance
〈Wi(t)〉 = 0, 〈Wi(t)Wi(t′)〉 = δ(t− t′).
N = Ni denotes the noise amplitude parameter, which, for simplicity, is the same
for all species. P refers to a vector of phenomenological parameters.
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A.2 Network Models
Network models are crucial for shaping our understanding of complex networks
and help to explain the origin of observed network characteristics. Rapid advances
in biological network indicate that cellular networks are governed by universal laws
and offer a new conceptual framework that could potentially revolutionize our view
of biology and disease pathologies in the twenty-first century (Baraba´si and Oltvai,
2004). Network models have become common in a wide range of disciplines. In
particular, systems biology has focused attention on the need to study biological
systems from a “top-down” point of view rather than from a reductionist “bottom-
up” point of view. Thus, networks have to be studied. Recent revolutionary
technological advances have made it possible to study the molecular networks
that make up the complex intracellular biochemistry of organisms, including gene
regulatory networks, signal transduction networks, and metabolic networks. The
availability of system-level data for these networks makes it possible to represent
complex biochemical reaction networks through mathematical network models.
Gene Regulatory Networks. (also called a GRN or genetic regulatory network).
Genes are stretches of DNA that, once activated, are transcribed into mRNA.
The mRNA fragments then are translated into proteins that carry out the cellular
processes. The activation of genes depends on the binding of specific proteins called
transcription factors to the promoter region of a gene. Within gene regulatory
networks, the nodes represent genes, and the links specify how a gene activates or
inactivates other genes. Gene regulatory networks are modeled using a variety of
different techniques. See review by de Jong (2002) for an overview.
Signal Transduction Networks. Cells detect external signals by receptor pro-
teins permeating the cell membrane. The signal is then propagated through a
phosphorylation cascade inside the cell and finally reaches the nucleus where a
change in transcription constitutes the response to the extracellular signal. In
such networks, the nodes represent proteins and compounds that are involved in
signal detection, propagation, and processing. The links can detail biochemical
reactions or on a more abstract level functional and causal relationships between
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the nodes. A review on the reconstruction and analysis of signal transduction
networks is provided by Papin et al. (2005).
Metabolic Networks. The uptake and utilization of nutrients within the cell
is detailed in metabolic networks. Nutrients enter the cell and are consecutively
transformed into different metabolites by enzymes. These processes can be modeled
in networks where the nodes represent the metabolites and the links the enzymatic
reactions. An overview on modeling and analyzing metabolic networks is given
in (Heinrich and Schuster, 1996).
Beside these intracellular networks, many more biological networks exist. Con-
sidering a slightly larger scale, cells communicate with each other in intercellular
networks as the endocrine network and the immune network. On an even larger
scale, the species within an ecosystem form foodwebs, a special network describing
which species depend on which others as their food source. And finally, on a
more abstract level, the evolutionary lineage of species can be depicted in phylo-
genetic trees and networks (reviewed by Centler (2008)). In this studies, we use
biochemical network (signal transduction networks) as a base of our models.
A.3 Algebraic Models (Discrete/State Time)
In recent years, methods from algebra, and discrete mathematics play an important
role in systems biology, through the use of discrete dynamical models and the use
of theoretical concepts for their analyzes. We are going to give a brief review of two
algebraic methodologies for systems biology: Theory of Chemical Organizations
and Petri Nets (PNs) models. We will explain PNs because its widespread use
and application as well as Organization theory which is new and growing fast
approach.
A.3.1 Theory of Chemical Organizations
The theory of chemical organizations (Dittrich and Speroni di Fenizio, 2006)
provides a new method to analyze complex reaction networks. Extending ideas
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by Fontana and Buss (1994), one main objective is to determine combinations of
network species that are more likely to be present over long periods of (simula-
tion) time than others. Such sets of species are called organizations. To be an
organization, a species set has to fulfill two properties (for review see Kaleta et al.
(2007).
Algebraic closure and self-maintenance. The first property – closure – ensures
that given the molecular species of an organization, there is no reaction within
the reaction network that could create a novel species not yet present in the
organization. The second property – self-maintenance – guarantees that every
molecular species that is consumed within the organization can be recreated from
organization species at a sufficient rate for its maintenance.
A rigorous link between organizations and the potential dynamics of a reaction
system is provided by Theorem 1 from Ref. (Dittrich and Speroni di Fenizio, 2006):
Assume that the dynamics is modeled as a “chemical” differential equation system
dx(t)/dt = Sv(x(t)),(where S is a Stoichiometry matrix1, and v is a flux2 vector)
then all steady states of the system are instances of organizations. In other words,
the species with concentration levels greater than zero in a particular steady state
are exactly those species contained in a corresponding organization. Note that
organizations do not necessarily contain a steady state, as they can also embody
growth in which species have increasing concentrations.
Organization theory is an efficient approach to analyze large scale network models.
The theory handles a discrete time state, and has been applied in different
areas (Centler, 2008). However, this theory is not able yet to include rates of
a chemical reaction (fast, intermediate, slow,...) and inhibition rules. Future
work needs for recognizing different types of steady states (e.g. find and handel
chaotic behavior), or even include time. These more open question need to be
addressed by the organization theory teams in the future. Finally, if you will
try our MSAC models for instance with organization theory, we see only two
organization, one for all species and one with very low number. It can give
1Stoichiometry Matrix: is the calculation of the quantities of reactants and products in
a chemical reaction.
2Flux: is the speed of a chemical reaction
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us qualitative behavior, or steady states. It is unable, yet, to reproduce any
quantitative results. Thus, we are not going to use organization theory in this
thesis.
A.3.2 Petri Nets
Petri nets (PNs) have been named after Carl Adam Petri who invented them early
sixties (Petri, 1962). It provides a graphical notation with a formal mathematical
semantics for modeling and reasoning about concurrent, asynchronous, distributed
systems. A Petri net is a directed bipartite graph and consists of four basic
components: places, which are denoted by circles; transitions denoted by rectangles;
arcs denoted by arrows; and tokens denoted by black dots. An example of a Petri
net for the template model is given in Figure A.2. The places, transitions and
arcs describe the static structure of the Petri net. Each transition has a number
of input places (places with an arc leading to the transition) and a number of
output places (places with an arc leading to them from the transition). It normally
views places as representing resources or conditions and transitions as representing
actions or events. Note arcs that directly connect two transitions or two places
are not allowed (Murata, 1989; Steggles et al., 2007).
Petri Nets of various different kinds have been used in several studies in systems
biology, both as structural network models for qualitative analyzes and as quanti-
tative models using high level nets (Pinney et al., 2003; Sackmann et al., 2006;
Chaouiya, 2007).
These discrete-qualitative methods have the advantage that they only require
information about the stoichiometry and reversibility of the constituent reactions,
rather than relying on the availability of measurements of kinetic parameters.
However, overcoming the combinatorial explosion associated with larger networks
is recognized as a difficult challenge for these new approaches to networks analyzes.
Since our aim and interest is on quantitative approaches and therefore, we are
not going to use PNs model. We show here an example of the template model
(Figure A.2), in such an example and so for our models and in general for
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O−Mad2
Mad1:C−Mad2
Mad1:C−Mad2:O−Mad2S Cdc20:C−Mad2
Cdc20
Place
Token
Transition
Arc
Legend
Figure A.2: Petri Net example: The Template model for Mad1 and Mad2 function
of sequestering Cdc20 (for details see Chapter 3). We use colored Petri Net, e.g.
red transition to emphasize the kinetochore effects (details in Chapter 3).
modelers, PNs is a good starting point to get an idea about the discrete dynamics
or what could be expected from a dynamical model. In the following section, rich
(continuous) dynamical modeling will be surveyed.
A.4 Time Dynamical Models
Understanding the dynamical behavior of a biological systems from the interaction
of its molecular species is a rather difficult task (Bryja et al., 2004). A model based
approach proposes a framework to express some hypotheses about a dynamical
system and make some predictions out of it, in order to compare with experimental
observations. Traditional approaches include differential equations (deterministic
models) or stochastic processes (stochastic models).
A.4.1 Deterministic versus Stochastic (Probabilistic) Models
The most widespread formalism to model dynamical systems in science and
engineering, ordinary differential equations (ODEs) have been widely used to
analyze biological systems. The ODE formalism models the concentrations of
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proteins, and other molecules by time-dependent variables with values contained
in the set of nonnegative real numbers. Regulatory interactions take the form of
functional and differential relations between the concentration variables.
Stochastic (or Probabilistic) modeling usually starts by describing real world
objects on different spatial and temporal scales and uses different advanced
mathematical approaches and techniques. It can be simple to reproduce the
deterministic behavior (e.g. ODEs), or to bring more detailed modeling (interacting
systems of individual agents or particles, random walks, random media).
Generally, stochastic kinetic models are more detailed. The disadvantage of a
stochastic kinetic analyzes is that it can be computationally expensive, making
such implementations impractical or impossible. A comparison between both
approaches is shown in Table A.2.
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Deterministic versus Stochastic models
- Deterministic approaches - Stochastic approaches
- Less complicated. - More complicated.
- Input determines unique output. - Produce different results for
the same input.
- Reproducible results/simulations. - Include random influences.
- Easy to analyze. - Rather difficult to analyze and
usually averaged results of interest.
- Often good enough and secure. - Could lead to a insecure sense.
- DEs methods require considerable - Common and easy to impliment.
mathematical skill and understanding
(not common among biologists).
- Hard to capture noise or any stochasticity. - Can be captured noise and stochasticity.
- In some cases, it can not (or hardly) - Can be always simulated.
simulated
- Required less knowledge. - Required more knowledge
- Computationally less expensive. - Computationally much more expensive.
...
...
Table A.2: Deterministic versus stochastic models: A comparison overview.
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A.4.2 Multi-Scale Models
Typically, the same system can be modeled on different scales, and it is of crucial
interest to study the interaction of different modeling approaches in systems
biology. Practitioners even describe different scales of biological models, which are
generally grouped into the three scaling categories: macroscopic1, mesoscopic2,
and microscopic3, (or concisely, as macro-, meso-, micro-, scales).
Figure A.3: Multi-scale modeling scheme in systems biology. Characterizing the
simulation time and length scales. starting from Macroscale and ended with
Molecular scale, where u is meter unit.
1The prefix “macro” comes from the Greek word, “mackros” that means long. Macroscopic
objects are those that can easily be seen by humans.
2The prefix “meso” comes from the Greek word “mesos” meaning “intermediate”.
3The prefix “Micro” comes from the Greek word “mikros” meaning small. In the everyday
world the word microscopic is used to refer to objects that are too small for the unaided eye to
see. People often think of bacteria or viruses when considering the microscopic world.
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Macroscopic. The term “Macroscopic” is used to describe the largest scale of
modeling. For example, dynamic of molecule concentrations mostly is represented
in deterministic models (differential equations).
Advantages and disadvantages at macroscopic scales:
- Macroscopic model fails in small-length-scale regions.
- Microscopic details are usually not included.
- Lot of calculations but fast (should be carefully handel, e.g. stiffness systems).
Microscopic. Microscopic simulation models on the other hand are at the op-
posite end of the spectrum which is mostly stochastic models (e.g. interacting
systems of individual agents or particles, random walks, random media).
Advantages and disadvantages at microscopic scales:
- Control over each component.
- Difficult implementation and tune.
- Most realistic.
Mesoscopic. Mesoscopic models fall between microscopic and macroscopic mod-
els. Dynamic of single molecules, without consideration of physical forces, mostly
stochastic models.
Advantages and disadvantages at mesoscopic scales:
- Micro scale components deployed in a macro scale scenario.
- Better interactions tuning.
- Attributes of molecules are not consider.
One can start with macroscopic level (usually differential equations), for an
overview of an essential continuous dynamics, then one moves to detailed micro-
scopic level, the analysis of their long-time or average behavior and large deviations
gives rise to models on the mesoscopic level. Analyzing these models on any level
is a necessary prerequisite for their practical use.
We should emphasize that properties of a stochastic model could lead to a different
behavior from that of a deterministic model for intracellular kinetics that initially
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involved a low number of reactants. The reason might be due to the assumption
of continuity of biochemical species in the deterministic model. In this thesis,
quantitative modeling approach will be used. Additionally, stochastic effects will
be examined.
A.5 Space Dynamical Models
Time dynamics can produce quantitative output for each time step. It can capture
behavior, intrinsic properties, like bifurcation analyzes, robustness, etc, and even
predict. Thus, it is widely used in systems biology. To keep going for deeper
understanding of topological ’environment’ (structure, diffusion, locations, binding
sides) There are two disadvantages of space dynamical models. First, they need
more kinetic knowledge, which are usually hard to get from the lab and not precise;
second, it is computationally very expensive (consume very long time).
Classic spatial approaches use PDEs or SPDEs, which are able to acquire macro-
scopic details of a system for each time point and anywhere. Stochastic simulations
(e.g. cellular automata, particles simulations) are used for capturing meso or
microscopic levels.
A.6 Methods
“An idea which can be used once is a trick. If it can be used more than once it
becomes a method.” George Polya and Gabor Szego
Broadly speaking, we can divided methods into two categories our modeling
approaches: Solvers (solving DEs mostly) and optimizations (parameters fitting).
For solving DEs different, we used different methods base on the DEs type.
For ODEs, to solve the nonlinear systems of highly stiff ODEs, which arise in
our optimization besides non stiff systems, a variety of computational approaches
have been applied. In particular, we use high order (seven-eighth) Runge-Kutta
(Fehlberg and Prince) formulas, a modified Rosenbrock formula, variable order
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Adams-Bashforth-Moulton, an explicit Runge-Kutta, backward differentiation
formulas, and an implicit Runge-Kutta formula. We switch between these methods
automatically according to the system’s stiffness state. We implemented our code
in MATLAB. The numerical results were also validated Octave’s (Eaton, 2008)
ODEs solver (LSODE solver) and Copasi (Mendes group at VBI and Kummer
group at EML research, 2008). For SDEs, the simulations were performed using
standard numerical techniques for stochastic differential equations (including the
strong implicit 1.5 order Runge-Kutta method, and the explicit Runge-Kutta
method of order 1.5, Kloeden and Platen, 1999b). We implemented our code
in (MATLAB , Matrix Labrotory) and/or Octave (Eaton, 2008). For PDEs
in general use of Finite Element Methods (see tools example, COMSOL, 2008
and VCell, 2008).
Optimization methods for the estimation of unknown parameters are central
and of great importance to this field of research. For this task, evolutionary
approaches as well as deterministic algorithms have been applied to infer parame-
ters in biochemical models. The nonlinear evolutionary optimization was usually
validated with an independent evolutionary optimizer (Ibrahim et al., 2007). For
optimization we applied the covariance matrix adaptation nonlinear evolutionary
strategy (CMA-ES) (Hansen and Kern, 2004; Hansen et al., 2003), Quasi-Newton
and sequential quadratic programming. We validate with Differential Evolution
(DE) Storn and Price (1997). We encountered with problems in case of large
search space. We demonstrate that parameter estimation can be efficiently and
more accurately performed using scaled search steps (Rohn et al., 2008).
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Appendix B
Template-like models
“Examples...show how difficult it often is for an
experimenter to interpret his results without
the aid of mathematics”. Lord Rayleigh (1842 - 1919)
(Nobel Prize Laureate in Physics 1904)
“The great tragedy of Science the slaying of a beautiful
hypothesis by an ugly fact”. Thomas H. Huxley (1725-95)
B.1 ODEs of the Exchange model
d[Mad1]
dt
=−αE .u[Mad1][O-Mad2] + k−2[Mad1:C-Mad2] +
k3[Mad1:C-Mad2]− k−3[C-Mad2][Mad1] (B.1)
d[O-Mad2]
dt
=−k1[O-Mad2] + k−1[C-Mad2]−αE .u[Mad1][O-Mad2] + k−2[Mad1:C-Mad2] +
ηE [Cdc20:C-Mad2] (B.2)
d[Mad1:C-Mad2]
dt
=αE .u[Mad1][O-Mad2]− k−2[Mad1:C-Mad2]− k3[Mad1:C-Mad2] +
k−3[C-Mad2][Mad1] (B.3)
d[C-Mad2]
dt
= k1[O-Mad2]− k−1[C-Mad2] + k3[Mad1:C-Mad2]− k−3[C-Mad2][Mad1]−
kE [C-Mad2][Cdc20] (B.4)
d[Cdc20]
dt
=−kE [C-Mad2][Cdc20] + ηE [Cdc20:C-Mad2] (B.5)
d[Cdc20:C-Mad2]
dt
= kE [C-Mad2][Cdc20]− ηE [Cdc20:C-Mad2] (B.6)
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B.2 ODEs of the Template model
d[Mad1:C-Mad2]
dt
=−αT .u[Mad1:C-Mad2][O-Mad2] + βT [Mad1:C-Mad2:O-Mad2∗] +
γT .u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (B.7)
d[O-Mad2]
dt
= −αT .u[Mad1:C-Mad2][O-Mad2] + βT [Mad1:C-Mad2:O-Mad2∗] +
ηT [Cdc20:C-Mad2] (B.8)
d[Mad1:C-Mad2:O-Mad2∗]
dt
=αT .u[Mad1:C-Mad2][O-Mad2]− βT [Mad1:C-Mad2:O-Mad2∗]−
γT .u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (B.9)
d[Cdc20]
dt
=−γT .u[Mad1:C-Mad2:O-Mad2∗][Cdc20] + ηT [Cdc20:C-Mad2] (B.10)
d[Cdc20:C-Mad2]
dt
= γT .u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]− ηT [Cdc20:C-Mad2] (B.11)
B.3 ODEs of the Template model with the Ampli-
fication effects
d[Mad1:C-Mad2]
dt
=−αT .u[Mad1:C-Mad2][O-Mad2] + βT [Mad1:C-Mad2:O-Mad2∗] +
γT .u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]−
k4[Cdc20:C-Mad2][O-Mad2] + k−4[Cdc20:C-Mad2:O-Mad2∗] (B.12)
d[O-Mad2]
dt
=−αT .u[Mad1:C-Mad2][O-Mad2] + βT [Mad1:C-Mad2:O-Mad2∗] +
ηT [Cdc20:C-Mad2]− k4[Cdc20:C-Mad2][O-Mad2] +
k−4[Cdc20:C-Mad2:O-Mad2∗] (B.13)
d[Mad1:C-Mad2:O-Mad2∗]
dt
=αT .u[Mad1:C-Mad2][O-Mad2]− βT [Mad1:C-Mad2:O-Mad2∗]−
γT .u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (B.14)
d[Cdc20:C-Mad2:O-Mad2∗]
dt
= k4[Cdc20:C-Mad2][O-Mad2]− k−4[Cdc20:C-Mad2:O-Mad2∗]−
k5[Cdc20:C-Mad2:O-Mad2
∗][Cdc20] (B.15)
d[Cdc20]
dt
=−γT .u[Mad1:C-Mad2:O-Mad2∗][Cdc20] + ηT [Cdc20:C-Mad2]−
k5[Cdc20:C-Mad2:O-Mad2
∗][Cdc20] (B.16)
d[Cdc20:C-Mad2]
dt
= γT .u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]− ηT [Cdc20:C-Mad2]−
k4[Cdc20:C-Mad2][O-Mad2] + k−4[Cdc20:C-Mad2:O-Mad2∗] +
2k5[Cdc20:C-Mad2:O-Mad2
∗][Cdc20] (B.17)
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B.4 ODEs of of p31 effects on the Template model
d[Mad1:C-Mad2]
dt
=−αT .u[Mad1:C-Mad2][O-Mad2] + βT [Mad1:C-Mad2:O-Mad2∗] +
γT .u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]
−δT .v[Mad1:C-Mad2][p31] + ζT [Mad1:C-Mad2:p31] (B.18)
d[O-Mad2]
dt
=−αT .u[Mad1:C-Mad2][O-Mad2] + βT [Mad1:C-Mad2:O-Mad2∗] +
ηT [Cdc20:C-Mad2] (B.19)
d[Mad1:C-Mad2:O-Mad2∗]
dt
=αT .u[Mad1:C-Mad2][O-Mad2]− βT [Mad1:C-Mad2:O-Mad2∗]−
γT .u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (B.20)
d[Cdc20]
dt
=−γT .u[Mad1:C-Mad2:O-Mad2∗][Cdc20] + ηT [Cdc20:C-Mad2] (B.21)
d[Cdc20:C-Mad2]
dt
= γT .u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]− ηT [Cdc20:C-Mad2] (B.22)
d[p31]
dt
=−δT .v[Mad1:C-Mad2][p31] + ζT [Mad1:C-Mad2:p31] (B.23)
d[Mad1:C-Mad2:p31]
dt
= δT .v[Mad1:C-Mad2][p31]− ζT [Mad1:C-Mad2:p31] (B.24)
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B.5 ODEs of of p31 effects on the Template model
with amplification
d[Mad1:C-Mad2]
dt
=−αT .u[Mad1:C-Mad2][O-Mad2] + βT [Mad1:C-Mad2:O-Mad2∗] +
γT .u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]−
k4[Cdc20:C-Mad2][O-Mad2] + k−4[Cdc20:C-Mad2:O-Mad2∗]−
δT .v[Mad1:C-Mad2][p31] + ζT [Mad1:C-Mad2:p31] (B.25)
d[O-Mad2]
dt
=−αT .u[Mad1:C-Mad2][O-Mad2] + βT [Mad1:C-Mad2:O-Mad2∗] +
ηT [Cdc20:C-Mad2]− k4[Cdc20:C-Mad2][O-Mad2] +
k−4[Cdc20:C-Mad2:O-Mad2∗] (B.26)
d[Mad1:C-Mad2:O-Mad2∗]
dt
=αT .u[Mad1:C-Mad2][O-Mad2]− βT [Mad1:C-Mad2:O-Mad2∗]−
γT .u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (B.27)
d[Cdc20:C-Mad2:O-Mad2∗]
dt
= k4[Cdc20:C-Mad2][O-Mad2]− k−4[Cdc20:C-Mad2:O-Mad2∗]−
k5[Cdc20:C-Mad2:O-Mad2
∗][Cdc20] (B.28)
d[Cdc20]
dt
=−γT .u[Mad1:C-Mad2:O-Mad2∗][Cdc20] + ηT [Cdc20:C-Mad2]−
k5[Cdc20:C-Mad2:O-Mad2
∗][Cdc20] (B.29)
d[Cdc20:C-Mad2]
dt
= γT .u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]− ηT [Cdc20:C-Mad2]−
k4[Cdc20:C-Mad2][O-Mad2] + k−4[Cdc20:C-Mad2:O-Mad2∗] +
2k5[Cdc20:C-Mad2:O-Mad2
∗][Cdc20]−
ξT .v[Cdc20:C-Mad2][p31] + σT [Cdc20:C-Mad2:p31] (B.30)
d[p31]
dt
=−δT .v[Mad1:C-Mad2][p31] + ζT [Mad1:C-Mad2:p31]−
ξT .v[Cdc20:C-Mad2][p31] + σT [Cdc20:C-Mad2:p31] (B.31)
d[Mad1:C-Mad2:p31]
dt
= δT .v[Mad1:C-Mad2][p31]− ζT [Mad1:C-Mad2:p31] (B.32)
d[Cdc20:C-Mad2:p31]
dt
= ξT .v[Cdc20:C-Mad2][p31]− σT [Cdc20:C-Mad2:p31] (B.33)
B.6 Materials, Methods, and Optimization
The objective function f(P ) assigns a quality (i.e., a positive real number) to a
given set of parameters P . In our case, the parameters are the reaction constants.
In order to fit the parameters with respect to the observed qualitative function of
the MSAC control, we use the Cdc20 concentration before and after kinetochore
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attachment as a criterion. In each single simulation experiment, we simulate two
phases of the spindle attachment status. Our simulation begins in the kinetochore
unattached case (phase 1), until equilibrium is reached, then it continues in the
attached state (phase 2), again, until steady state conditions are met. We measure
the Cdc20 concentration at the end of each phase i, when all concentrations have
reached steady state, and compare it with a user given value Ai, which describes the
experimentally observed behavior. The two difference values are combined linearly:
f(P ) = W1([Cdc20]Unattached − A1)2 +W2([Cdc20]Attached − A2)2
where W1, and W2 are the weights which were 10, and 1 respectively. A1, and A2
are the desired phase levels, which we set 0 and 0.01, respectively.
For optimization we applied the covariance matrix adaptation nonlinear evolu-
tion strategy (CMA-ES) Hansen and Kern (2004), Quasi-Newton and sequential
quadratic programming. To solve the nonlinear systems of highly stiff ODEs, which
arise in our optimization besides non stiff systems, a variety of computational
approaches have been applied. In particular, we use high order (seven-eighth)
Runge-Kutta (Fehlberg and Prince) formulas, a modified Rosenbrock formula,
variable order Adams-Bashforth-Moulton, an explicit Runge-Kutta, backward
differentiation formulas, and an implicit Runge-Kutta formula. We switch be-
tween these methods automatically according to the system’s stiffness state. We
implemented our code in MATLAB. The numerical results were also validated
with Copasi. The nonlinear evolutionary optimization was validated with an
independent evolutionary optimizer.
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Appendix C
MCC formation models
“As far as the laws of mathematics refer to reality,
they are not certain; and as far as they are certain,
they do not refer to reality”. Albert Einstein (1779 - 1955)
“If you don’t fail regularly you are not trying hard enough
things”. Ivan Sutherland (1938-)
C.1 MCC “kinetochore dependent model”
d[Mad1:C-Mad2]
dt
=−k1.u[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (C.1)
d[O-Mad2]
dt
=−k1.u[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k3[Cdc20:C-Mad2]− k6[Cdc20][O-Mad2] (C.2)
d[Mad1:C-Mad2:O-Mad2∗]
dt
= k1.u[Mad1:C-Mad2][O-Mad2]− k−1[Mad1:C-Mad2:O-Mad2∗]−
k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (C.3)
d[Cdc20]
dt
=−k2.u[Mad1:C-Mad2:O-Mad2∗][Cdc20] + k3[Cdc20:C-Mad2]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20]−
k6[Cdc20][O-Mad2] (C.4)
d[Cdc20:C-Mad2]
dt
= k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]− k3[Cdc20:C-Mad2]−
k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC] + k6[Cdc20][O-Mad2](C.5)
d[Bub3:BubR1]
dt
=−k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20] (C.6)
d[MCC]
dt
= +k4.u[Cdc20:C-Mad2][Bub3:BubR1]− k−4[MCC] (C.7)
d[Bub3:BubR1:Cdc20]
dt
= k5.u[Cdc20][Bub3:BubR1]− k−5[Bub3:BubR1:Cdc20] (C.8)
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C.2 Amplification effects
d[Mad1:C-Mad2]
dt
=−k1.u[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (C.9)
d[O-Mad2]
dt
= −k1.u[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k3[Cdc20:C-Mad2]− k6[Cdc20][O-Mad2]−
k7[Cdc20:C-Mad2][O-Mad2] + k−7[Cdc20:C-Mad2:O-Mad2∗] (C.10)
d[Mad1:C-Mad2:O-Mad2∗]
dt
= k1.u[Mad1:C-Mad2][O-Mad2]− k−1[Mad1:C-Mad2:O-Mad2∗]−
k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (C.11)
d[Cdc20]
dt
=−k2.u[Mad1:C-Mad2:O-Mad2∗][Cdc20] + k3[Cdc20:C-Mad2]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20]− k6[Cdc20][O-Mad2]
−k8[Cdc20:C-Mad2:O-Mad2∗][Cdc20] (C.12)
d[Cdc20:C-Mad2]
dt
= k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]− k3[Cdc20:C-Mad2]−
k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC] + k6[Cdc20][O-Mad2]−
k7[Cdc20:C-Mad2][O-Mad2] + k−7[Cdc20:C-Mad2:O-Mad2∗] +
2k8[Cdc20:C-Mad2:O-Mad2
∗][Cdc20] (C.13)
d[Bub3:BubR1]
dt
=−k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20] (C.14)
d[MCC]
dt
= +k4.u[Cdc20:C-Mad2][Bub3:BubR1]− k−4[MCC] (C.15)
d[Bub3:BubR1:Cdc20]
dt
= k5.u[Cdc20][Bub3:BubR1]− k−5[Bub3:BubR1:Cdc20] (C.16)
d[Cdc20:C-Mad2:O-Mad2∗]
dt
= +k7[Cdc20:C-Mad2][O-Mad2]− k−7[Cdc20:C-Mad2:O-Mad2∗]−
k8[Cdc20:C-Mad2:O-Mad2
∗][Cdc20] (C.17)
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C.3 p31comet contribution
d[Mad1:C-Mad2]
dt
=−k1[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k2[Mad1:C-Mad2:O-Mad2
∗][Cdc20]−k7p.v[Mad1:C-Mad2][p31comet ] +
k−7p[Mad1:C-Mad2:p31comet ] (C.18)
d[O-Mad2]
dt
=−k1[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k3[Cdc20:C-Mad2]− k6[Cdc20][O-Mad2] (C.19)
d[Mad1:C-Mad2:O-Mad2∗]
dt
= k1[Mad1:C-Mad2][O-Mad2]− k−1[Mad1:C-Mad2:O-Mad2∗]−
k2[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (C.20)
d[Cdc20]
dt
=−k2[Mad1:C-Mad2:O-Mad2∗][Cdc20] + k3[Cdc20:C-Mad2]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20]− k6[Cdc20][O-Mad2](C. 1)
d[Cdc20:C-Mad2]
dt
= k2[Mad1:C-Mad2:O-Mad2
∗][Cdc20]− k3[Cdc20:C-Mad2]−
k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC] + k6[Cdc20][O-Mad2]−
k8p.v[Cdc20:C-Mad2][p31
comet ] + k−8p[Cdc20:C-Mad2:p31comet ] (C.22)
d[Bub3:BubR1]
dt
=−k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20] (C.23)
d[MCC]
dt
= +k4.u[Cdc20:C-Mad2][Bub3:BubR1]− k−4[MCC] (C.24)
d[Bub3:BubR1:Cdc20]
dt
= k5.u[Cdc20][Bub3:BubR1]− k−5[Bub3:BubR1:Cdc20] (C.25)
d[p31comet ]
dt
=−k7p.v[Mad1:C-Mad2][p31comet ] + k−7p[Mad1:C-Mad2:p31comet ]−
k8p.v[Cdc20:C-Mad2][p31
comet ] + k−8p[Cdc20:C-Mad2:p31comet ] (C.26)
d[Mad1:C-Mad2:p31comet ]
dt
= k7p.v[Mad1:C-Mad2][p31
comet ]− k−7p[Mad1:C-Mad2:p31comet ] (C.27)
d[Cdc20:C-Mad2:p31comet ]
dt
= k8p.v[Cdc20:C-Mad2][p31
comet ]− k−8p[Cdc20:C-Mad2:p31comet ] (C.28)
C.4 Fitness function
Same as in Appendix B.6.
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Appendix D
The Dissociation and the Convey
Model
“The great aim of education is not knowledge but action”.
Herbert Spencer (1820 - 1903)
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D.1 ODEs of the MSAC model Dissociation variant
 First (uncontrolled) case: u′= 1
 Second (controlled) case: u′= 1−u
where u = 1 for unattached kinetochore and u = 0 at the attached kinetochore.
d[Mad1:C-Mad2]
dt
=−k1.u[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (D.1)
d[O-Mad2]
dt
=−k1.u[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k3[Cdc20:C-Mad2]− k6[Cdc20][O-Mad2] (D.2)
d[Mad1:C-Mad2:O-Mad2∗]
dt
= k1.u[Mad1:C-Mad2][O-Mad2]− k−1[Mad1:C-Mad2:O-Mad2∗]−
k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (D.3)
d[Cdc20]
dt
=−k2.u[Mad1:C-Mad2:O-Mad2∗][Cdc20] + k3[Cdc20:C-Mad2]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20]− k6[Cdc20][O-Mad2]−
k8[APC][Cdc20] + k−8[APC:Cdc20] (D.4)
d[Cdc20:C-Mad2]
dt
= k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]− k3[Cdc20:C-Mad2]−
k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC] + k6[Cdc20][O-Mad2] (D.5)
d[Bub3:BubR1]
dt
=−k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20] (D.6)
d[MCC]
dt
= +k4.u[Cdc20:C-Mad2][Bub3:BubR1]− k−4[MCC]−
k7.u[MCC][APC] + k−7.u′[MCC:APC] (D.7)
d[Bub3:BubR1:Cdc20]
dt
= k5.u[Cdc20][Bub3:BubR1]− k−5[Bub3:BubR1:Cdc20] (D.8)
d[APC]
dt
=−k7.u[MCC][APC] + k−7.u′[MCC:APC]− k8[APC][Cdc20] +
k−8[APC:Cdc20] (D.9)
d[MCC:APC]
dt
= +k7.u[MCC][APC]− k−7.u′[MCC:APC] (D.10)
d[APC:Cdc20]
dt
= +k8[APC][Cdc20]− k−8[APC:Cdc20] (D.11)
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D.2 ODEs of the MSAC model Convey variant
 First (uncontrolled) case: u′= 1
 Second (controlled) case: u′= 1−u
where u = 1 for unattached kinetochore and u = 0 at the attached kinetochore.
d[Mad1:C-Mad2]
dt
=−k1.u[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (D.12)
d[O-Mad2]
dt
=−k1.u[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k3[Cdc20:C-Mad2]− k6[Cdc20][O-Mad2] + k−7.u′[MCC:APC] (D.13)
d[Mad1:C-Mad2:O-Mad2∗]
dt
= k1.u[Mad1:C-Mad2][O-Mad2]− k−1[Mad1:C-Mad2:O-Mad2∗]−
k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (D.14)
d[Cdc20]
dt
=−k2.u[Mad1:C-Mad2:O-Mad2∗][Cdc20] + k3[Cdc20:C-Mad2]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20]− k6[Cdc20][O-Mad2]−
k8[APC][Cdc20] + k−8[APC:Cdc20] (D.15)
d[Cdc20:C-Mad2]
dt
= k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]− k3[Cdc20:C-Mad2]−
k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC] + k6[Cdc20][O-Mad2] (D.16)
d[Bub3:BubR1]
dt
=−k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20] +
k−7.u′[MCC:APC] (D.17)
d[MCC]
dt
= +k4.u[Cdc20:C-Mad2][Bub3:BubR1]− k−4[MCC]−
k7.u[MCC][APC] (D.18)
d[Bub3:BubR1:Cdc20]
dt
= k5.u[Cdc20][Bub3:BubR1]− k−5[Bub3:BubR1:Cdc20] (D.19)
d[APC]
dt
=−k7.u[MCC][APC]− k8[APC][Cdc20] + k−8[APC:Cdc20] (D.20)
d[MCC:APC]
dt
= +k7.u[MCC][APC]− k−7.u′[MCC:APC] (D.21)
d[APC:Cdc20]
dt
= +k8[APC][Cdc20]− k−8[APC:Cdc20] + k−7.u′[MCC:APC] (D.22)
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D.3 Optimization
The objective function f(P ) assigns a quality (i.e., a positive real number, P=(k7,
k−7,k8, k−8)T) to a given set of parameters P . In our case, the parameters
are the reaction constants. In order to fit the parameters with respect to the
observed qualitative function of the MSAC control, we use the APC:Cdc20
concentration before and after kinetochore attachment as a criterion. In each
single simulation experiment, we simulate two phases of the spindle attachment
status. Our simulation begins in the kinetochore unattached case (phase 1),
until equilibrium is reached, then it continues in the attached state (phase
2), again, until steady state conditions are met. We measure the APC:Cdc20
concentration at the end of each phase i, when all concentrations have reached
steady state, and compare it with a user given value Ai, which describes the
experimentally observed behavior. The two difference values are combined linearly:
f(P ) = W1(
5∑
i=1
[APC:Cdc20]i,Unattached − A1,i)2 +W2(
5∑
i=1
[APC:Cdc20]i,Attached −
A2,i)
2
where W1, and W2 are the weights which were 10, and 1 respectively. A1, and A2
are the desired phase levels for 5 different point at the beginning, and at the end
of each phase ( we set A1, i = 0, 0, 0, 0, 0 and A2, i = 0.001, 0.005, 0.01, 0.01, 0.01
respectively).
For optimization Techniques and ODEs solvers see Appendix B.
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Appendix E
The Integrative Model of MSAC and
EFM Mechanisms
“Gravitation cannot be held responsible for people falling in love.
How on earth can you explain in terms of chemistry and physics
so important a biological phenomenon as first love? Put your hand
on a stove for a minute and it seems like an hour. Sit with that
special girl for an hour and it seems like a minute. That’s relativity”.
Albert Einstein (1879 - 1955)
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E. THE INTEGRATIVE MODEL OF MSAC AND EFM
MECHANISMS
E.1 ODEs of the integrative model of MSAC (Dissociation
variant) and EFM
d[Mad1:C-Mad2]
dt
=−k1.u[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (E.1)
d[O-Mad2]
dt
=−k1.u[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k3[Cdc20:C-Mad2]− k6[Cdc20][O-Mad2] (E.2)
d[Mad1:C-Mad2:O-Mad2∗]
dt
= k1.u[Mad1:C-Mad2][O-Mad2]− k−1[Mad1:C-Mad2:O-Mad2∗]−
k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (E.3)
d[Cdc20]
dt
=−k2.u[Mad1:C-Mad2:O-Mad2∗][Cdc20] + k3[Cdc20:C-Mad2]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20]− k6[Cdc20][O-Mad2]−
k8[APC][Cdc20] + k−8[APC:Cdc20] (E.4)
d[Cdc20:C-Mad2]
dt
= k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]− k3[Cdc20:C-Mad2]−
k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC] + k6[Cdc20][O-Mad2] (E.5)
d[Bub3:BubR1]
dt
=−k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20] (E.6)
d[MCC]
dt
= +k4.u[Cdc20:C-Mad2][Bub3:BubR1]− k−4[MCC]−
k7.u[MCC][APC] + k−7.u′[MCC:APC] (E.7)
d[Bub3:BubR1:Cdc20]
dt
= k5.u[Cdc20][Bub3:BubR1]− k−5[Bub3:BubR1:Cdc20] (E.8)
d[APC]
dt
=−k7.u[MCC][APC] + k−7.u′[MCC:APC]− k8[APC][Cdc20] +
k−8[APC:Cdc20] (E.9)
d[MCC:APC]
dt
= +k7.u[MCC][APC]− k−7.u′[MCC:APC] (E.10)
d[APC:Cdc20]
dt
= +k8[APC][Cdc20]− k−8[APC:Cdc20]+k14[APC:Cdc20][Cdh1] (E.11)
d[APC:Cdh1]
dt
= +k14[APC:Cdc20][Cdh1] (E.12)
d[Cdh1]
dt
=−k14[APC:Cdh1][Cdh1]−k13[Cyclin B] [Cdh1]
k13M + [Cdh1]
+k−13[Cdc14A*]
[Cdh1P]
k-13M + [Cdh1
P]
(E.13)
d[Cdh1]P
dt
= +k13[Cyclin B]
[Cdh1]
k13M + [Cdh1]
−k−13[Cdc14A*] [Cdh1
P]
k-13M + [Cdh1
P]
(E.14)
d[Separase:Securin]
dt
=−k9[APC:Cdc20][Separase:Securin] (E.15)
d[Separase]
dt
= +k9[APC:Cdc20][Separase:Securin] (E.16)
d[Cyclin B]
dt
= +k11−k10[APC:Cdc20][Cyclin B]−k15[APC:Cdh1][Cyclin B] (E.17)
d[Cdc14A]
dt
= +k12[Cdc14A*]−k−12[Separase] [Cdc14A]
k-12M + [Cdc14A]
(E.18)
d[Cdc14A*]
dt
=−k12[Cdc14A*]+k−12[Separase] [Cdc14A]
k-12M + [Cdc14A]
(E.19)
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E.2 ODEs of the integrative model of MSAC ( Con-
vey variant ) and EFM
d[Mad1:C-Mad2]
dt
=−k1.u[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (E.20)
d[O-Mad2]
dt
=−k1.u[Mad1:C-Mad2][O-Mad2] + k−1[Mad1:C-Mad2:O-Mad2∗] +
k3[Cdc20:C-Mad2]− k6[Cdc20][O-Mad2] + k−7.u′[MCC:APC] (E.21)
d[Mad1:C-Mad2:O-Mad2∗]
dt
= k1.u[Mad1:C-Mad2][O-Mad2]− k−1[Mad1:C-Mad2:O-Mad2∗]−
k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20] (E.22)
d[Cdc20]
dt
=−k2.u[Mad1:C-Mad2:O-Mad2∗][Cdc20] + k3[Cdc20:C-Mad2]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20]− k6[Cdc20][O-Mad2]−
k8[APC][Cdc20] + k−8[APC:Cdc20] (E.23)
d[Cdc20:C-Mad2]
dt
= k2.u[Mad1:C-Mad2:O-Mad2
∗][Cdc20]− k3[Cdc20:C-Mad2]−
k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC] + k6[Cdc20][O-Mad2] (E.24)
d[Bub3:BubR1]
dt
=−k4.u[Cdc20:C-Mad2][Bub3:BubR1] + k−4[MCC]−
k5.u[Cdc20][Bub3:BubR1] + k−5[Bub3:BubR1:Cdc20] +
k−7.u′[MCC:APC] (E.25)
d[MCC]
dt
= +k4.u[Cdc20:C-Mad2][Bub3:BubR1]− k−4[MCC]−
k7.u[MCC][APC] (E.26)
d[Bub3:BubR1:Cdc20]
dt
= k5.u[Cdc20][Bub3:BubR1]− k−5[Bub3:BubR1:Cdc20] (E.27)
d[APC]
dt
=−k7.u[MCC][APC]− k8[APC][Cdc20] + k−8[APC:Cdc20] (E.28)
d[MCC:APC]
dt
= +k7.u[MCC][APC]− k−7.u′[MCC:APC] (E.29)
d[APC:Cdc20]
dt
= +k8[APC][Cdc20]− k−8[APC:Cdc20] + k−7.u′[MCC:APC]−k14[APC:Cdc20][Cdh1](E.30)
d[APC:Cdh1]
dt
= +k14[APC:Cdc20][Cdh1] (E.31)
d[Cdh1]
dt
=−k14[APC:Cdh1][Cdh1]−k13[Cyclin B] [Cdh1]
k13M + [Cdh1]
+k−13[Cdc14A*]
[Cdh1P]
k-13M + [Cdh1
P]
(E.32)
d[Cdh1]P
dt
= +k13[Cyclin B]
[Cdh1]
k13M + [Cdh1]
−k−13[Cdc14A*] [Cdh1
P]
k-13M + [Cdh1
P]
(E.33)
d[Separase:Securin]
dt
=−k9[APC:Cdc20][Separase:Securin] (E.34)
d[Separase]
dt
= +k9[APC:Cdc20][Separase:Securin] (E.35)
d[Cyclin B]
dt
= +k11−k10[APC:Cdc20][Cyclin B]−k15[APC:Cdh1][Cyclin B] (E.36)
d[Cdc14A]
dt
= +k12[Cdc14A*]−k−12[Separase] [Cdc14A]
k-12M + [Cdc14A]
(E.37)
d[Cdc14A*]
dt
=−k12[Cdc14A*]+k−12[Separase] [Cdc14A]
k-12M + [Cdc14A]
(E.38)
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